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Abstract
Obesity in the Western world is on the rise. Both epidemiological studies and experimental
studies in model organisms have demonstrated that offspring born to obese mothers are at a
greater risk of developing obesity than those born to normal weight mothers. While obesity
is usually thought of as a disease of the periphery, body weight is ultimately regulated by the
brain, and therefore dysregulation of the neural circuitry controlling bodyweight represents
one way in which an individual might become predisposed to obesity. The hypothalamus is a
key area of the brain involved in the synthesis of and response to neural, endocrine, and nutri-
tional signals concerning body weight. Interestingly, the ability of body weight regulating
Neuropeptide Y (NPY) neurons in the arcuate nucleus of the hypothalamus to innervate their
targets appropriately is disrupted in the offspring of obese mothers. The mechanisms behind
this are unknown. However, it has recently emerged that maternal obesity is associated with
increases in certain inflammatory cytokines, including interleukin-6 (IL-6), in both the mater-
nal and fetal circulation. This led to the hypothesis that activation of the maternal immune
system during pregnancy affects the expression of important developmental molecules in
the fetal arcuate nucleus. This in turn impairs the way arcuate neurons develop axons and
establish connections, thus disturbing their ability to communicate with other important
weight regulatory regions of the brain, and ultimately leading to obesity predisposition.
To in investigate this hypothesis, firstly, the normal development of NPY neuron projec-
tions to their target regions in the prenatal mouse brain was determined. I found that NPY
neuron axons were already leaving the arcuate nucleus at gestational day (GD) 15, and first
began to innervate one of their target regions, the paraventricular nucleus (PVN), at GD17.
The initial formation of this circuitry in the prenatal period indicates that these projections
may be acting as pioneers, forming a scaffold which later follower axons can elaborate upon
in the postnatal period. The role of the axon growth modulator Netrin-1 in the development
of these prenatal projections was then investigated. Using in situ hybridisation, I have shown
that in late gestation Netrin-1 was expressed in a spatial and temporal pattern consistent with
an involvement in the growth of NPY neuron axons to their targets. Additionally using a
primary neuron culture model it was found NPY neurons respond to Netrin-1 treatment by
increased elaboration of their growth cones when compared to controls. This data represents
the first time a growth factor critical in the prenatal development of NPY circuitry has been
identified and studied.
Secondly, both in vitro and in vivo methods were used to investigate the effects of mater-
nal obesity on NPY neuron development. Acute exposure of fetal mouse arcuate nucleus
explants to IL-6 in vitro induced gene expression changes in the Netrin-1 receptor Dcc
which were similar to those found in vivo using a mouse model of maternal obesity. In
addition, IL-6 treatment of fetal NPY neurons in primary culture appeared to block the
normal growth cone response to Netrin-1. This suggests that during maternal obesity the
developing fetus is exposed to aberrant levels of IL-6, which may act extrinsically to dis-
rupt Netrin-1 signalling, and therefore perturb the correct formation of prenatal NPY circuitry.
Lastly, the ability of an environment of maternal obesity to alter the intrinsic capacity
of NPY neurons to develop normally was assessed. Fetal NPY neurons which had been
exposed in vivo to maternal obesity were more immature in culture then those from control
pregnancies, and had a blunted growth cone response to Netrin-1. These data suggest that
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exposure to maternal obesity results in intrinsic changes in NPY neurons which alter the way
they develop and respond to growth cues in their local environment.
Overall, the data presented in this thesis are supportive of a mechanism by which NPY
neurons exposed to maternal obesity are firstly hit with intrinsic changes, mediated by factors
in the maternal environment, which slow their maturation, and alter their later responsiveness
to Netrin-1. A second extrinsic hit mediated by IL-6 occurs later in development and further
alters growth cone responsiveness to Netrin-1. The sum of these changes could lead to the
dysregulation of pioneer NPY axon growth resulting in incorrect formation of the prenatal
scaffolding of this circuitry. This work significantly contributes an improved understanding
of the molecular mechanisms which underpin the process by which maternal obesity can
elevate offspring risk of obesity. Greater understanding of these mechanisms will contribute
to improved human health by creating a research-informed basis for human pregnancy health
guidelines to reduce the risk of childhood obesity.
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1.1 Obesity and the metabolic syndrome
Obesity is one of the biggest health problems facing the Western world today and has in-
creased to epidemic levels [7, 210]. As well as being debilitating in and of itself, it often
leads to the development of the metabolic syndrome, an umbrella term which describes the
collection of co-morbidities often associated with obesity. These include hyperglycemia,
hypercholesterolemia and hypertension which in turn lead to significantly increased risks
of type 2 diabetes, cardiovascular disease and stroke [52, 106, 132, 143, 151, 157, 303].
Consequently obesity places considerable economic burden on the healthcare system with
the US spending an estimated $75 billion in 2003 in extra costs associated with obesity, and
the UK projecting that by 2050 £5.5 billion will be spent on obesity related problems by
the National Health Service if obesity rates continue to rise [82, 306]. Additionally there is
the human cost associated with this epidemic: in 2010 3.4 million deaths worldwide were
attributed to obesity - a 70% increase from 1990 estimates, as well as other studies suggesting
increased illness-related absences from work, and increased risk of early retirement and
subsequent unemployment or reliance on disability pensions [128, 173, 249].
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Of even greater concern is the rapid rise in childhood obesity seen within the last few
decades, and the resulting increase of co-morbidities such as childhood type 2 diabetes,
early puberty and hypertension [151]. Also on the rise are obesity related psychosocial
stresses, for example poor self image, social isolation and behavioral problems [26, 151].
New Zealand has not escaped this epidemic, with 1 in 10 children aged 5 to 14 years old
considered obese, and a further 20% overweight [292]. The picture is even poorer for Pacific
Island communities where up to 45% of 2 to 5 year olds may be obese [101]. The reasons
behind this epidemic are often thought of as similar to that of adult obesity: too much energy
intake and not enough expenditure [64]. There is no doubt that since the rates of childhood
obesity began rising in the 1980s, children are being raised in an increasing more obesogenic
environment with the rise of fast food, sugar rich soft drinks, and a more sedentary lifestyle
including television and video games [5]. Several studies have focused on linking a lack of
activity in childhood with levels of obesity, others have gone further to attempt to make this
link with levels of television viewing [19, 115, 154, 156]. However, over the last couple of
decades evidence has mounted to suggest that often childhood obesity may be underpinned
by changes that occur much earlier in development.
1.2 Prenatal origins of obesity
Throughout an individual’s life there are many times in which the environment’s interaction
with their genome plays a role in their development, as well as their later life health and
disease risk. Perhaps the most important time is at the very beginning of life. The interactions
between the fetus and the maternal environment it is exposed to in utero coincide with a
critical period of growth and development, so it has long been acknowledged that adverse
life events experienced by a pregnant woman can have major effects on the fetus and that
individual’s health in later life. The classic example focuses on pregnancies during the Dutch
famine of 1944-1945. This famine provides a unique opportunity for epidemiological study
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because (a) it occurred over a short period (5-6 months) enabling researchers to study the
effects of prenatal famine exposure in isolation, and (b) the Dutch were a well nourished
population both pre- and post-famine, reducing the confounding effects of famine exposure
both preconception and postnatally [253, 254]. Researchers found that in adulthood, individ-
uals who had been exposed to the famine in utero had a higher incidence of cardiovascular
disease, obesity and glucose intolerance than individuals born the year before or after the
famine [241, 243, 252]. These studies have also found that there are critical windows during
gestation in which a fetus is most at risk of having their development perturbed by an en-
vironmental insult. For example individuals exposed to famine during early gestation had
the highest risk of cardiovascular disease and obesity, where as those exposed during mid
or late gestation were more at risk of glucose intolerance [241, 242, 252]. Further studies
looking at another incidence of maternal under-nutrition - the Chinese famine (1959-1961)
have found similar increases in risk for components of the metabolic syndrome, including
obesity, hypertension and glucose intolerance, in individuals exposed prenatally to the famine
[168–170]. These studies also make the observation that the obesity phenotype was worsened
when the famine exposed offspring were introduced to a fat and sugar rich western diet in
adulthood [168–170].
Although a lot of attention has been placed on the effects of maternal under nutrition
on a developing fetus, this scenario is probably not entirely relevant to the modern Western
world. Instead, maternal over nutrition, or obesity, is becoming one of the main causes of
pregnancy complications in developed countries [36], with a 2005 study indicating that at
least one in five pregnant women in the USA are obese, and that relatively higher rates exist
in low socio-economic populations [45]. Therefore, of high relevance is the finding that
maternal obesity is a major risk factor for offspring obesity. Epidemiological studies of
obese mothers and their children have highlighted this [76, 162, 195, 244, 311, 321] (see
3
1.2 Prenatal origins of obesity
table 1.1). For example, a retrospective cohort study conducted by Whitaker (2004) found
that almost a quarter of children born to mothers who were obese during the early stages of
pregnancy were obese themselves by age four, compared to nine per cent from normal weight
mothers [311]. Further studies have suggested that offspring obesity may even begin within
the first two years of life with a Dutch birth cohort study finding maternal pre-pregnancy
BMI is positively associated with increased offspring bodyweight at 14 months of age [195].
This association continues well into adulthood with offspring of mothers with elevated BMI
during pregnancy having increased BMI and body fat mass at 61 years of age [76]. Similarly
to maternal under-nutrition, maternal obesity also seems to be associated with increased
offspring risk of other components of the metabolic syndrome such as heart disease and type
2 diabetes [37, 77, 199, 245]. In fact offspring of overweight mothers have overall increased
risk of developing metabolic syndrome in childhood [23].
Although the epidemiological evidence is strong for a correlation between maternal
obesity and offspring obesity/metabolic syndrome, animal studies are still very valuable for
several reasons. Firstly, they are not confounded by the effect of offspring learning eating
and exercising behaviours from their parents during childhood, which have been reported
to influence offspring behaviours later in life to varying degrees [163, 273]. Secondly, most
of the epidemiological studies are retrospective, and so can suffer from biases in selection
of cases and controls, and also cases which are lost to follow up. Lastly, animal studies
allow a greater level of control than epidemiological studies, allowing researchers to further
investigate when the critical windows for programming are, and what factor in the obese
maternal environment might be responsible for this programming.
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1.2 Prenatal origins of obesity
A multitude of animal studies have shown unequivocally that maternal consumption of a
high fat diet and subsequent obesity biologically programmes offspring to develop obesity
later in life (see table 1.2). The majority of these studies have been carried out in the rodent
model, taking advantage of their quick gestation time, short lifespans, and the relative ease
by which they can be fed on high calorie diets. Two different approaches have been taken to
modelling the amount of fat consumed in a classic ’Western diet’ in a rodent model. The
first is to feed dams throughout pregnancy on what is termed a ’cafeteria diet’ - a collection
of high fat, high sugar foods typically found in cafeterias, which could include muffins,
doughnuts, chocolate bars, sweetened breakfast cereal and potato chips. One study found
that dams fed on such a diet during pregnancy and lactation had offspring with increased
adiposity both at weaning and at 10 weeks of age, especially when fed on the cafeteria diet
themselves postnatally [17, 18]. A similar finding was reported a few years later by Ong
and Muhlhausler (2011) although the effect of a maternal cafeteria diet on offspring overall
bodyweight appeared variable between the two studies [221]. This variability may be due to
the different components that made up the cafeteria diets in these two studies, and therefore
the different levels of sugar, fat and other nutritional components the rats would have been
receiving.
6

















































































































































































































































































































































































































































































































































































































































































































1.2 Prenatal origins of obesity
More conclusive data has come from the second approach in which studies used a more
standardised feeding method where only the fat content of the diet was increased in compar-
ison to the control or chow diet. One study fed dams on a diet supplemented with animal
lard (25.7% fat wt/wt) and found that a year after birth the female offspring of high fat fed
mothers (maternal high fat, mHF) were significantly heavier than offspring from control fed
(5.3% fat) mothers [150]. In a subsequent study the same researches found increased body fat
depots in both male and female mHFD offspring, a phenotype which was further exacerbated
by feeding the offspring on a high fat diet after weaning [149]. Both these studies found
that mHFD offspring also displayed other components of the metabolic syndrome such as
increased blood pressure, blood glucose and cholesterol [149, 150]. Similarly Howie et al.
(2009) fed rats on either a standard chow or high fat diet (45% kcal as fat) from weaning age
right through pregnancy and lactation, or a high fat diet during pregnancy and lactation only.
Offspring of both the mHFD groups had decreased body weights at birth compared with
controls, but increased body weights and adiposity at both weaning and during adulthood,
a phenotype which again was further increased by a high fat post natal diet [130]. mHFD
offpring also displayed increased leptin and insulin levels. Lastly even higher fat diets have
been analysed with similar findings. White et al. (2009) found that offspring of mothers fed
on a 60% kcal as fat diet also had increased adiposity in adulthood [312].
These findings have been replicated in mice. Female mice that are fed a high fat diet
(45% kcal as fat) have offspring with increased body weight and glucose intolerance in
adulthood [72]. Another study had similar findings when they fed female mice on a high
fat diet consisting of 20% animal lard, and supplemented with sweetened condensed milk
to boost the level of obesity experienced by these mice before breeding. Their offspring
too had a phenotype of increased body weight and glucose intolerance, as well as increased
adiposity, blood pressure, heart rate and decreased locomotor activity - a very ‘metabolic
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syndrome-like’ set of conditions [258].
While most maternal high fat feeding studies have been carried out in rodents, a few
have been performed in larger mammals due to their longer gestation time, smaller offspring
number, and aspects of their developmental maturity being more similar to humans. In sheep
several studies have been carried out where ewes were fed on a diet containing 150% of
their energy needs and mated when they were approximately 30% heavier than controls.
Their offspring had increased adiposity at birth, increased plasma insulin levels in the early
postnatal period, and increased body weight, plasma glucose, and plasma insulin in adulthood
[86, 176–178]. Non-human primates also show a very similar response to maternal obesity.
McCurdy et al. (2009) fed Japanese macaques a 32% kcal from fat diet and found that their
offspring were smaller in weight at birth than offspring born to control monkeys, but that
percent body fat had almost doubled in the mHFD offspring 3 and 6 months later [191].
Evidence from animal studies has also been valuable in understanding when during
development the maternal obesogenic environment is most detrimental in programming pre-
disposition to obesity and metabolic syndrome in offspring. Studies have compared cohorts
of rat offspring exposed to high fat diet throughout the prenatal and early post natal period
with those only exposed prenatally by cross-fostered pups of high fat fed mothers to control
mothers at birth [39, 269]. They found that regardless of post natal diet, offspring exposed
to high fat diet in utero developed increased body weight and caloric intake [39, 269]. This
indicates that this phenotype is at least in part a result of changes occurring prenatally, not as
a result of lactation or post-natal care.
Overall, the evidence from human epidemiological studies and animal models over-
whelmingly supports the hypothesis that maternal obesity during pregnancy programmes a
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developing fetus towards a greater risk of obesity in later life, especially when presented with
an obesogenic postnatal environment. What is less clear is what factor(s) in the maternal
environment may be having this effect. The first line of evidence comes from studies that
attempt to separate out whether the programming effect is coming from factors in the mater-
nal obese environment, or from the high fat diet itself. One of these studies found that by
pair feeding rats the same number of calories consumed by control fed rats with a high fat
diet the effects of maternal high fat diet could be separated from those of maternal obesity
[312]. They found that while mHFD offspring developed increased adiposity in adulthood,
offspring of high fat pair fed rats did not. This research indicates that factors present in
the maternal obese environment, rather than the high fat diet itself, may be responsible for
offspring programming of obesity.
1.3 A role for the immune response
1.3.1 Inflammation and obesity
A prevailing theory as to the causative factor(s) of maternal obesity-induced offspring is
activation of the maternal immune system. Obesity has long been recognised as a state of
chronic low grade inflammation. This is caused by abnormal hypertrophy and apoptosis of
adipocytes resulting in macrophages infiltrating the adipose tissue and secreting a range of
pro-inflammatory cytokines [49, 310, 324]. During pregnancy this obesity driven inflamma-
tory environment is also present. Studies have found that several pro-inflammatory cytokines
are increased in the maternal circulation during pregnancies complicated by obesity including
interleukin-6 (IL-6) and C-reactive protein (CRP) [37, 38, 248]. These findings in humans
have been backed by mouse models of maternal obesity, where increases in a range of
different cytokines have been detected, including IL-6, tumor necrosis factor alpha (TNFα),
and interferon gamma (IFNG) [118, 136, 153]. Interestingly, this inflammation does not
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seem to be confined to maternal tissues. Several studies have focused on inflammation in the
placenta at birth as this tissue is heavily involved in regulation of normal levels of inflamma-
tion during pregnancy, and is the gatekeeper which regulates transfer between the fetal and
maternal circulation [70, 256]. Challier et al. (2008) have found that in placentas from obese
pregnancies there is increased macrophage invasion, and increases in IL-1, IL-6 and TNFα
[38]. Likewise Roberts et al. (2011) also found evidence for obesity mediated placental
inflammation, with increases in the cytokines IL-1 and IL-8 among others [248]. Again this
is backed up by studies in both sheep and mouse models which report increased macrophage
invasion, and increases in an array of different cytokines including IL-6 and TNFα [153, 331].
Although there is strong evidence of an elevated pro-inflammatory response in both
maternal and placental tissues only recently has evidence been accumulating that the devel-
oping fetus is exposed to this environment. In human pregnancies it is difficult to sample
the fetal environment but several studies have analysed either cord blood samples taken at
birth, or amniotic fluid samples collected at 15-20 weeks gestation and found increases in
IL-6 (cord blood), CRP and TNFα (amniotic fluid) in obese pregnancies [31, 37]. However
perhaps the clearest evidence comes from a study of a mouse model of maternal obesity
where IL-6, IL-17A and IFNG were all found to be elevated directly in the fetal circulation
in late gestation [153].
Some of the best evidence that these increases in pro-inflammatory cytokines during
maternal obesity are somehow programming the developing fetus comes from maternal
pro-inflammatory environments, unrelated to obesity, which have a similar programming
effect.
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1.3.2 Evidence from other maternal inflammatory situations
Maternal undernutrition
Similar to obesity, undernutrition is associated with chronic low grade inflammation. For
example eating disorders such as anorexia nervosa display increases in cytokines such as
IL-6 and TNFα which return to normal levels with weight gain during recovery [235, 297].
Unfortunately no studies to date have looked at the circulating levels of these cytokines in
undernourished pregnancies. However rodent studies of maternal undernutrition have found
maternal circulating increases in TNFα and fetal liver increases in both TNFα and IL-6 [271].
As described above (see section 1.2) maternal undernutrition is also similar to obesity in
that offspring are predisposed to obesity. Animal models back this up with studies in both
sheep and rodents showing that maternal undernourished offspring have increased adiposity
and body weight in adult life [21, 85, 129].
Maternal smoking
Numerous human studies have reported chronic inflammation both in the lungs and periph-
eral circulation of smokers of tobacco. For example Bermudez et al. (2002) conducted a
cross-sectional study of 340 healthy women and found that smokers had increased circulating
levels of four markers of systemic inflammation [20]. Numerous other cross-sectional studies
have looked at cohorts of both men and women and found evidence of systemic inflammation
in smokers (reviewed in [326]). Additionally, animal studies have supported these human
findings, showing that cigarette smoke exposed mice had clear chronic inflammation, with
increases in inflammatory cells and proinflammatory cytokines locally in the lung, and
peripherally in the circulation and skeletal muscle [99].
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With this in mind it is pertinent that maternal smoking is also associated with increased
risk of obesity and the metabolic syndrome in offspring. Epidemiological studies have found
a possible association with some reporting that around the age of puberty both boys and
girls are at a higher risk of increased BMI and overweight/obesity, and that this risk may
increase with age [3, 237]. In some of these studies it is often difficult to tease apart the effect
of smoking during pregnancy, and exposure during early postnatal life. However evidence
points to the critical window being prenatal with studies finding offspring risk of elevated
BMI is only increased if the mother smoked during pregnancy, and not if she quit smoking
before conception, or smoked at other times during the child’s life [3, 218] . In fact we may
be able to time lock this critical window even further to first trimester, as smoking during
this time confers similar risk to smoking throughout the entire pregnancy [295].
Animal models also support a prenatal smoking and metabolic disease association. Chen
et al. (2011) conducted a study looking at metabolic disease parameters in mice prenatally
exposed to cigarette smoke [42]. They found that exposed offspring had increased body
weight at weaning, and increased body weight and fat mass at 12 weeks of age. These
offspring also had higher plasma leptin levels and impaired glucose tolerance – both markers
of the metabolic syndrome.
Air pollution
Animal models have shown that the air pollution present in modern day cities could cause
a proinflammatory state during pregnancy and have metabolic effects on the developing
offspring. Bolton et al. (2012) used a mouse model that was exposed to diesel exhaust in
the latter half of pregnancy [22]. They detected increases in proinflammatory cytokines, and
chemokines in the fetal brain indicating that pollutant exposure can activate the fetal immune
system as well as the mother’s. Interestingly they also found that in adulthood exposed
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male offspring were heavier than controls. When put on a high fat diet the exposed female
offspring gained more weight than controls but exposed males developed insulin resistance.
Therefore prenatal diesel exposure appears to be able to program offspring feeding behaviours
and predisposition to obesity and this is likely due to elevated inflammatory cytokines during
gestation. The authors of this study note that these results are of particular concern given that
low socioeconomic groups are more likely to come in contact with high fat diets and high air
pollution [22].
Gestational diabetes mellitus (GDM)
Maternal systemic inflammation seems to be associated with gestational diabetes, although
there is debate as to which cytokines are increased in the maternal circulation [98]. However
a very recent study of GDM pregnancies has found strong evidence of IL-6 being increased in
the maternal circulation at midgestation [116]. In addition to this, GDM mothers have been
shown to have children with higher BMI, even when the pre-pregnancy BMI of the mother
is controlled for [13, 57, 223]. These observations are supported by studies in rats, where
gestational diabetes was induced pharmacologically using streptozotocin. Offspring from
these pregnancies display higher adult body weight, increased food intake, hyperinsulinemia,
and a whole host of changes to the architecture of the hypothalamic feeding areas in the brain
[228–230].
Pre-eclampsia (PE)
Inflammation and increased levels of proinflammatory cytokines are a distinguishing feature
of preeclampsia [257, 262]. Epidemiological studies also support a detrimental effect on
offspring metabolism by exposure to PE. Washburn et al. (2013) compared children born
preterm from preeclampsic and non-preeclampsic pregnancies at 14 years of age [307]. They
found PE exposed male children had higher measures of adiposity, although they did not find
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this association in female offspring. Interestingly, Vatten et al. (2003) only looked at female
offspring and found that PE exposed girls had higher blood pressure, and were more obese
during adolescence than girls not exposed to PE [299].
1.3.3 Which cytokines are important?
Overall there is a large amount of correlative data supporting the hypothesis that maternal
inflammation plays a role in programming offspring for later life obesity. The fact that multi-
ple different incidences of maternal inflammation result in offspring obesity only strengthens
this relationship. What remains unclear at this point is a mechanism for how inflammation
might programme offspring later life obesity.
The first step is understanding which components of the immune response are important.
Of particular interest is the cytokine IL-6 which is increased in both the maternal and
fetal circulation, and the placenta (see section 1.3.1), as well as a lot of the other maternal
inflammatory situations described above. IL-6 is most widely known for its role in the
pro-inflammatory response. During this response it is produced by activated cells at the
site of acute inflammation and subsequently promotes neutrophils into the area [261]. It is
also important in the switching between an acute and chronic inflammatory response, and
is often a target for treatment of chronic inflammatory disorders [89, 261]. Apart from its
role in the pro-inflammatory response, IL-6 is also known to be involved in a wide range
of other biological processes, including muscle contraction, bone metabolism, and neural
regeneration [109, 281, 286]. Indeed there is also evidence that it is involved in regulation
of body weight. When this cytokine alone was injected into pregnant rats the offspring
were found to have increased adipose tissue and body weight indicating that it has a direct
effect on fetal programming of body weight [59]. Additionally in humans increased maternal
circulating IL-6 levels correlate positively with offspring adiposity at birth [239]. Thus IL-6
15
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looks like a likely candidate for being involved in offspring programming of obesity via
maternal inflammation. The next step is to understand where and how a factor, such as IL-6,
may be disrupting the innate mechanisms that control body weight.
1.4 Neural regulation of body weight
In order to begin to answer how a child might be predisposed to obesity it is important to
understand how body weight is normally regulated. The balance between energy expendi-
ture and intake is highly regulated via communication between the periphery and the brain.
Different areas of the body produce hormonal signals to inform the brain of their energy
needs. Some of the most well known of these signals include leptin produced by adipose
tissue, ghrelin produced by the stomach and insulin produced by the pancreas [87, 266, 296].
The levels of these hormones in the blood are informative of an individual’s energy status
in reference to how much fat tissue they possess, when they last ate, and how much energy
substrate they have [110, 174, 320]. Their importance to regulating energy balance in concert
with the brain has been demonstrated by multiple rodent knockout studies showing that loss
of functioning leptin or leptin receptor, or neuronal expression of insulin receptor, leads to
hyperphagia and obesity [30, 46, 164, 327]. Additionally, central administration of ghrelin
directly in the brain induces feeding and decreases locomotor activity in rats [291], whereas
central administration of leptin or insulin reduces feeding and increases locomotor activity
[50].
The hypothalamus is a key area of the brain involved in receiving these peripheral signals
and acting upon the information they contain (see Fig. 1.1). Its importance in the neural
regulation of energy homeostasis was first identified in 1940 when Hetherington and Ranson
found that hypothalamic damage in the rat caused severe feeding regulation problems and
obesity [121]. More specifically, a decade later, Anand and Brobeck (1951) were able to
16














Fig. 1.1 The major hypothalamic nuclei regulating body weight in the mouse brain.
Simplified schematic diagrams displaying the rostro-caudal (a), and dorso-ventral (b) spatial
relationship between the major hypothalamic nuclei regulating body weight in the mouse
brain. PVN, paraventricular nucleus; DMH, dorsomedial hypothalamus; VMH, ventromedial
hypothalamus; ARC, arcuate nucleus; LHA, lateral hypothalamic area.
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show that lesioning the ventromedial hypothalamus (VMH) or the lateral hypothalamic area
(LHA) in rats resulted in severe states of either obesity or anorexia, respectively [4]. Next, in
the late 1970s and early 1980s researchers discovered that the paraventricular nucleus of the
hypothalamus (PVN) also plays a very important role in feeding behaviour. Stimulation of the
PVN using noradenaline initiated feeding behaviour, however lesioning resulted in obesity,
implying a role in satiety [165, 166]. The dual role of the PVN in both feeding and satiety
has since been replicated with direct microinjection of orexigenic neuropeptides into the
PVN resulting in feeding, and anorexigenic neuropeptides resulting in satiety [159, 161, 278].
However it is only relatively recently that the role of the arcuate nucleus in the neural
regulation of body weight has been appreciated. It is a particularly important component
of the neural body weight system because it lies adjacent to and may even contain a ‘leaky’
area of the blood-brain barrier. This location is key so that peripheral hormones, such leptin,
ghrelin and insulin can access its resident cells directly. The neurons within the arcuate
nucleus that regulate body weight are able to detect these signals carrying information about
the body’s energy needs, integrate this information and translate it into neural signals for
other areas of the brain to act upon. There are two populations of neurons in the arcuate
nucleus that are responsible for this: POMC (Pro-opiomelanocortin) expressing neurons,
which co-express CART (Cocaine and amphetamine regulated transcript), suppress appetite,
and NPY (Neuropeptide-Y) expressing neurons, which co-express AgRP (Agouti related
protein), stimulate appetite [8] (see Fig. 1.2).
1.4.1 Anatomy and actions of POMC neurons
The hypothalamic POMC neurons are the largest and most well studied population of POMC
neurons within the brain. These neurons lie close to the fenestrated capillaries of the median
eminence so they are easily targeted by hormones from the peripheral circulation such as
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Fig. 1.2 Regulation of body weight by hypothalamic neurons. Peripheral signals from all
over the body either inhibit (red line) or activate (green arrow) the expression of POMC
or NPY. The relative levels of these neuropeptides signal to second order neurons in the
Paraventricular Nucleus (PVN), the Dorsomedial Hypothalamus (DMH) and the Lateral
Hypothalamic Area (LHA) to adjust food intake.
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leptin and insulin. POMC neurons express both leptin and insulin [47, 316] receptors and
are powerfully activated by them [75, 316]. The relative levels of these hormones in the
circulation indicate the energy status of the periphery and can thus explain the observation
that Pomc mRNA in the arcuate nucleus is upregulated in response to overfeeding [107] and
downregulated in response to dietary restriction [201].
Within the important hypothalamic feeding areas POMC neuronal fibres from the arcuate
nucleus project in to the PVN, LHA, VMH and dorsomedial hypothalamus (DMH) as well
as to other neurons within the arcuate nucleus itself [10, 53, 140]. These projections then
release processed forms of the POMC protein into these target nuclei when activated by
exogenous signals such as leptin or insulin. The effect of this is a strong anorexigenic signal
spread across multiple brain regions.
POMC protein is a precursor poly peptide which is post-translationally processed into
several different functional proteins the most important of which in relation to regulation of
feeding is alpha-melanocyte-stimulating hormone (α-MSH). α-MSH binds the melanocortin
receptors MC3R and MC4R. Both these receptors are expressed in the aforementioned areas
of the hypothalamus that the POMC neurons target [141, 206] and both are instrumental in
regulating energy balance as loss of either of them results in obesity or metabolic syndrome
[32, 133].
1.4.2 Anatomy and actions of NPY neurons
Opposing the anorexigenic POMC neurons are the orexigenic NPY neurons. Although NPY
neurons are present in many areas throughout the brain, the arcuate nucleus population is
defined by its co-expression of AgRP [104]. Like POMC neurons, their location within the
arcuate nucleus enables them to interface with peripheral hormones via the median eminence.
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NPY neurons express receptors for insulin and leptin [16, 188], which then inhibit their
activity, and receptors for ghrelin, a powerful stimulator of NPY orexigenic neuronal activity
[315]. Conversely to POMC neurons, Npy mRNA levels are upregulated in response to
fasting [201] and decreased as a result of feeding [192]. NPY is a powerful orexigenic
neuropeptide, as intracerebroventricular (ICV) administration of NPY, and optogenetic acti-
vation of the NPY neurons in the arcuate nucleus, results in a rapid feeding response, even in
satiated animals [6, 134].
NPY neurons innervate very similar hypothalamic regions to POMC neurons, namely
the PVN, LHA, DMH, and possibly, to a lesser extent, the VMH [104] (see Fig. 1.3). The
release of AgRP in these regions inhibits POMC activity by antagonising MC3 and MC4
receptor activity [83]. Additionally NPY has direct orexigenic actions acting through the Y
family of G protein-coupled receptors – the Y1 and Y5 receptors being the most important
NPY receptors in feeding regulation. Both these receptors are expressed throughout the
aforementioned hypothalamic feeding areas [73, 158]. When Y1 is knocked out or pharma-
cologically inhibited there is a significant reduction in the acute feeding response to ICV
administration of NPY [9, 144]. Furthermore, selective activation of Y5 receptors induces
feeding in satiated rats [134].
In the PVN, oxytocin neurons are an important synaptic target of NPY projections from
the arcuate nucleus. This population of oxytocin neurons act to suppress feeding behaviours
[160]. However, activation of the NPY neurons which target them leads to supression of their
activity and rapid feeding behaviour [9]. Additionally, when NPY signalling is pharmacolog-
ically suppressed in the PVN, and all arcuate nucleus NPY neurons activated, there was a
marked decrease, but not a complete loss, in the rapid feeding response [9]. This indicates that
the PVN projecting NPY neurons are very important in rapid feeding, but that this behaviour
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Fig. 1.3 NPY neuron projections in the hypothalamus. Within the hypothalamus the
population of NPY neurons in the arcuate nucleus innervate the Paraventricular Nucleus
(PVN), Dorsomedial Nucleus (DMH), Lateral Hypothalamic Area (LHA), as well as forming
local connections within the arcuate nucleus itself. There is also some evidence of a small
number of projections to the Ventromedial Hypothalamus (VMH).
must be in part controlled by circuitry to other hypothalamic, or extra-hypothalamic regions.
NPY projections are also detected within the arcuate nucleus where they make con-
nections with other neurons such as POMC [104]. Via this mechanism NPY neurons can
modulate the activity of POMC neurons, although activation of this circuitry is not enough
to evoke rapid feeding, indicating it may be more important in long term feeding responses
[9, 55, 194]. AgRP is additionally able to inhibit POMC activity via the MC3R receptor [83].
This innervation is reciprocal with POMC neurons being able to modulate NPY neuronal
activity predominantly via MC3R [194, 205].
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1.4.3 Maternal obesity and the development of feeding circuitry
The environmental insults on the developing fetus by the maternal immune system could
have permanent effects on the development of the arcuate nucleus and hypothalamic feeding
circuitry with life long consequences for offspring energy regulation. We already know that
in offspring parts of this system appear to be dysregulated. For example, Chang et al. (2008)
found that expression of a variety of hypothalamic metabolic related genes were changed in
mHFD rat offspring, including a decrease in both Npy and Agrp expression in the arcuate
nucleus [39]. This finding is corroborated by Chen et al. (2008) who found in the rat model
that mHFD offspring had decreased hypothalamic expression of Npy, as well as increased
expression of Pomc [43].
There also appears to be structural changes in the hypothalamic circuitry in response
to maternal obesity. Grayson et al (2010) have reported decreased innervation of the PVN
by NPY projections from the arcuate nucleus in fetuses of Japanese macaques fed on a
high fat diet before and during pregnancy [102]. Interestingly this study found evidence
of an activated inflammatory response in the mHFD exposed fetal hypothalamus [102]. In
rats it has also been found that mHFD offspring have a reduction of arcuate nucleus NPY
projections in the PVN [155]. Work in our lab has shown that in mice this phenotype is
already present at birth, suggesting this programming of hypothalamic circuitry occurs before
birth [259]. Therefore a proper understanding of how the arcuate nucleus develops prenatally,
and how the hypothalamic feeding circuitry is formed is instrumental in understanding how
factors in the maternal high fat environment might be affecting these processes.
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1.5 Arcuate nucleus development
How exactly the arcuate nucleus develops prenatally is only just starting to be understood,
with most of this work being done in the mouse model. Progenitor cells that will eventually
form cell types present in the arcuate nucleus and other ventral medial hypothalamic nuclei
are located in the ventricular zone lining the 3rd ventricle [180]. The bulk of cells that will go
on to form the arcuate nucleus become post mitotic and begin to migrate into the presumptive
arcuate nucleus between gestational day (GD)11.5 and 12.5, with some differentiating a
day earlier or later [222]. POMC neurons begin expressing transcript very soon after dif-
ferentiation (GD10-12), whereas Npy transcript is not detected in the arcuate nucleus until
GD14 [222]. Pomc transcript is initially expressed by a number of neurons in the developing
arcuate nucleus, with mRNA expression peaking at GD13. Only 50% of these original Pomc
expressing neurons still express Pomc transcript in the adult [222]. Interestingly, 25% of
mature NPY neurons transiently expressed Pomc, the very peptide they will later antagonise,
during their development [222].
After arcuate nucleus neurons have differentiated and migrated into their mature locations
they begin to form projections, and connect up the mature hypothalamic feeding circuits.
The majority of studies looking at arcuate nucleus development have focused on the early
postnatal period in the mouse, when most projections are elaborated under the influence
of the offspring’s postnatal nutritional environment, but when their growth is no longer
influenced by the maternal environment. However, the existence and role of early pioneer
axons developing prior to birth is beginning to be described and appreciated.
1.5.1 Postnatal arcuate nucleus projections
One of the first major studies of the development of projections out of the arcuate nucleus
came when Bouret et al. (2004) used DiI labelling to look at axonal projections from all
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arcuate neurons [24]. They found evidence of immature projections in the periventricular
region dorsal to the arcuate nucleus at postnatal day 4 (P4), the earliest age they reported in
this study. It also appeared these initial projections were extended and elaborated on quite
rapidly, with the DMH, PVN and LHA containing a significant number of projections by P6,
P8, and P12, respectively. Arcuate nucleus projection pathways appear to reach their adult
pattern by P18. In another study this same group also defined leptin as a major promoter of
postnatal axon outgrowth specifically in the arcuate nucleus [25]. They showed that in leptin
knockout mice arcuate nucleus projections are severely disrupted, a phenotype that can be
reversed by exogenous administration of leptin within the neonatal period. These findings
explained the initial observation of a early neonatal surge in leptin that seemed to have no
effect of feeding behaviours [2, 69].
Work has also been done specifically looking at the postnatal development of projections
from arcuate nucleus NPY neurons. Grove et al. (2003) used NPY and AgRP co-localisation
as marker of NPY neuronal projections specifically from the arcuate nucleus, as opposed to
from another population of NPY neurons situated in the brain stem [104]. When they looked
at the innervation of the hypothalamic feeding centres by NPY neurons across post-natal
development they obtained very similar results to what Bouret et al. (2004) found for the
whole arcuate nucleus [24]. NPY/AgRP co-expressing projections significantly innervate the
PVN at P10-11, and the DMH at P5-10. While there were single labelled NPY projections in
the DMH, LH, and PVN at the earliest age they examined, P2, none of these co-expressed
Agrp. However, not all of these NPY expressing projections could be defined as coming from
the brainstem population. Additionally, cell bodies in the arcuate nucleus at P2 are not yet
expressing Agrp mRNA to the level seen in the adult [104]. This leaves open the possibility
that some of these single label projections seen at P2 are indeed from arcuate nucleus NPY
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neurons.
While postnatal development of arcuate nucleus NPY neuronal projections has been
reasonably well studied, the same is not true for POMC neurons in the same region. They are
generally assumed to follow the post natal development pattern of NPY neurons as discussed
above. POMC projections have been observed to significantly innervate the PVN at P14,
however this study did not look at any earlier ages or innervation to other hypothalamic
feeding centres [54].
1.5.2 Prenatal arcuate nucleus projections
Although the majority of studies of the ontogeny of arcuate nucleus projections have con-
cluded that they develop entirely in the postnatal period, these studies have neglected to look
at any ages prior to P2. Therefore there is a possibility that a smaller number of pioneer
projections occur much earlier, in the prenatal period. Pioneer axons are a well described
phenomenon where a small number of early axons will slowly traverse the complicated route
through the developing brain to their target region, and form a guiding path along which
the majority of axons can then follow at a quicker pace [41]. Pioneers are critical to the
development of many axon tracts throughout the brain. For example, the two main tracts
coming out of the mammalian cortex (the corpus callosum and the corticothalamic pathway)
both develop initially as a small set of pioneer axons which are later elaborated on by follower
axons [62, 240]. Ablation or misguidance of these pioneer pathways severely reduce these
axon tracts, highlighting their importance to axon projection development [190, 226].
Additionally there is an increasing amount of evidence supporting the idea that arcuate
nucleus neurons may begin to form projections during the prenatal period. Firstly, previous
studies have identified NPY neuronal projections in the PVN at P1 [142, 319]. It has also
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recently been shown that other ventro-medial hypothalamic nuclei involved in the food
intake circuitry begin sending out projections as early as GD10-12 when neurogenesis is
still occurring in these areas [44, 180]. Lastly, recent work in our lab has confirmed the
embryonic development of arcuate-PVN projections from NPY neurons at GD15 in the
mouse (unpublished data). Overall, it appears that pioneer projections out of the arcuate
nucleus may well occur before birth in the mouse, forming a scaffold over which the later,
well described postnatal projections can develop.
1.6 Axon development in the arcuate nucleus
The correct development of neural circuitry, such as that described above, is regulated by a
very specific temporal and spatial expression of developmental molecules. These molecules
are responsible for the herculean task of initiating development of neurites, specifying these
neurites as either axonal or dendritic, guiding these developing axons and dendrites through
the developing brain to synapse with their correct target cells, and regulating any branching
that needs to occur on the way, for every neuron within the brain and all in a very specified
time frame. Of the molecules involved in the formation of neuronal circuitry, the most well
known are termed ‘axon guidance factors’ and, as their name suggests, are responsible for
guiding developing axons to their correct anatomical destinations.
Axon guidance factors act upon a unique structure at the distal end of a developing axon
called a growth cone. The growth cone is a highly specialised structure which not only acts
to elongate the developing axon, but can also shift its direction of growth in response to these
factors. In order to understand how a growth cone drives axon growth and directionality it
is important to understand its structure. Growth cones are made up of a ‘central domain’,
largely consisting of the microtubules that run the length of the axon, and a ‘peripheral
domain’, largely consisting of filamentous actin (f-actin) forming finger-like filipodial protru-
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sions with webbing-like lamellipodium between them [92, 224, 330]. The ‘transition zone’
is sandwiched between these domains, where the microtubules and f-actin interact [224, 330].
The forward advance to the growth cone, and subsequent elongating of the developing
neurite happens in a three step process containing (1) protrusion, (2) engorgement, and (3)
consolidation (see Fig. 1.4). In the first step the filipodia in the peripheral domain begin to
protrude further distally out from the growth cone [97, 224, 330]. This occurs through rapid
polymerisation of monomeric g-actin, transported up from the central domain, into f-actin
filaments [68, 92, 224]. As the filipodia protrude further out the f-actin will be shipped
back down to the central domain, broken back down into g-actin and then, again, shipped
back to the peripheral domain, a process termed ‘actin tread-milling’ [68, 92, 224]. In the
second step the microtubules move from the central domain to inhabit the newly protruded
regions, leading to engorgement of these regions [92, 246]. And finally in the last step the
newly formed piece of axon is consolidated through bundling of microtubules and collapse
of f-actin structures at the base of the growth cone [92, 288].
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1.6 Axon development in the arcuate nucleus
Another important property of the growth cone is that it is rich in receptors for axon guid-
ance factors [131]. Depending on which receptors the growth cone expresses, these factors
are able to attract or repel developing axons by polarising the process of axon elongation.
This means that one side of the growth cone will protrude forward while the opposing side
will collapse, allowing the axon to turn corners, and be able to navigate long complex paths
through the developing brain [92].
There are four major classes of axon guidance factors; the netrins, slits, semaphorins
and ephrins [152]. Additionally molecules classically identified as being developmental
morphogens have also been shown to have axon guidance properties. This includes the Wnt
family, Sonic Hedgehog (SHH) and brain derived neurotrophic factor (BDNF) [40, 152, 275].
It is virtually unknown which guidance factors are important in guiding arcuate nucleus
projections, especially prenatally. Some clues can be garnered from gene expression pattern
studies looking at the developing hypothalamus as a whole. These have found Robo/Slit, and
Semaphorin family expression in the embryonic mouse PVN, as well as other hypothalamic
areas [53, 323]. Knockout mouse studies have also been helpful. For example, it has been
found that heterzygous Bdnf knockout mice develop early onset obesity, and homozygous
knockout mice for the long 3’UTR form of Bdnf have reduced POMC and NPY neuron
innervation of the PVN and DMH, suggesting an axon guidance role in these neurons
[172, 181]. Recent work in our lab however has focused on the guidance factor Netrin-1, and
its role in arcuate nucleus development.
1.6.1 Netrin-1
Axon guidance
Netrin-1 is an important guidance factor in the ventral midline of the developing central
nervous system. It was first discovered in vertebrates as playing a role in axon guidance in the
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developing spinal cord [148, 268], however it has since been shown to be expressed along the
midline and ventral ventricular zone of the developing brain, and in several other structures
such as in the hippocampus and thalamus [27, 267]. Knocking out Netrin-1 expression in
the mouse creates a multitude of neurodevelopmental defects, most notably the failure of
several major commissures in the forebrain, such as the corpus callosum and hippocampal
commissure, to form due to the loss of Netrin-1’s axon guidance properties [267].
Netrin-1 is able to act as a bi-functional cue, either attracting or repulsing developing
axons [51, 148]. For example commissural axons are attracted to Netrin-1 at the midline
[148, 268], whereas trochlear axons are repulsed away from areas of Netrin-1 expression
[51]. The type of receptor being expressed by a developing axon is key to attraction or
repulsion. There are two classes of Netrin-1 receptor - the DCC class, which includes
both DCC and Neogenin, and the UNC5 class, which includes UNC5A-D. The DCC class
receptors are primarily involved in axon attraction. Growth cones expressing DCC will
direct their growth towards Netrin-1, however if DCC is blocked or knocked out this does
not occur, resulting in loss off axon outgrowth in vitro or severe axon projection defects
in vivo [80, 146]. DCC was initially thought to be the only attraction mediating receptor
of Netrin-1 but later work, first in the African clawed frog Xenopus laevis, and then in
the mouse, have demonstrated that Neogenin plays a role here too [317, 325]. The UNC5
class receptors mediate axon repulsion [114]. This can occur via a DCC/UNC5 receptor
complex in cases of long range repulsion, or on their own for short range repulsion [124, 147].
Unfortunately, no studies to date have examined developmental deficits of arcuate nucleus
neurons in Netrin-1, or Netrin-1 receptor, knock out mice. In addition, assessing bodyweight
phenotypes is hindered by the inability of these mice to suckle, and consequentially their
survival for only a few days after birth [267]. However, considering its role as a ventral
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midline guidance factor, Netrin-1 is already a good candidate for being involved in guiding
arcuate nucleus axons to other nuclei within the ventral hypothalamus. Netrin-1 and DCC
have been shown to be expressed in areas throughout the hypothalamus at GD12, and work
within our lab has confirmed expression of DCC by a subset of NPY expressing arcuate
nucleus neurons at GD17 [66, 259]. This suggests further that Netrin-1 is involved in NPY
neuron axon growth.
Axon branching
Although it was first discovered for its axon guidance properties, Netrin-1 also plays several
other equally important roles in the development of neural circuitry. One of those is in the
process of axon branching. Axon branching occurs throughout the central nervous system,
and allows one neuron to create connections with multiple different targets, or conversely,
multiple connections with one specific target [94]. Just like with axon guidance, branching is
a process that must be very strictly controlled in order to create correctly functioning neural
circuitry. The degree of branching an axon undergoes is incredibly variable and can take
several different forms. Arborisation is a process in which the terminal end rapidly branches
into a tree-like structure [94]. This usually occurs in the target region of the developing axon
as it forms connections with its targets [175]. Axons can also bifulcate into two branches at
the growth cone, essentially forming a ‘T’ or ‘Y’ intersection in the axon [91, 263]. Lastly,
multiple branches can also form de novo along the shaft of the axon in a process called
collateral formation and usually innervate different target cells to the primary axon [92, 94].
Netrin-1 has been shown to play a role in both arborisation and collateral formation
[67, 186, 290]. For example Manitt et al. (2009) found that injecting Netrin-1 into the
developing Xenopus leavis optic tectum increased the total branch number of the retinal
ganglion cell terminal arbours [186]. Additionally they showed that this process was mediated
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through the receptor DCC by injecting DCC blocking antibodies into the optic tectum and
finding this decreased the branch number of the RGC teminal arbours when compared to
controls [186]. Dent et al. (2004) found that in vitro bath application of Netrin-1 rapidly
increased the number of collateral branches present on cortical neurons in dissociated cell
culture [67]. They also found that directed application of Netrin-1 to an otherwise smooth
area of the axon shaft initiated rapid formation of filipodia which extended into branches
specifically in the area of application [67].
Axon specification
Lastly, Netrin-1 also appears to play a role in neuron polarisation and axon specification. A
neuron starts out as a symmetrical round cell covered in lamellipodia [71]. Neurite initiation
will begin, with the formation of multiple immature neurites [71]. The symmetry of the
neuron will then be broken, with one of these neurites displaying accelerated growth and
differentiating into the axon, and the rest of the neurites becoming dendrites [71]. Several
studies have shown the ability of Netrin-1 to specify the axon. One study looked at developing
rat hippocampal neurons and found that neurites developing on the side of the cell body
closest to a Netrin-1 gradient were more likely to become an axon than those developing
further away [184]. Another study looked in vivo using the nematode worm Caenorhabditis
elegans as a model and found that Netrin-1 plays a crucial role in asymmetric growth of
motor neurons, and determines the position where the axon will form [1]. Interestingly the C.
elegans homologue of DCC is also instrumental in these processes, indicating that Netrin-1
is acting through this receptor to carry out this function [1].
1.6.2 Interleukin-6 and Netrin-1 signalling
Work in our lab has already shown that in vitro the cytokine IL-6 is able to increase gene
expression of the Netrin-1 receptor Dcc [259]. If this were to be occurring in vivo in the
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fetal brain during maternal obesity it raises the question of by what mechanism the IL-6
is exerting these changes. There are two main possibilities here. Either (a) IL-6 acts to
extrinsically disrupt the Netrin-1 signalling pathway during fetal development, or (b) IL-6
has acted upon NPY neurons in a way which intrinsically alters how they respond to Netrin-1.
If IL-6 were to be acting to disrupt development extrinsically then we would expect
it to be inducing transient changes in gene expression via its signalling pathway. IL-6
binds the common signal transducer gp130, via its specific receptor IL-6Rα [276]. In this
configuration it can influence gene expression in several ways. First via activation of the
JAK/STAT pathway culminating in phosphorylation of the transcription factor STAT3 which
translocates to the nucleus and modulates gene expression [119]. This pathway is well known
to be active in IL-6 signalling in the central nervous system [276]. Second, by activation
of the transcription factor NF-κB , which then translocates to the nucleus and also affects
expression of target genes [182, 304]. The other important IL-6 activated signalling cascade
is the Erk1/2 pathway [119]. This pathway also regulates transcription factor activity via
phosphorylation, and so also has the ability to modulate expression of specific genes. Using
in silico analysis we have already shown that Dcc contains several binding sites for NF-κB
and IL-6 regulatory element binding protein, demonstrating the potential for it to be regulated
by IL-6 signalling [259].
If, however, IL-6 exposure resulted in changes to the intrinsic ability of neurons to
respond to Netrin-1 then we would expect the changes it induces to be more permanent and
epigenetic in nature. Exactly how cytokines may change the level of epigenetic regulation
of different genes is largely unknown. There is some in vitro evidence from research on
cancer cell lines that has indicated cytokines may be able to affect levels of methylation in a
cell’s genome via the enzymes responsible for laying down and upkeeping these epigenetic
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marks – termed DNA methyltranferases (DNMTs). For example there are studies showing
that the IL-6 is able to both affect the expression and nuclear translocation of DNMT1,
consequently changing its activity within the cell [84, 122]. This could lead to changes in the
global levels of DNA methylation across the genome. Additionally, IL-6 induced changes
to cellular DNMT1 levels have also been shown to target specific gene promoter regions
[167]. However as these studies were carried out in relation to cancer states their relevance
to healthy tissue is as yet unknown. Additionally the effect of cytokines on the expression
and action of enzymes creating and upkeeping other epigenetic mechanisms such as histone
modifications is entirely unknown at this point.
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1.7 Hypothesis and aims
Overall I hypothesised that activation of the maternal immune system during pregnancy
affects the expression of important developmental molecules in the fetal arcuate nucleus,
a key weight regulatory area of the brain. This in turn impairs the way arcuate neurons
develop axons and establish connections, thus disturbing their ability to communicate with
other important weight regulatory regions of the brain. Ultimately, this may lead to obesity
predisposition. My PhD research can be summarised in four main aims:
Aim 1 To determine the prenatal development of NPY neuron projections from the arcuate
nucleus to the PVN, which are disrupted in offspring of obese mothers (Chapter 3)
Aim 2 To determine a possible role for Netrin-1 as a developmental signal driving NPY
neuron axon growth and development (Chapter 4).
Aim 3 To determine whether maternal obesity directly impairs the developmental signals
driving NPY axon growth and development (Chapter 5).
Aim 4 To determine whether developmental changes to NPY neurons in response to maternal





All animal procedures performed in this study were approved by the University of Otago
Animal Ethics Committee.
2.1.1 Maternal High Fat (mHFD) mouse model
Female C57BL/6 mice were obtained at 6 weeks of age and housed in cohorts of 3-5 per
cage under standard conditions (25°C, 12hr light-dark cycle, and free access to food and
water). Mice were weighed on arrival and randomly assigned to receive either a standard
control diet (10% kcals as fat, D12450B, Research Diets, New Brunswick, NJ, USA) or a
high fat diet (HF diet, 45% kcals as fat, D12451, Research Diets, New Brunswick, NJ, USA).
Mice were kept on their respective diets for 6-8 weeks until being used in experiments.
2.1.2 Tissue collection
For all experiments in this thesis female C57BL/6 mice were time mated with chow-fed
normal weight males, with the presence of a vaginal plug marked as gestational day 0
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(GD0). For fetal tissue collection female mice were sacrificed at either GD14, 15 or 17
of pregnancy via cervical dislocation followed by decapitation. Embryos were dissected
out of the uterus and transferred into ice cold sterile phosphate buffered saline (PBS). The
crown to rump length was measured to confirm gestational age. Whole heads were removed
from the embryos and processed for either in situ hybridisation, immunohistochemistry,
qRTPCR, acute slice culture or primary cell culture applications. Post natal day 0 (P0)
pups were collected the morning of birth and sacrificed via decapitation. Whole heads
were briefly washed in sterile PBS and then processed for either in situ hybridisation or
immunohistochemistry applications.
2.2 In situ hybridisation
2.2.1 Sectioning
Tissue was collected as descibed above (section 2.1.2). Whole heads were removed from
the embryos or pups, placed in a RNase free microcentrifuge tube and immediately snap
frozen on dry ice. Heads were stored at -80°C until sectioned (maximum of 6 weeks). Heads
were embedded in O.C.T mounting medium (Leica), cryosectioned coronally at 14 µm and
collected onto RNase free superfrost slides.
2.2.2 Riboprobe synthesis
Agrp riboprobe template
Primers were designed using PrimerBlast to amplify 239bp of both Agrp mRNA transcripts
(GenBank accession NM_001271806.1 and NM_007427.3). Sequences for SP6 and T7 RNA
polymerase start sites were added to the forward and reverse primers, respectively (see table
2.1). The Agrp target sequence was PCR amplified (5x 25 µL reactions) using cDNA obtained
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from adult mouse arcuate nucleus. Reactions were pooled together and a 10µL sample
analysed using gel electrophoresis to confirm a single PCR product of the correct molecular
weight. Pooled PCR product was purified using the QIAquick PCR purifcation kit (Qiagen),
following the manufacturer’s instructions and eluting in 40 µL of provided elution buffer.
Table 2.1 in situ hybridisation probe primer sequences (5’-3’). Bold text indicates SP6







E. coli with Netrin-1 cDNA-containing plasmid were grown overnight in 25 mL LB media
containing 20 mg/mL ampicillin at 37°C, 225 rpm. Cells were lysed, and plasmid DNA
extracted and purified using the PureLink HiPure Plasmid Midiprep Kit (Invitrogen) and
following the manufacturer’s instructions. DNA yield and purity were assessed using a
spectrophotometer (Nanodrop 2000, Thermo-Scientific). Plasmid DNA was linearised using
the restriction enzyme NcoI (Roche) where 10U of enzyme was incubated with 5 µg plasmid
DNA in a 20 µL reaction for 2 hours at 37°C. DNA was then purified via ethanol precipitation.
A 5 µL sample was analysed using gel electrophoresis to confirm complete linearisation of
the plasmid, and DNA yield and purity were assessed using a spectrophotometer.
In situ hybridisation riboprobe synthesis
Antisense and sense probes were generated by combining 1 µg of linearised plasmid template
DNA (Netrin-1 probe) or 4 µL of PCR product template DNA (Agrp probe) with 20 U of T7
(antisense probe; Roche) or SP6 (sense probe, Roche) RNA polymerase, dNTP mix (ATP,
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GTP and CTP 1 mM; UTP 0.7 mM; Promega), DIG labelled UTP (0.3 mM, Roche) and
1X polymerase buffer (Roche).Reactions were incubated at 37°C for 2 hours and then DNA
template removed by adding 4U of DNase 1 (Life Technologies) and incubating at 37°C for a
further 15 minutes. Reactions were stopped by adding 2 µL 50 mM EDTA and increasing the
volume of the reaction to 50 µL with TE buffer. Unincorporated nucleotides were removed
by passing probes through a sephadex G-50 spin column (Roche) following manufacturer’s
instructions. Probes were further purified using an ethanol precipitation, and resuspended in
50 µL of TE buffer. Agrp probe was stored at -80°C in 5 µL aliquots. Netrin-1 probe was
hydrolysed into 100bp pieces in 40 mM NaHCO3, 60 mM Na2CO3 for 78 minutes at 60°C,
purified using an ethanol precipitation, and then also stored at -80°C in 5 µL aliquots.
Dot blot analysis of riboprobes
A dot blot was run on both Agrp and hydrolysed Netrin-1 probe to confirm levels of incorpo-
ration of digoxygenin labeled uracils and estimate probe concentration. Briefly, probes and
DIG-labelled control RNA (100ng/µL) were serially diluted to 1 in 1,000 and then 10 µL of
each concentration was dotted onto a piece of positively charged nylon membrane (Amer-
sham Biosciences). Membrane was baked at 80°C for 30 minutes, and then digoxygenin was
detected using peroxidase conjugated sheep anti-DIG antibody (Roche) at a 1:1500 dilution.
2.2.3 In situ hybridisation protocol
All in situ hybridisation experiments were performed using RNase-free glassware and
solutions. Slides of cryostat sections were thawed for 30 minutes, and then fixed for 15
minutes in 4% paraformaldehyde in 0.1 M phosphate buffer (PB). Sections were treated with
0.1 µg/ml Proteinase K (PK) in 10 mM Tris-HCl (pH 8.0), 1 mM EDTA at room temperature
for 10 minutes, followed by a second fixation in 4% paraformaldehyde in 0.1 M PB for 15
minutes at room temperature to deactivate PK. Sections were washed for 10 minutes each
40
2.3 Immunohistochemistry
with 0.2 M HCl, then 0.1 M TEA, 0.25% acetic anhydride. Sections were rinsed in 0.1 M
PB then dehydrated in successive ethanol washes (70, 80, 90, 100%), followed by a final 10
minute wash in chloroform. Sense or antisense riboprobe (Netrin-1 probes, 1 µg/mL; Agrp
probes, 500 ng/mL) were combined with hybridisation buffer (50% Formamide, 200 µg/ml
tRNA, 1X Denhardt’s Solution, 10% w/v Dextran Sulphate, 0.25%w/v SDS, 600 nM NaCl,
10 mM Tris-HCl, 1 mM EDTA). Riboprobe solution was denatured at 85°C for 5 minutes
then placed on ice before being applied to sections. Hybridisation was performed at 55°C
for 16-18 hours. The following post hybridisation washes were performed at 55°C, for 30
minutes each. Sections were washed twice in 5X SSC, twice in 2X SSC, treated with 12.5
µg/ml RnaseA in 10 M Tris-HCl, 500 mM NaCl, 1 mM EDTA at 37°C, then washed twice
in 2X SSC, and twice in 0.2X SSC at 55°C. Sections were washed three times with 100 mM
Tris-HCl, 150 mM NaCl at room temperature, and then blocked with 1% Blocking Reagent
(Roche) 0.1% Triton-X in 100 mM Tris-HCl, 150 mM NaCl for 1 hour. Sections were
incubated overnight at 4°C with peroxidase conjugated sheep anti-DIG antibody (Roche)
at a 1:1500 dilution. Sections were incubated in NBT/BCIP detection solution (0.4 mg/mL
NBT; 0.19 mg/mL BCIP ;100 mM Tris buffer, pH 9.5; 50 mM MgSO4) at room temperature
for 24-48 hours. Once staining was fully developed, sections were washed in distilled water
and cover slipped using Fluoromount-G mounting medium (SouthernBiotech). Images were
taken using an Olympus BX51 microscope.
2.3 Immunohistochemistry
Tissue was collected as descibed above (section 2.1.2). Whole brains were dissected out of
GD15 or GD17 embryos, or P0 pups in ice cold sterile PBS and fixed in 4% paraformaldehyde
for 4 hours at 4°C. Brains were then incubated in 30% sucrose in 0.1M PBS solution overnight
at 4°C and then embedded in O.C.T mounting medium (Leica), cryosectioned coronally
through the hypothalamus at 20 µm and mounted onto gelatin coated slides. Sections were
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permeabilised with 0.1% Triton-X in 0.1M PBS for 10 minutes, blocked for 1 hour in
blocking solution (2% bovine serum albumin, 2% normal goat serum, 0.1% Triton-X in
0.1M PBS), and then incubated for 48 hours at 4°C in either rabbit anti-NPY (Peninsular
Labs, T-4070; diluted 1:3,000 in blocking solution), or guinea pig anti-AgRP (Antibodies
Australia, GPAAGRP.1; diluted 1:2,500 in blocking solution). Sections were washed 3 times
for 20 minutes in 0.1M PBS. For slides incubated in rabbit anti-NPY, Alexa Fluor 488 goat
anti-Rabbit IgG (Life Technologies) was diluted 1:500 in blocking solution and incubated
on the sections for 90 minutes at room temperature. For slides incubated in guinea pig
anti-AgRP, biotinylated anti-guinea pig IgG (Vector; diluted 1:500 in blocking solution) was
incubated on slides for 90 minutes, followed by 3 15 minute 01.M PBS washes, and a further
90 minute incubation with Alexa Fluor 488 Streptavidin conjugate (Thermo Fisher Scientific,
diluted 1:500 in blocking solution). All slides were then washed 3 times for 15 minutes,
cover slipped using Fluoromount-G mounting medium (SouthernBiotech) and imaged using
an Olympus BX51 microscope.
2.4 Gene expression analysis
2.4.1 In vitro model
GD17 fetuses were collected as described above (section 2.1.2) and decapitated in ice cold
aCSF (artificial cerebral spinal fluid). The top of the skull was dissected off and the heads
were then suspended in blocks of 4% agarose (low gelling temperature, Sigma-Aldrich)
for stability during sectioning. Agarose stabilised heads were sectioned using a vibratome
(Leica VT2000S) while completely submerged in ice cold aCSF (118 mM NaCl, 3 mM KCl,
2.5 mM CaCl2, 1.2 mM MgCl2, 5 mM HEPES, 25 mM NaHCO3, 11 mM D-glucose, pH
7.3) being actively bubbled with carbogen gas. The agarose block was positioned so the
head was nose down, and was sectioned coronally in a caudal to rostral direction, with the
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blade entering the dorsal surface first. Sections were cut at a thickness of 300 µm, with a
vibration amplitude of 1.75 mm, and a speed of 0.6 mm/sec. Sections that contained the
arcuate nucleus were transferred into ice cold aCSF being actively bubbled with carbogen
gas. Tissue sectioning was completed within 2 hours of the mouse being sacrificed to ensure
all tissue remained metabolically active. Sections were transferred into aCSF, pre-warmed to
37°C, and containing either 100 ng/mL interleukin-6 (Human IL-6, Peprotech, Inc.) or PBS
vehicle. Sections were incubated at 37°C for one hour. Sections were then microdissected
(see Fig. 2.1) using fine forceps and pieces of arcuate nucleus from both IL-6 treated and
control sections, were pooled in RNase-free microcentrifuge tubes containing ice cold Trizol
(Thermo Fisher Scientific), and then stored at -80°C for no more than 1 month before RNA
extraction and qRTPCR analysis.
2.4.2 In vivo model
Whole heads of GD15 or GD17 embryos from chow fed control weight pregnancies were
collected for RTPCR analysis as described above (section 2.1.2). Additionally whole heads
of GD15 embryos from both mHFD and matched control pregnancies were collected for
qRTPCR as described above (section 2.1.2). Heads were cryosectioned coronally at 100
µm, and sections containing the arcuate nucleus were collected onto slides, and incubated
in 50 µL/section RNAlater ICE (Thermo Fisher) at -20°C overnight. Sections were then
microdissected (see Fig. 2.1) using fine forceps and pieces of arcuate nucleus from embyos
in the same pregnancy were pooled in RNase free microcentrifuge tubes containing ice cold
Trizol (Thermo Fisher Scientific), and then stored at -80°C for no more than 1 month before
RNA extraction and RTPCR or qRTPCR analysis.
43
2.4 Gene expression analysis
Fig. 2.1 Image of a section of GD 17/18 mouse brain taken at the level of the ARC
(from Ref. [259]). The dotted line indicates the border of the ARC along which tissue was
microdissected for PCR analyses (section: 2.4) and primary cell culture (section: 2.5.1)
analyses.
2.4.3 RNA extraction and cDNA conversion
Tissue was removed from the -80°C freezer, defrosted on ice and lysed by vigorous vortexing.
RNA was extracted and purified using a Zymo Direct-zol RNA MiniPrep kit. RNA was eluted
in 25 µL RNase free H2O. RNA concentration was quantified using both a spectrophotometer
(Nanodrop 2000, Thermo Fisher Scientific) and a fluorometer (Qubit 2.0, Life Technologies).
RNA was DNase treated using the Ambion DNA-free kit (Thermo Fisher Scientific) following
the manufacturer’s protocol. cDNA was created using the Supercript III First Strand Synthesis
System (Invitrogen), following the manufacturer’s protocol and using both random hexamers
(0.5 ng/µL) and oligodTs (0.05 µg/µL) as primers, and 7 µL of sample RNA. A no reverse
transcriptase (no RT) reaction was also run alongside the experimental samples. Samples
were then used in qRTPCR and RTPCR analyses.
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2.4.4 Quantitative reverse transcription PCR (qRTPCR)
Primer design
Primers were designed for the genes Unc5a, Unc5b and Unc5d using their GenBank se-
quences (GenBank gene ID 107448, 107449 and 210801, respectively; see table 2.2). Design
was undertaken using NCBI’s primerBLAST (http://www.ncbi.nlm.nih.gov/tools/primer-
blast) function to find primer sequences that best fit the following criteria:
Primer sequence or amplified product fall over intron/exon boundary
Product size: 80 - 120 bp
Primer size: 18 - 24 bp
Primer Tm: 55 - 65°C
Primer GC content: min 40% max 60%
Primer pairs were found in the literature for the genes Pgk1, Tbp, Unc5c and Neogenin.
For all primers, gene sequence on Ensembl mouse genome browser (release 70) [58]
was used to check candidate primer pairs did not contain known SNP sites, and the In-
tegrated DNA Technologies oligoanalyser (PrimerQuest program, IDT, Coralville, USA.
http://www.idtdna.com/Scitools) was used to identify primers with low likelihood of forming
dimers or hairpin loops.
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A range of primer concentrations (50 nM, 300 nM, 500 nM, 900 nM) were tested on a
positive control sample (adult mouse hypothalamus GD12.5 spinal cord cDNA). The lowest
primer concentration with the lowest crossing values was chosen for subsequent experiments.
In all cases this was a 300 nM concentration. Primer efficiency was tested on four 10-fold
dilutions of positive control cDNA (i.e. 470 ng /µL (undiluted), 47 ng/µL, 4.7 ng/µL, 0.47
ng/µL, 0.047 ng/µL). The crossing values were then plotted on a standard curve and the
reaction efficiency calculated using the equation:
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Efficiency = 10(-1/slope)-1
Using this equation a primer efficiency of 100% indicates the primers amplify the target
cDNA by 2-fold each cycle. Values below or above this value indicate poorly designed
primers, pipetting error and/or co-amplification of a nonspecific product such as primer dimer.
All primers used in subsequent experiments fell within the accepted range of efficiency (80-
110%) [265]. Melt curves were analysed for each primer set, with a single peak indicating
the generation of a single specific product. Additionally, PCR products for each primer set
were run on a 1.5% agarose gel with ethidium bromide. This was then visualised under UV
light to check for non-specific products and primer dimers.
qRTPCR protocol and analysis
All qRTPCR was carried out with a Viia7 Real-Time PCR machine (Applied Biosystems)
using white 96 well plates (Roche) and the SybrGreen system. Individual reactions were run
in triplicate and contained: 5 µL 2x SybrGreen mastermix (Bioline SensiFAST SYBR), 1
µL forward and reverse mixed primer (300 nM), 3 µL H2O (Molecular grade), 1 µL cDNA.
These reactions were run using the following protocol: 95°for 5 minutes (pre incubation); 45
cycles of 95°for 10 seconds, 60°for 30 seconds and 72°for 40 seconds (amplification); 95°for
1 second, 50°for 1 minute (melting curve); 40°C for 30 seconds (cooling). cDNA sample
concentrations were standardised via dilution in fresh MilliQ H2O so that equal ng amounts
of experimental and control cDNA (i.e. HF vs control fed, or IL-6 treated vs untreated) were
used. All qRTPCR runs also included both no reverse transcriptase and no cDNA negative
controls. The 2-∆∆CT relative quantification method was used to calculate fold change gene
expression in the control and experimental groups relative to reference genes known not to
change across the groups (Pgk1 and Tbp) [265].
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2.4.5 Reverse transciption PCR (RTPCR)
Primers for the Netrin-1 receptors (Dcc, Neogenin and Unc5a-d; see table 2.2), Npy (arcuate
nucleus positive control; see table 2.3), and Pgk1 (positive control; see table 2.2) were used
in a standard PCR with GD15 and GD17 arcuate nucleus cDNA. PCR was carried out with
reactions containing 10 µL 2x ReddyMix PCR Master Mix (Thermo Fisher Scientific), 1
µL forward and reverse mixed primer (300 nM), 7 µL H2O (Molecular grade), 2 µL cDNA.
These reactions were run using the following protocol: 95°for 3 minutes (pre incubation); 40
cycles of 90°for 30 seconds, 60°for 40 seconds and 72°for 45 seconds (amplification); 72°for
5 minutes. PCR products were then analysed on a 1.5% agarose gel using ethidium bromide,
and visualised under UV light. For each primer set a negative control reaction was also run
with water in place of cDNA.






2.5 In vitro model of NPY neuron development
2.5.1 Primary cell culture
GD14 and GD15 tissue was collected as described above (section 2.1.2). Whole heads
were removed from the embryos and placed in ice cold Leibovitz’s L-15 Medium (Life
Technologies; with added 3.25% glucose) wherein whole brains were removed and arcuate
nuclei dissected and pooled. Cells were washed with Hank’s Balanced Salt Solution (Life
Technologies) then dissociated with Trypsin-EDTA (0.025%, Gibco) at 37°C for 50 minutes.
FBS (1 in 10 final concentration; Moregate Biotech) was added to stop dissociation and cells
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were pelleted at 220 x g for 5 minutes. Cells were then re-suspended in Neurobasal Media
(Life Technologies) supplemented with 2% B27 (serum free; Life Technologies), 0.5 mM
Glutamax (Life Technologies) and 0.1% Penicillin/Streptomycin (Life Technologies). Cells
were cultured in 24 well plates containing 13 mm round coverslips coated with sterile filtered
50 /µg/mL Poly-D-Lysine at a density of 12x104 per well. Cultures were incubated for 48
hours at 37°C, 5% CO2, 60% humidity and then processed for immunocytochemistry. For
Netrin-1 and IL-6 assays, recombinant mouse Netrin-1 (R&D systems), recombinant mouse
IL-6 (Biolegend) or PBS vehicle control, was diluted in plating media and added drop-wise
to wells 4 hours after plating at a final concentration of 200 ng/mL (Netrin-1) or 100 ng/mL
(IL-6). Reconstituted stock solutions of Netrin-1 and IL-6 were stored at -80°C and used
within 3 months of reconstitution.
2.5.2 Immunocytochemistry
Culture plates were removed from the incubator and coverslips were fixed with ice cold
4% paraformaldehyde for 10 minutes and cells permeabilised with 0.25% Triton-X in 0.1M
PBS for a further 10 minutes. Coverslips were blocked for 30 minutes in blocking solution
(2% bovine serum albumin, 2% normal goat serum, 0.1% Triton-X in 0.1M PBS) and then
incubated overnight at 4°C in rabbit anti-NPY (Peninsular Labs, T-4070; diluted 1:3,000 in
blocking solution) followed by 3 10 minute washes in 0.1M PBS.
NPY and TUJ1 double label
For NPY and TUJ1 double label experiments, coverslips were incubated at room temperature
for 90 minutes with mouse anti-TUJ1 (R&D Systems, MAB1195; diluted 1:1,000 in blocking
solution) followed by 3 10 minute washes in 0.1M PBS and another incubation for 90 minutes
with secondary antibodies Alexa Fluor 488 Goat anti-Rabbit IgG (Life Technologies) and
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Alexa Fluor 546 Goat Anti-Mouse IgG (Life Technologies; both diluted 1:500 in blocking
solution).
NPY and UNC5D double label
For NPY and UNC5D double label experiments, coverslips were incubated at room tempera-
ture for 90 minutes with mouse anti-UNC5D (Abcam, AB58141; diluted 1:100 in blocking
solution) followed by 3 10 minute washes in 0.1M PBS and another incubation for 90 minutes
with secondary antibodies Alexa Fluor 488 Goat anti-Rabbit IgG (Life Technologies) and
Alexa Fluor 546 Goat Anti-Mouse IgG (Life Technologies; both diluted 1:500 in blocking
solution).
NPY, TUJ1 and Phalloidin triple label
For NPY, TUJ1 and Phalloidin triple label experiments coverslips were incubated at room
temperature for 90 minutes with chicken anti-TUJ1 (ABCAM, ab107216; diluted 1:1,000
in blocking solution) followed by 3 10 minute washes in 0.1M PBS and another incubation
for 90 minutes with secondary antibodies Alexa Fluor 488 Goat anti-Rabbit IgG (Life Tech-
nologies) and Alexa Fluor 647 Goat Anti-Chicken IgY H&L (ABCAM; both diluted 1:500
in blocking solution). This was followed by another 3 10 minute washes in 0.1M PBS, and
incubation in 3 units of Alexa Fluor 555 Phalloidin (Life Technologies, stock solution diluted
in 0.1M PBS) for 30 minutes.
All coverslips were then washed 3 times for 10 minutes in 0.1M PBS, counterstained with




2.5.3 Analysis of NPY neuron development
NPY and TUJ1 double labelled neurons in culture were imaged using an Olympus BX51
microscope. NPY, Phalloidin and TUJ1 triple labelled neurons, and NPY and UNC5D double
labelled neurons were imaged using a Zeiss 710 confocal microscope. Images of NPY
neurons were staged using established criteria (see Fig.2.2) [60, 71]. Briefly, stage one NPY
neurons were defined by having no neurite outgrowth; stage two were defined by having
multiple neurites, but no neurite longer than twice the width of the cell body; and stage three
were defined by the formation of a primary neurite with length greater than twice the width
of the cell body. During this analysis stage one NPY neurons were further sub-categorised n
into stage 1, defined by their symmetrical circular appearance, and stage 1.5, defined by the
breaking of cell symmetry with lamellipodial and microtubule protrusions but an absence of
neurites (see Fig. 2.3). Stage three growth cone analysis was carried out by using ImageJ
software to trace around the area of the growth cone labelled by both TUJ1 and NPY, where
the beginning of the growth cone was defined as where the neurite doubled in width before
terminating, and the encircled area calculated. Neurite number, length and branching of stage
three neurons were assessed using Image J software with the NeuronJ plugin [193].
2.6 Data analysis
All statistical analysis was conducted using PRISM software (GraphPad Inc., San Diego,
CA). All data are represented as a mean ± SEM and a P value of under 0.05 was accepted as
statistically significant. * P < 0.05, ** P < 0.01. G*Power 3 (v3.17) [79] was used to test
statistical power of all experiments where a significant change is reported.
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Fig. 2.2 Morphological differences between stage 1, 2 and 3 neurons in culture. Note
the appearance of multiple neurites at stage 2, and specification of the axon at stage 3. Fig.
modified from reference [71]
Fig. 2.3 Morphological differences between stage 1 and stage 1.5 neurons in culture.
Note the asymmetric appearance of lamellipodial and microtubule protrusions which mark
stage 1.5. Fig. modified from reference [60]
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Chapter 3
Prenatal NPY projections to the PVN
3.1 Introduction
The arcuate nucleus is a very crucial component of the hypothalamic control of feeding.
Peripheral signals such as leptin, ghrelin and insulin are received by arcuate neurons and
this information is relayed through hypothalamic feeding circuitry to other areas of the brain
in order to initiate feeding behaviour that is appropriate for the body’s needs [8]. Within
this nucleus resides a population of neurons defined by their co-expression of the orexigenic
peptides Neuropeptide Y (NPY) and Agouti-related protein (AgRP) [8]. Although NPY is
expressed in numerous areas throughout the brain, AgRP is only present in NPY expressing
neurons in the arcuate nucleus [105, 108].
Arcuate NPY neurons send projections to numerous different hypothalamic and extra-
hypothalamic nuclei [9, 104]. Of these, projections into the PVN, are extremely important in
the rapid feeding response [9]. Within the PVN oxytocin neurons are important regulators
of feeding. It has been shown that ICV injection of oxytocin into the brain suppresses food
intake in fasted rats, and that blocking the oxytocin receptor can reverse this effect [219, 220].
Not surprisingly then it is with this population of oxytocin neurons that NPY projections
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from the arcuate nucleus synapse. NPY and AgRP peptide from these projections are able
to powerfully override the anorexigenic effects of oxytocin in the PVN [279]. Firstly it
has been shown that direct injection of NPY into the PVN stimulates rapid feeding in rats.
Additionally Atasoy et al. (2012) have recently shown that optogenetic activation of PVN
projecting NPY neurons in the arcuate nucleus was enough to also induce rapid feeding in
mice [9]. They also found that the arcuate nucleus to PVN projection was the most important
part of NPY circuitry when it came to short term feeding behaviour [9].
It is with this in mind that the reduction of the arcuate nucleus to PVN NPY projection in
offspring who underwent gestation in obese mothers is of particular interest [102, 155, 259].
Before understanding how the formation of this projection pathway is being disrupted, it is
first necessary to understand at what time point in development it is occurring. Despite the
importance of NPY circuitry in the control of feeding, relatively little is known about the
timeline of its formation. The first studies in this area were undertaken in the mid 2000s. One
of the first to look at mice, as opposed to rats, was carried out by Bouret et al. (2004) and
used DiI to label axons extending out of the arcuate nucleus at a range of postnatal ages [24].
This study found little evidence of projections extending out of the arcuate nucleus at birth
indicating that this circuitry may form entirely during the postnatal period in the mouse. In
fact, they did not find any arcuate nucleus to PVN projections until 6 days after birth. Other
studies have generally agreed with these observations [104]. Although NPY positive axons
can be seen in the mouse PVN in the neonatal period it is rationalised that they are from a
NPY neuron population outside of the arcuate nucleus [104]. Collectively, this work implies
that, at least in the rodent model, neonatal environment is much more important that prenatal
environment in possibly influencing the development of arcuate NPY projections.
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However, there is some emerging evidence that NPY projections from the arcuate nucleus
to the PVN may begin to form before birth. About the same time that the original DiI
experiments were being undertaken, Nilsson et al. (2005) published a study looking at the
development of NPY neurons via AgRP expression. They found expression of Agrp mRNA
in the arcuate nucleus, albeit much lower expression than in the adult, and evidence of AgRP
positive axons in the PVN, over a week earlier than the Bouret et al. (2004) study [24, 212].
This timeline suggests that a subset of arcuate NPY neurons may begin to project their axons
in the prenatal period so that they are present in the PVN at birth. This is consistent with
other areas of the brain in which scaffold circuits are formed early, and then this scaffolding
is further elaborated on later in development [227, 277, 313]. If this is occurring in NPY
circuitry formation then the presence of initial prenatal projections opens up the possibility
of the maternal environment acting to reduce arcuate nucleus to PVN NPY projections.




3.1.1 Hypothesis and aims
I hypothesised that:
1 NPY neurons in the arcuate nucleus begin to extend their axons in the prenatal period
2 A subset of the final adult number of NPY neuronal projections will be present in the
PVN before birth
To address these hypotheses I aimed to:
1 Assess the developmental time course of NPY projections to the PVN during the
prenatal period
2 Confirm projections as originating in the arcuate nucleus via assessment of the speci-




3.2.1 Prenatal developmental timecourse of NPY projections
In order to understand the developmental timecourse of arcuate nucleus to PVN NPY pro-
jections NPY immunohistochemistry was undertaken in the prenatal mouse hypothalamus.
Ages in late gestation (GD15, GD17, P0) were focused on as this is just after when NPY
neurons in the arcuate nucleus start to differentiate and express Npy transcript.
At GD15 expression of NPY peptide was identified in cell bodies in the arcuate nucleus
(see Fig. 3.1A). At this age NPY positive axons were present both within the arcuate nucleus
and just dorsal to it indicating that NPY projections are beginning to leave the arcuate nucleus.
In the PVN at this age there were no identifiable NPY positive projections (see Fig. 3.1B).
At GD17 expression of NPY peptide was again found in arcuate nucleus cell bodies
(see Fig. 3.1C). Once again at GD17 NPY positive processes were identified within and
just dorsal to the arcuate nucleus indicating NPY projections are moving out of the arcuate
nucleus at this time point. In the PVN, clear NPY positive projections were present providing
evidence that arcuate nucleus NPY projections first make it to the PVN between GD15 and
GD17, albeit in low numbers (see Fig. 3.1D).
At P0 no NPY positive cell bodies were found in the arcuate nucleus (see Fig. 3.1E).
This is most probably due to the majority of NPY peptide being transported down to the
distal end of the axon as is the case in adulthood. In the PVN there was a large group of NPY




























Fig. 3.1 Expression NPY peptide in the developing arcuate nucleus and PVN at GD15 (A,B),
GD17 (C,D), and P0 (E,F). Arrows point to examples of NPY positive projections. Non
specific green label in (B) considered background. Arcuate nulceus, ARC; median eminence,
ME; third ventricle, 3V. Scale bar: 50µm.
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3.2.2 NPY and AgRP expression at birth
In order to confirm that the NPY positive projections identified in the PVN at P0 were indeed
from the arcuate nucleus I undertook immunohistochemistry in the hypothalamus to label
AgRP peptide in cell bodies and projections. I also used in situ hybridisation to label cell
bodies expressing Agrp mRNA as conformation I was identifying all neurons across the brain
which may be expressing AgRP peptide at this age.
In the PVN fewer AgRP positive axons than NPY postitve axons were found at this same
age, likely due to AgRP peptide not being transported as efficiently down the axon as NPY.
However there were a substantial number clearly present, and specifically occupying the
same area as we observed the NPY axons to be (see Fig. 3.2A, B). In the arcuate nucleus at
P0 AgRP positive cell bodies can be clearly observed (see Fig. 3.2C). This confirms their
presence here despite their lack of NPY immunoreactivity, which again is likely due to be
because NPY is transported away from the cell body. In addition to this AgRP positive
axons can be seen within the arcuate nucleus, indicating intra-arcuate circuitry has begun to
form, and axons can also be seen moving out dorsally from the arcuate nucleus along the
periventricular path to the PVN.
In the arcuate nucleus in situ hybridisation signal for Agrp mRNA can be seen in the
same area as AgRP peptide positive cell bodies (see Fig. 3.2D). This mRNA signal was not
observed in any other area of the brain, indicating that just like in the adult brain, at P0 Agrp











Fig. 3.2 Expression of AgRP and NPY peptide and Agrp mRNA in the P0 hypothalamus.
AgRP positive projections (A, examples labelled with arrows) and NPY positive projections
(B) in the PVN. AgRP positive cell bodies in the arcuate nucleus, and projections both
leaving the arcuate (arrow) and within the arcuate (arrowhead) (C). Agrp mRNA positive
cell bodies in the arcuate nucleus (D). Arcuate nucleus, ARC; median eminence, ME; third




3.3.1 NPY circuitry begins to form before birth
The data presented here show that during late gestation (GD15-P0) NPY projections have
already begun to move out of the arcuate nucleus and innervate the PVN. At P0 there are
a significant number of NPY positive projections in the PVN but a lower number of AgRP
labelled projections at this age. These data are in general agreement with the current literature
overall showing that in the rodent model, arcuate nucleus NPY circuitry is not fully developed
at birth [24, 104, 212]. These results are also in agreement with the 2005 Nilsson et al. study
which found expression of Agrp mRNA in the arcuate nucleus, and AgRP peptide positive
projections in the PVN at P0 [212], and support the hypothesis that, in the mouse, NPY
projections from the arcuate nucleus in to the PVN begin to develop prenatally.
As this study did not trace projections from the arcuate nucleus to the PVN an argument
could be made that the projections reported here are coming from another region of the
hypothalamus, or brain as a whole. In the case of NPY peptide this may be a possibility.
NPY is expressed in other areas of the brain, including the solitary tract nucleus (NTS) in the
brainstem, which may also project into the PVN [104, 105]. The developmental timecourse
of this projection is unknown and so it is not clear whether it begins to innervate the PVN
during the prenatal period, and thus could be a confounding factor to this analysis. However,
in the case of AgRP peptide, expression is seen specifically in the arcuate nucleus in the adult
brain, and is not reported to be transiently expressed in any other regions during development
[105, 108, 212]. To confirm this, in situ hybridisation was carried out in this study throughout
the P0 mouse brain and no evidence of Agrp mRNA expression outside of the arcuate nucleus
was found. This result, coupled with the observation of AgRP positive projections in the
PVN at this same age provides strong evidence that NPY neuron projections from the arcuate
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nucleus are present in the PVN at P0 and therefore must begin to innervate this region during
the prenatal period.
However the difference in levels of NPY and AgRP peptide in NPY neuron cell bodies in
the arcuate nucleus also needs to be considered. Despite high levels of expression at GD15
and GD17, in the P0 arcuate nucleus there were no cell bodies positive for NPY peptide.
This is a problem often encountered when labelling neuropeptides, such as NPY and AgRP,
which are shipped to the axon terminals rather than being stored in the cell body [104]. Since
strong NPY labelling was present in the PVN the most reasonable explanation is that the
NPY neurons in the arcuate nucleus are expressing NPY, but then immediately shipping it
down their projection. On the other hand, high levels of AgRP peptide were observed in the
cell bodies of the P0 arcuate nucleus. This suggests that AgRP may not be shipped down
to the axon terminal as readily as NPY peptide, providing an explanation for why there are
more AgRP than NPY cell bodies in the arcuate nucleus at P0, but fewer projections in the
PVN. A future study where NPY and AgRP are double labelled, and able to be visualised
simultaneously would be an important confirmation of this. In addition, at both GD15 and
GD17 NPY axons are observed leaving the arcuate nucleus and heading dorsally towards the
location of NPY projection target regions, such as the PVN. This further supports the notion
that the NPY axons observed in the PVN at GD17 and P0 are specifically coming from the
arcuate nucleus.
If this is the case, then it is at odds with the Bouret et al. (2004) study which traced
projections out of the arcuate nucleus using DiI labelling and found no evidence of projections
in the PVN until P6 [24]. DiI is a lipophilic dye which can label neuronal projections by
incorporating into the membrane of the cell, and is often used for the labelling of large or
dense axon tracts in the brain [11, 74, 96, 126, 215]. However the projections of axons out
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of the arcuate nucleus reported here are much less dense then their adult levels. Therefore it
is possible that DiI labelling is not a sensitive enough technique to identify these projections
until their density increases rapidly in the postnatal period.
3.3.2 Conclusions
The data presented here provides good evidence that the first projections from the arcuate
nucleus population of NPY neurons arrive at the PVN during the prenatal period. These
data are consistent with a model by which a small number of ‘pioneer’ axons traverse the
complicated path from the arcuate nucleus to the PVN, creating a scaffold over which later
axons can follow when this circuitry is massively elaborated on in the postnatal period.
This concept is interesting when addressing the issue of maternal obesity and the forma-
tion of bodyweight circuitry. It is known that in the mouse, exposure to a maternal obese
environment results in reduction of the arcuate nucleus to PVN NPY neuron projection
[102, 155, 259]. Pioneer axons are an intricately important component in the development
of neural circuitry. Studies have found that ablating or perturbing pioneer axons causes
disruption to the formation of major axon tracts within the vertebrate brain [190, 226, 227].
Additionally, Pittman et al. (2008) reported that misguiding pioneer axons in the zebrafish
resulted in misguidance of the ‘follower’ axons that formed later [227]. If components of the
maternal obese environment were able to disrupt the correct path finding of NPY pioneer
axons leaving the arcuate nucleus, on their way to the PVN, this would disrupt the ability of
the follower axons to find their way to the PVN during post natal elaboration of this circuitry.
Further analysis of how these prenatal projections develop is critical in the understanding of
how this disruption might occur.
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A Role for Netrin-1 in NPY neuron
development
4.1 Introduction
The formation of the nervous system is a extremely complex task dependent on the precise
spatial and temporal expression of many different developmental factors. These factors have
roles in specifying neural progenitor cells into their discrete neuronal phenotypes, guiding
the migration of these neurons into the correct location within the brain, and finally, initiating
and regulating the growth of axon projections to their target regions to form the connections
between neurons that are critical for proper brain function.
Very little is known about how projections from neurons in the arcuate nucleus develop
and how they form their connections. Leptin has been identified as having a trophic action
on neurite outgrowth from the arcuate nucleus neurons, and formation of neural circuitry
between the arcuate nucleus and its target regions. This observation came from a study which
found mice lacking functional leptin (often referred to as Ob/Ob mice), had decreased overall
innervation of these target regions, including the PVN, DMH and LHA, from the arcuate
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nucleus, and in particular decreases in innervation from the weight regulating NPY and
POMC neurons [25]. This phenotype could be reversed by intraperitoneal (IP) injection of
leptin during a critical window in the early postnatal period, however not when it was injected
during adulthood [25]. This time locks the trophic action of leptin on arcuate projections
into the early postnatal period, where it is known that a massive elabortaion of this circuitry
occurs [24]. However leptin does not seem to be playing a role in the development of this
circuitry prenatally. Although leptin is expressed by the fetus, no expression is detected in
the brain, and leptin receptor is not detected in the hypothalamus before birth [123].
As discussed in chapter 3 a small number of NPY neurons begin to extend their axons
to project into their target regions, such as the PVN, during the prenatal period. These
projections could well be acting as pioneers, marking a path for the bulk of axons out of the
arcuate nucleus to follow with the trophic effect of leptin encouraging their growth. This then
leads to the question of what factors are regulating the growth and guidance of the prenatal
pioneer projections out of the arcuate nucleus and along the complicated path to the PVN.
Not much is known about the expression of neurite growth cues in the fetal hypothalamus. A
few families of growth factors have been reported to be expressed there but exactly which
neuronal populations they are acting upon remains unclear [53, 323]. Likewise mice with a
deleted isoform of the growth factor Bdnf have decreased NPY and POMC innervation of
nuclei such as the PVN, implicating a possible role as a hypothalamic growth or guidance
cue [172]. However some of the clearest evidence for a neurite growth mechanism is the
discovery in our lab that GD17 NPY axons express DCC, a receptor for Netrin-1 [259].
Netrin-1 is a modulator of axon growth. Although its exact pattern of expression in the
developing mouse hypothalamus is not well described its broad expression pattern in the
developing brain, along the midline and ventral ventricular zone, is consistent with a role in
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hypothalamic development [267]. Netrin-1 was first recognised for its effect on the growth
cone of a developing axon, where it acts bifunctionally, positively affecting developing axon
growth cones which express the receptors DCC or Neogenin, and negatively affecting those
which express any of the UNC5 family of receptors (UNC5A-D) - sometimes dimerised
with DCC for long range effects [80, 124, 147, 325]. However Netrin-1 also has other well
described affects on axon growth away from the growth cone. For example it is involved
in axon branching, where it induces axon arbors in target regions or collateral branches off
the side of a developing axon, and axon specification, both important roles in the correct
development of neural circuitry [67, 184, 186]. Therefore if Netrin-1 is involved in the
formation of NPY projections then there are many different aspects of the growth of NPY
axons it may be involved in.
4.1.1 Hypothesis and aims
I hypothesised that:
The axon growth factor Netrin-1 is involved in the growth of NPY axons from the
arcuate nucleus to their target regions
To address this hypothesis I aimed to:
1 Define the expression pattern of Netrin-1 in the fetal hypothalamus




Figures 4.2 and 4.3B have been published in Endocrinology (Sanders et al. (2014) [259]).
4.2.1 Netrin-1 and its receptors within the developing hypothalamus
In order to understand the temporal and spatial expression pattern of Netrin-1 in the develop-
ing mouse hypothalamus I undertook in situ hybridsation. I focused on two ages, GD15 and
GD17, when NPY axons are beginning to leave the arcuate nucleus to project to the PVN
(chapter 3).
At GD15 Netrin-1 expression was detected throughout the medial basal hypothalamus,
an area which includes the arcuate nucleus (see Fig. 4.1A). At this age there was also a
distinct patch of expression in the DMH, which is also a target for NPY axons (see Fig.
4.1B). No expression was observed in any of the other hypothalamic regions targeted by NPY
projections, including the PVN. At GD17 Netrin-1 was expressed with in the arcuate nucleus
(see 4.2A). Expression was also observed in the PVN and VMH (see Fig.4.2B, C), but no
longer in the DMH. In both the GD15 and GD17 in situ hybridisation experiments sense
control probes were also used and showed no specific staining (see Fig4.2D for example).
The gene expression of Netrin-1 receptors in the arcuate nucleus was also investigated
using non-quantitative reverse transcription PCR (RTPCR). Arcuate nucleus was dissected
from fetal brains at both GD15 and GD17 and RTPCR was performed using primers specific
to all 6 Netrin-1 receptors (Dcc, Neogenin, Unc5a-d), and using water, in place of cDNA, as
a negative control. mRNA expression of all of these receptors was detected in both GD15
and GD17 arcuate nucleus samples (see Fig. 4.3A). Using immunocytochemistry it was also










Fig. 4.1 Netrin-1 in situ hybridisation staining in the GD15 hypothalamus. Netrin-1
is expressed in the medial basal hypothalamus including the arcuate nucleus (A) and the
dorsomedial hypothalamus (B). Dotted lines surround areas of staining. Third ventricle, 3V.












Fig. 4.2 Netrin-1 in situ hybridisation staining in the GD17 hypothalamus. Netrin-1 is
expressed in the arcuate nucleus (A), ventromedial hypothalamus (B), and paraventricular
nucleus (C). Arrow in (C) indicates broad area of Netrin-1 expression in the thalamus. Sense
probe negative control sections show no specific staining (D). Dotted lines surround areas of
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Fig. 4.3 Netrin-1 receptors are expressed in the developing arcuate nucleus. At both
GD15 and 17 RTPCR detected the expression of all Netrin-1 receptors in the developing
arcuate nucleus (A). Lanes on gel are as follows: 1. Npy (arcute nucleus specific positive
control), 2. Dcc, 3. Neogenin, 4-8. Unc5a-d, 9. Pgk1 (positive control). UNC5D is expressed
by cultured GD14 NPY neurons grown 2 days in vitro (B). Arrow points to NPY cell body,
and arrowheads demarcate the length of the primary neurite. MW, molecular weight marker,
100bp increments; Neg, negative control.
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4.2.2 Response of developing NPY neurons to Netrin-1 in vitro
In order to understand the function of Netrin-1 on NPY neuron development I established
an in vitro primary cell culture model of arcuate nucleus development. Cultured arcuate
nucleus neurons from GD15 fetuses were treated with either PBS vehicle control or 200
ng/mL Netrin-1 4 hours after plating. This concentration was chosen as it had been pre-
optimised within our laboratory as sufficient to induce a Netrin-1 response in fetal mouse
motor cortex neurons (see Appendix A). I then measured different growth parameters of
these NPY neurons after 2 days in vitro (2DIV).
Effects on neuron maturity
Firstly, maturity of control NPY neurons from GD15 fetuses which had been treated with
PBS was established. In order to do this, cultured neurons were immuno-labelled for NPY, to
identify NPY neurons, and neuron specific beta-tubulin (TUJ1) to visualise the microtubules
forming the entire neuronal cytoskeleton, including its processes. The developing neurons
were then categorised into one of 4 developmental stages (see Fig.4.4A) [60, 71]. There was
a mixed population of NPY neurons in terms of maturity, with 43.2% (± 5.8) of neurons with
no outgrowth (stage 1), 28.2% (± 2.6) with cellular asymmetry but no neurite outgrowth
(stage 1.5), 16.3% (± 4.7) with 2 or more neurites (stage 2), and finally 12.3% (± 3.0) with
one dominant neurite longer than twice the width of the cell body (stage 3) (n = 468 PBS
treated NPY neurons across 8 experiments, see Fig. 4.4B).
The same staging analysis was then carried out on NPY neurons which had been treated
with Netrin-1. A similar distribution of NPY neurons across the 4 stages was observed upon
Netrin-1 treatment, with slightly fewer in stage 1 (33.9%± 4.2), slightly more in stage 2
(22.7%± 5.0) and stage 3 (14.8%± 2.2), and very similar numbers in stage 1.5 (28.6%±
3.2) (n = 580 Netrin-1 treated NPY neurons across 8 experiments, see Fig. 4.4B). However
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none of these differences were statistically significant indicating that they are probably
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Fig. 4.4 Cultured GD15 NPY neurons display 4 developmental stages after 2DIV. Im-
ages of the 4 stages displayed by cultured GD15 NPY neurons (A), proportions in PBS and
Netrin-1 treated groups graphed in B. Neurons labelled for NPY (green), TUJ1 (red) and




Effects on the growth cone
I then moved to establishing the effect of Netrin-1 treatment on the growth and development
of the primary neurite in vitro. To do this I focused entirely on the stage 3 NPY neurons
present in the fetal arcuate nucleus cultures.
Stage 3 NPY neurons treated with Netrin-1 tended to have enlarged areas of tubulin
(TUJ1) immuno-label at the distal end of their primary neurite, an area associated with
growth cone formation (see Fig 4.5A). The size of these presumptive growth cones was
measured, defining the beginning of the growth cone as where the neurite shaft doubled in
width, and found that growth cone area was significantly increased in Netrin-1-treated NPY
neurons (average area of 118 µm2 ± 12.7) when compared to vehicle control treated NPY
neurons (average area of 74 µm2 ± 9.92, P<0.05, Student’s two-tailed t-test, 70% statistical
power, n = 75 PBS and 67 Netrin-1 treated stage 3 neurons across 10 experiments, see Fig.
4.5B).
To confirm this distal region of the NPY neurite was a growth cone, NPY neurons were
again immuno-labelled for NPY peptide and tubulin, but also stained with phalloidin, a toxin
which binds and labels f-actin. The distal end of the primary neurite in stage 3 NPY neurons
displayed classic growth cone morphology, with a tubulin rich central domain, and an actin
rich peripheral domain, and that it was this area that was enlarged in response to Netrin-1











































Fig. 4.5 Netrin-1 increases growth cone area in vitro. Examples of PBS and Netrin-1
treated stage 3 NPY neurons in culture labeled for NPY (green), TUJ1 (red) and DAPI (blue)
(A). White boxes outline area of TUJ1 staining which was measured as the growth cone,
beginning where the neurite shaft doubled in width. Growth cone area in Netrin-1 treated
group is significantly increased over the PBS treated group, graphed in B. n = 75 PBS and
67 Netrin-1 treated stage 3 neurons across 10 experiments. Scale bar, 10 µm. * P < 0.05,

















Fig. 4.6 NPY growth cones display classic morphology in vitro. Examples of growth
cones from PBS and Netrin-1-treated stage 3 NPY neurons in culture labeled for tubulin
(TUJ1, red) and F-actin (Phalloidin, blue). Merged images show tubulin staining in the




Effects on neurite growth
Lastly, I investigated the effect of Netrin-1 on the growth and development of the primary
neurite. It was observed that both PBS and Netrin-1-treated neurons had a similar average
number of branch points along their primary neurite (0.62 ± 0.17 and 0.67 ± 0.23, respec-
tively. See Fig.4.7A). Average total number of neurites extending from each stage 3 NPY
neuron was also assessed, but again no differences were found between the two groups (1.2
± 0.09 in PBS treated, and 1.3 ± 0.16 in Netrin-1 treated. See Fig. 4.7B).
In order to understand whether Netrin-1 has trophic actions on the development of
NPY neurites the average length of stage 3 neuron primary neurites was measured but no
differences were found in the Netrin-1 group when compared to the PBS treated group
(average length of 57.3 µm± 4.4 in the PBS treated and 59.8 µm± 3.8 in Netrin-1-treated.
See Fig4.7C). When average combined length of all neurites per NPY neuron was measured
a slight increase in length was found in the Netrin-1 treated group (77.7 µm± 9.1) over
the PBS treated group (65.2 µm± 4.0), however this change did not reach significance (see
Fig.4.7D). n=75 PBS and 67 Netrin-1 treated stage 3 neurons across 10 experiments for all




























































































Fig. 4.7 Netrin-1 has no effect of NPY neurite branching, number or length. Graphs
displaying average neurite branch point number (A), average total neurite number (B),
average length of the primary neurite only (C) and average total neurite length (D) in stage 3




Projections from NPY neurons begin to leave the arcuate nucleus around GD15 and first make
it to one of their target regions, the PVN, about GD17. The molecular cues that coordinate
this journey are currently unknown. I chose to focus on the axon growth regulator Netrin-1
as I knew that GD17 NPY projections leaving the arcuate nucleus expressed a receptor for
Netrin-1, DCC [259]. In addition to this I have found that mRNA for all 6 Netrin-1 receptors
are expressed in the fetal arcuate nucleus at GD15 and GD17, and confirmed that fetal NPY
neurons in primary culture express UNC5D. At these ages Netrin-1 mRNA is also expressed
in the fetal hypothalamus in a pattern consistent with NPY axon development. Based on this
evidence I defined the role of Netrin-1 in vitro in NPY axon growth cone elaboration.
4.3.1 Netrin-1 is expressed in the source and target regions of NPY
neuron projections
Netrin-1 mRNA was detected in the developing hypothalamus at both GD15 and GD17. At
GD15 expression was widespread throughout the ventral portion of the MBH, as well as
specific expression in the DMH. At GD17 Netrin-1 expression was found in distinct patches
in the arcuate nucleus, VMH and PVN. This pattern of temporally and spatially specific
Netrin-1 expression is consistent with Netrin-1 having a role in the modulation of NPY axon
growth and development.
Netrin-1 expression in the arcuate nucleus
At GD15 it appears that arcuate nucleus neurons would be surrounded by Netrin-1 signal
(see Fig. 4.1). During this time NPY neuron pioneer axons are initiating growth and moving
out of the arcuate nucleus (Chapter 3). By GD17, expression of Netrin-1 in this region had
distinctly changed. There was a clear patch of expression specifically located across the
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arcuate nucleus (Fig. 4.2). Additionally, all other Netrin-1 mRNA expression in the MBH,
save for a couple of specific nuclei (see section below) had ceased. When the pattern was
compared to the location of NPY cell bodies at the same age (Chapter 3) it became apparent
that Netrin-1 signal was located dorsally adjacent to the majority of NPY cell bodies, and
that developing NPY axons would move through this patch of expression on their way to
target regions.
Therefore it appears that Netrin-1 is expressed in the arcuate nucleus in a spatial and
temporal pattern consistent with involvement in the development of NPY neuron projections.
In other systems Netrin-1 has been found to be involved in initiation of axonal outgrowth.
Studies investigating this role of Netrin-1 have concentrated on it as a directional cue which
polarises the development of the neuron and specifies the axon [1, 184]. However work
on axon initiation in hippocampal neurons both in vitro and in vivo has found that neu-
ron polarity is determined during initial migration out of the ventricular zone by intrinsic
mechanisms [60]. Developmental cues later on initiate, rather than specify, the growth of
the axon [60, 61]. If this is also true of NPY neurons then Netrin-1 may be involved in
the initiation of axon outgrowth, consistent with the ubiquitous expression we see in the
ventral aspect of the MBH at GD15, rather than actual neuronal polarisation and specification
of where the axon will initiate, were we might expect Netrin-1 to be acting as a directional cue.
At GD17, Netrin-1 signal may also be involved in axon initiation, as the axons of some
NPY neurons are still initiating growth during this period. This could also include promoting
growth of the developing arcuate nucleus axons towards the high concentration of Netrin-1
more dorsally, and then acting as a long range cue to repel them further dorsally towards their
target regions, or localising them within the arcuate nucleus to receive further developmental
cues from their environment. Switches in Netrin-1 responsiveness by developing axons have
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been well described and can be under the control of either intrinsic (receptor expression
changes over time), or extrinsic (developmental cues in the environment) factors [272, 282].
Netrin-1 expression in NPY projection target regions
The possible role of Netrin-1 expression in the DMH (see Fig. 4.1) at GD15 is unclear. The
DMH is a known target region of NPY projections out of the arcuate nucleus [24, 63]. As
NPY projections into the DMH are diffuse over a large area it has not been possible yet to
reliably establish the timecourse of NPY innervation during the prenatal period. However, if
prenatal NPY projections follow a similar relative schedule to the well established postnatal
innervation of the DMH from the arcuate nucleus then they would arrive about 2 days before
projections to the PVN [24]. Since NPY neuron axons are present in the PVN at GD17
(Chapter 3) then it could be estimated that they might arrive at the DMH about GD15,
exactly when Netrin-1 is expressed in this area. Further to this, at GD17, Netrin-1 expression
has ceased in the DMH, but clear specific expression in the PVN and VMH was observed
(see Fig. 4.2). The expression of Netrin-1 in the PVN is of particular interest because it
overlaps with the timepoint at which NPY projections are beginning to innervate this region
(Chapter 3).
The finding of Netrin-1 mRNA expression in the VMH is also interesting. Although the
evidence in the field is not entirely clear cut, the VMH may receive a small amount of NPY
innervation, at least some of which could be from the arcuate nucleus as AgRP released from
NPY neurons can inhibit the activity of VMH neurons [171, 185]. Very little is known about
the timecourse of development of these projections as due to their small number, they are
largely ignored within the field. Further experiments cataloguing NPY projections through
the extent of the VMH in the adult brain, and when any projections might start to develop
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would be helpful in understanding a possible role of VMH expression of Netrin-1 in relation
to NPY axon development.
Netrin-1 expression within target regions could play several different roles in NPY
axon development. Netrin-1 has been well described as having axon guidance properties
[51, 148, 268]. Therefore a possible role of Netrin-1 expressed in the the NPY target regions,
the DMH and PVN, is as a long range cue, promoting axon growth into this area. However
in this scenario it must be noted that, especially at GD17, there is an absence of Netrin-1
signal along the periventricular path that NPY axons would take to their target regions. This
means that other axon guidance molecules are likely to be heavily involved in the directional
guidance of NPY axons en route to the PVN. Another role Netrin-1 might be playing in
NPY target regions is as a short range cue. For example, Netrin-1 also plays a role in axonal
branching once a neurite arrives at its correct target location [67]. Therefore one can imagine
a scenario in which, in a time dependent manner, Netrin-1 in NPY axon target regions may
act as a long range promoter of NPY axon growth into this area, or control branch behaviour
of newly arrived axons.
Other roles for hypothalamic Netrin-1 expression
When interpreting the expression pattern of such a prevalent neurodevelopmental regulator as
Netrin-1 it is important to keep in mind that expression within the developing hypothalamus
will not exclusively be responded to by developing NPY neurons. For example, at this
age GnRH neurons are projecting their axons from the pre optic area of the hypothalamus
down through the MBH to eventualy end up in the median eminence [66]. Several studies
have found that at least some of these GnRH projections appear to be guided by Netrin-1
signalling [66, 179]. In addition developing axons from extrahypothalamic neurons have also















Fig. 4.8 Schematic of Netrin-1 expression in the GD15 and GD17 hypothalamus. Netrin-
1 mRNA is expressed (purple shading) in both the source and target regions of NPY neurons
at GD15 (left) and GD17 (right). As indicated on the schematic, the possible roles of Netrin-1
in these locations include axon initiation, or as a directional cue, either short range out of the
arcuate nucleus, or long range towards target nuclei. PVN, paraventricular nucleus; DMH,
dorsomedial hypothalamus; VMH, ventromedial hypothalamus; LHA, lateral hypothalamic
area; NPY, NPY neurons in the arcuate nucleus.
neurons in the developing eye send projections which form the optic tract through the MBH,
eventually forming the optic chiasm at the base of this region [78]. This process is known to
be guided by Netrin-1 [66]. However the identification of Netrin-1 receptor in the arcuate
nucleus at both GD15 and GD17 (see Fig. 4.3) indicates that neurons in this region at least
have the potential to respond to Netrin-1 signalling. When specifically addressing Netrin-1
receptor expression by developing NPY neurons, work within our lab has already identified
that at GD17, NPY axons leaving the arcuate nucleus are expressing DCC [259]. In addition
it appears that primary cultured NPY neurons also express the receptor UNC5D (see Fig. 4.3).
Overall, from this in situ hybridisation data and Netrin-1 receptor analysis I concluded
that at both GD15 and GD17 Netrin-1 was expressed in both the source and targets of the
arcuate NPY axons in a pattern consistent with its involvement in aspects of arcuate nucleus
to PVN axon growth and development. In addition, Netrin-1 receptors were expressed within
83
4.3 Discussion
the developing arcuate nucleus, and specifically by NPY neurons indicating they have the
potential to respond to Netrin-1 signal.
4.3.2 NPY neuron growth cones respond positively to Netrin-1 in vitro
To further investigate the exact role of Netrin-1 in NPY axon maturation I moved to an in
vitro culture model where arcuate nucleus neurons from GD15 fetuses were cultured in vitro
for 2 days in the presence of 200 ng/mL Netrin-1. Choice of this age meant that NPY neurons
were assayed at roughly the same age that they would begin to send projections towards the
their target regions, and thus have their growth regulated by Netrin-1. Bath application of
Netrin-1 such as used here has been previously shown to model both positive and negative
growth responses to molecular guidance cues such as Netrin-1 via growth cone elaboration
or growth cone collapse [35, 270, 322]. We found that Netrin-1 treatment induced growth
cone elaboration in GD15 NPY neurons grown 2 days in vitro (see Fig. 4.5). While it is clear
that increases in growth cone area is indicative of a positive response to Netrin-1, its exact
relevance to the in vivo biology may have several different explanations.
Growth cone pausing
The large growth cone size, and looped microtubule morphology (see Fig. 4.6 for example)
often observed in the Netrin-1 treated NPY neurons is associated with growth cone pausing
behaviour [120]. Growth cone pausing has be linked with two different behaviours. Firstly,
growth cones pause and become more elaborate at decision points, intermediate targets or
upon entry into their target regions. For example work looking at developing retinal axon
growth cone morphology in vivo found that large paused growth cones were only found at
the optic chiasm where an extreme change in direction was required [187]. Other in vivo
work looking at developing callosal growth cones also found this same morphology was
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associated with growth cones pausing just below their targets, and then sending branches
into this area [112]. This fits well with the pattern of Netrin-1 expression we identified in the
NPY projection target regions in the developing hypothalamus. When NPY neuron growth
cones are exposed to Netrin-1 in vitro they may respond as they would when sensing target
derived Netrin-1 in vivo, pausing and elaborating their growth cones in preparation to either
change direction towards their target region or extend branches into it.
The other behaviour associated with growth cone pausing is in the formation of collateral
branches. It has been shown in vitro that the locations along the axon shaft where a growth
cone pauses later become sites where branches occur [112, 285]. From this observation it has
been proposed that the act of pausing in these situations is to rearrange the cytoskeleton of
the axon shaft to facilitate the formation of a branch later, once the growth cone has resumed
its forward advance [285].
Understanding if growth cone pausing by these mechanisms is responsible for the Netrin-
1 dependent elaboration in developing NPY neuron growth cones is difficult to tease apart
from the current data. If the growth cones were undergoing pausing behaviour, one simple
hypothesis to propose, is that the overall length that these developing neurites reach within 2
days in vitro would be reduced when compared to controls. When both primary and total
neurite length were measured in the cultured NPY neurons there was no difference between
the Netrin-1 and PBS treated groups (see Fig. 4.7). This could mean that the elaborated
growth cones are not associated with pausing activity and so are progressing forward at the
same rate as controls. However, PBS treated neurite length may not be the best control to use
in this circumstance as their length may be stunted by the absence of any growth factors. An
additional way that growth cone pausing could be identified is via analysis of the changes
in growth cone microtubule and actin content. When a growth cone pauses it undergoes
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changes in microtubule distribution, but not actin distribution [284]. In the current study only
the area of microtubule staining was quantified, so experiments looking at Netrin-1 mediated
actin changes at the growth cone would be a valuable future direction.
If NPY growth cones were undergoing pausing behaviour to produce collateral branches
then Netrin-1 treated NPY neurons would display an increased number of branch points on
their primary neurite. However, again there were no increases in this metric in the Netrin-1
treated group compared to the PBS treated group (see Fig. 4.7). Again this data is not
robust enough on its own to be convincing of a real lack of branching in the Netrin-1 treated
neurons. Firstly, the cultured NPY neurons were only grown for 2 days in vitro. In other in
vitro primary neuron culture systems branching will eventually occur on developing neurites
once they reach a certain level of maturity [71]. The overall lack of branching occurring on
NPY neurons in either treatment group suggests that they have not yet reached that level of
maturity and thus any future analysis of NPY branching should focus on neurons grown 3-4
days, or perhaps even longer, in vitro. Additionally Netrin-1 is well known to also induce
collateral branching in a manner independent of the growth cone [67]. With the current
experimental set up, where branching was assessed only at the end point of the experiment, it
would be impossible to distinguish between growth cone dependent and independent Netrin-1
branching effects.
To further understand possible Netrin-1 induced pausing behaviour in NPY neuron growth
cones some further experiments would need to be undertaken. Currently the cultures are
limited by the fact that they are a mixed population of arcuate nucleus neurons, and it is
impossible to tell which ones are NPY neurons until the cultures have undergone immunocy-
tochemistry. However, our lab has very recently acquired an Agrp-Ires-cre [294] mouse line
that, when crossed with a floxed fluorescent reporter mouse, would enable the identification
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of NPY neurons prior to immunocytochemistry. This would allow timelapse experiments in
which the speed of advance of specific NPY growth cones could be measured, resulting in a
better understanding of whether the amount of time they spend displaying pausing behaviour
correlates to the size of their growth cone. The specific locations along the developing neurite
that the growth cone pauses could also be recorded in order to understand if this correlates
to future sites of branch formation. This could be contrasted with looking at growth cone
independent branching effects of Netrin-1, by specific application of Netrin-1 to one region
of an NPY neurite to induce a localised branching effect [67]. If Netrin-1 dependent growth
cone pausing was identified in vitro, further in vivo work could be attempted in order to
understand the biological relevance of this behaviour. Portera-Cailliau et al. (2005) carried
out an elegant set of experiments following the in vivo growth trajectory of developing axons
of neocortical neurons in intact mouse pups during the first three weeks of postnatal life
using two-photon imaging [236]. A similar experiment to understand the growth trajectories
and locations of pausing behaviours of initial NPY projections could be undertaken, however
this would have to use a slice culture model due to these projections developing prenatally,
and in much deeper brain regions than the neocorical neurons of the Portera-Cailliau et
al. (2005) study. This technique would still be quite technically demanding, and require
specialised imaging technology, so a more straight forward experiment could be set up by
co-culturing fetal arcuate nucleus and PVN explants, which may still answer some of the
same questions. For example, similar studies have been carried out with other developing
hypothalamic nuclei, or in other regions of the nervous system, to study the role of target




Apart from pausing behaviour, the elaboration in NPY neuron growth cones may be due to
Netrin-1 acting as a positive guidance cue. In this scenario the increase in overall growth
cone size would be a normal response to a situation not usually encountered in nature. That
is to say, developing growth cones usually encounter Netrin-1 in a gradient, directional
concentration and not a diffuse uniform concentration throughout their environment as in this
in vitro assay. In the presence of a gradient of Netrin-1, as receptors along one side of the
the leading edge bind Netrin-1 the growth cone becomes polarised, and will either elaborate
or collapse, depending on whether it is attracted or repulsed by this cue [92]. Therefore it
follows that, in vitro, if a growth cone is surrounded by Netrin-1, this polarisation cannot
occur and all sides will either elaborate or collapse in response.
However, while the current culture data presented here are consistent with a role for
Netrin-1 in NPY axon guidance it is in no way conclusive. To robustly show the ability of
Netrin-1 to direct developing NPY axons, a guidance assay would need to be carried out.
Again, with the acquisition of the Agrp-Ires-cre mouse line and the ability to identify NPY
neurons before immunocytochemistry this could be undertaken in the current dissociated
cultures using a pipette assay. A pipette would be positioned near a known developing NPY
neuron, providing a constant directional source of Netrin-1, and then the positive or negative
turning angle of the developing neurite analysed. A directional assay could also be under-
taken using fetal arcuate nucleus explants and a directional source of Netrin-1 in a collagen
gel assay such has been used widely to show the effects of Netrin-1 and other guidance cues
[179, 217, 250]. This would allow NPY neurons to be labelled using immunocytochemistry
after the experiment has been carried out. However since it is unknown how many other cell
types in the fetal arcuate nucleus have the capacity to respond to Netrin-1 , this type of assay
may become confounded by indirect effects. For example, NPY axons may not be responsive
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to Netrin-1 but may appear to be guided directionally due to following other non-NPY axons
which are responsive. Therefore a specific directional assay would be preferable.
It is interesting to note at this point that while the average growth cone size of Netrin-1
treated NPY neurons across a specific culture experiment increased, not every single indi-
vidual NPY neuron exposed to Netrin-1 responded in this way. The sub population which
did not display increased growth cone size may well be non-responsive to Netrin-1. This
is not entirely surprising because previous data from our lab has found DCC receptor is
expressed by most, but not all, GD17 NPY axons leaving the arcuate nucleus [259]. Other
cues may well be responsible for the guidance of subpopulations of NPY axons, such as
BDNF, which had been implicated in NPY neuron growth due to decreased NPY innervation
of the PVN and DMH in a knock out model [172]. Alternatively the NPY neuron growth
cones which appear unresponsive to Netrin-1 treatment may actually be negatively responsive
to Netrin-1 and thus experience growth cone collapse instead of growth cone elaboration.
Again, this is quite a likely scenario since fetal NPY neurons appear to express both DCC
and UNC5D. To further analyse this it would be important to specifically tailor growth cone
analysis to NPY neurons either expressing DCC on its own, which would be expected to have
increased growth cone size in the presence of Netrin-1, or UNC5D either on its own or in
concert with DCC, which would be expected to have decreased or no growth cone size in vitro.
4.3.3 NPY neurons in culture are a mixed population
In order to assess the maturity of GD15 NPY neurons in culture after 2 days growing in
vitro the neurons were staged using established criteria [71]. I found that roughly 70% of
NPY neurons were in stage 1 or 1.5 having developed no neurite outgrowth, and the other
30% were in stage 2 or 3 having begun the process of neurite outgrowth (see Fig. 4.4).
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This range of developmental stages is representative of the NPY neuronal population at this
time point because NPY neurons differentiate across several days (~GD13-15), so some will
be more mature than others and presumably more ready to begin projecting neurites [222].
Additionally, as the neurons are cultured very soon after they differentiate we would also
expect that the majority of them would be in immature stages.
This mixed population of NPY neurons fits well with the hypothesis that a small number
of pioneer neurons begin to innervate NPY projection targets during the prenatal period and
are followed by a mass elaboration of this circuitry during the postnatal period (Chapter
3). Therefore the proportions of stage 1 and 1.5 in comparison to the proportions of stage
2 and 3 would be representative of the fact that only pioneer neurons would be putting out
neurites in this initial prenatal stage. Another interpretation of the staging data, which may
not be entirely exclusive of the previous one, is that the the staggered development of NPY
neurons is an intrinsic mechanism by which they can be defined into distinct subpopulations.
During development all NPY neurons would be exposed to a similar set of developmental
factors to regulate their differentiation, migration and guidance into their correct phenotype
and anatomical location. However, variation could be introduced into this system by how an
individual NPY neuron responds to a given factor depending on its maturity. For example, a
axon growth cue such as Netrin-1 would have a different effect on a stage 3 NPY neuron with
an already defined primary neurite, as opposed to a stage 1 neuron which has no neurites for
Netrin-1 to act upon. By this mechanism, different waves of developmental factors, could
affect and define different subpopulations of NPY neurons entirely based on their maturity.
This is consistent with studies carried out in the adult brain which find that specific target
regions are innervated by defined subpopulations of NPY neurons in the arcuate nucleus [9].
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Investigation of the growth properties of the less mature NPY neurons would be ben-
eficial in further understanding this system. For example, it would be interesting to grow
the GD15 arcuate nucleus cultures for longer in vitro and assess the proportions of the
different stages of neuron maturity as they have longer time to develop. Additionally, if
NPY neurons are given longer to grow in culture their response to different axons growth
factors in vitro could be assessed. For example if the stage 2 and 3 NPY neurons in the
2 days in vitro cultures were representative of pioneer neurons they would be responsive
to guidance factors such as Netrin-1, where as if the stage 1 and 1.5 neurons represent the
follower neurons they would to be responsive to non directional growth cues, such as leptin
which they are exposed to postnatally, in order for them to elaborate preexisting circuitry [25].
Treatment with Netrin-1 did not affect the proportions of different developmental stages
in culture (see Fig. 4.4). Several studies have investigated Netrin-1 as a factor which
specifies which neurite will become the axon [1, 184]. As described above (see section
4.3.1), it is possible that this is due to Netrin-1 encouraging the axonal growth of an already
predetermined neurite, rather than being the factor that actually polarises the neurons and
specifies the axon [60, 61]. Therefore, as the growth of the axon is essentially what defines
stage 3 neurons it was conceivable that Netrin-1 treatment might increase their number
in vitro. While there was no overall significant change in the proportion of stage 3 NPY
neurons in Netrin-1 treated cultures there was a slight trend towards a general increase in the
proportion of stage 2 and 3 NPY neurons. The GD15 arcuate nucleus cultures were analysed
after 2 days growth in vitro which meant that the majority of NPY neurons were still in a
relatively immature state (Stage 1 and 1.5). Therefore, further experiments where cultures
were left to grow for longer in vitro would be valuable as this would increase the pool of




The data presented in this chapter represent novel findings on the role of the axon growth
factor, Netrin-1, in the prenatal development of arcuate nucleus NPY neurons, and support
our hypothesis that it is involved in the growth of NPY axons from the arcuate nucleus to their
target regions. This data suggests 2 possible roles for Netrin-1 in NPY axon development.
Firstly, Netrin-1 may be acting to encourage growth cones to undergo pausing behaviour. If
this were the case it could be further hypothesised that Netrin-1 expression in the arcuate
nucleus may be acting to pause developing NPY growth cones as they first initiate, and
allowing them to identify and respond to further developmental cues to modulate their growth
to their targets. Additionally Netrin-1 expression in NPY axon target regions may act to
pause growth cones to encourage branching, or correct synaptic connections in these regions.
Netrin-1 may also be acting as a guidance factor. If this is the case then Netrin-1 expres-
sion in the arcuate nucleus may be acting to repulse NPY axons out, towards their targets,
whereas expression in target regions could be an attractive force, to encourage growth of
NPY axons into these areas. A role for Netrin-1 in guidance would have to be in concert with
other guidance factors as, especially at GD17, there is no Netrin-1 expression in intermediate
target regions along the periventricular path these axons take to their targets. These other
guidance factors would most likely include the slits, semaphorins and ephrins, which are
known to be expressed in other regions of the developing hypothalamus [53, 323]. These
two possible roles of Netrin-1 are, of course, not mutually exclusive. Additionally, although
the data was unsupportive, it cannot be totally ruled out that Netrin-1 plays roles in other
parts of NPY axon growth, such as branching and axon initiation.
Overall, I have be able to identify and characterise a large part of the Netrin-1 response in
NPY neurons which lays down groundwork for the future study. This could take advantage
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of transgenic mouse technologies to carry out directional growth and guidance assays, and
timelapse experiments, to determine the details of how NPY neurons respond to Netrin-1,
and how Netrin-1 signalling collaborates with other developmental cues to correctly form
NPY projections to their target nuclei.
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Chapter 5
Maternal obesity and IL-6 affect NPY
neuron development
5.1 Introduction
It is well established from both epidemiological studies in human populations, and experi-
mental studies in animal models that maternal obesity leads to an increased risk of obesity in
offspring (see table 1.1 and table 1.2). Additionally, rodent studies have been instrumental
in our understanding of the relative contributions of the prenatal and postnatal environment
complicated by maternal obesity on offspring obesity predisposition. Work in the field has
largely focused on the postnatal environment, and the effect of neonatal overfeeding on
offspring phenotype [88, 95, 231, 264]. However, studies where mice underwent gestation in
high fat fed mothers and then were cross fostered at birth to control fed mothers showed that
offspring still developed predisposition to obesity [39, 269]. This time locks a contribution
of the prenatal environment towards this phenotype, however the mechanism behind this
observation remains to be elucidated.
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Interestingly, evidence is mounting to implicate the maternal immune response in the
predisposition of offspring to obesity. Maternal obesity is associated with low-grade inflam-
mation characterised by increases in inflammatory cytokines in both the maternal circulation
and the placenta [36, 38, 248]. Further to this, it has recently been shown in our lab using a
maternal high fat diet (mHFD mouse model), that the fetus itself is exposed to the inflam-
matory environment, with increases in the cytokines interleukin-6 (IL-6), interleukin 17A
(IL-17A) and interferon gamma (IFNG) in the fetal circulation [153]. Of particular interest
is the increase in IL-6, as when IL-6 is injected into pregnant rats this results in offspring
with increased adipose tissue and body weight [59].
In other circumstances where the maternal immune system is activated, increased levels
of pro-inflammatory cytokines, including IL-6, have been implicated in dysregulated fetal
brain development, and subsequent risk of neurological disease. In rodents, maternal immune
activation (MIA) results in offspring with a phenotype modelling schizophrenia including
deficits in prepulse inhibition (PPI), latent inhibition (LI), anxiety, locomotion and social in-
teraction [197, 274]. Interestingly, the inflammatory cytokine IL-6 seems to play a significant
role during MIA. Use of an IL-6 receptor knock out mouse, or co- administration of an IL-6
antibody, is able to fully prevent the ability of MIA to induce a schizophrenic-like phenotype
[274]. Therefore it seems likely that IL-6 is directly affecting fetal brain development in the
MIA model.
Similarly, maternal obesity during pregnancy appears to affect fetal neurodevelopment.
For example, it has been reported in both rat and Japanese macaques mHFD models that
offspring have reduced NPY innervation of the PVN [102, 155]. Additionally, in the mHFD
mouse model, our lab has recently reported that this decreased innervation of the PVN is
present at birth, indicating that NPY projections are being affected by the mHFD environment
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prenatally [259]. This poses the intriguing possibility that increased IL-6 that the developing
fetus is exposed to during maternal obesity may be acting to disrupt the correct development
of hypothalamic feeding circuitry, resulting in offspring with dysregulated control of body
weight. The data in the preceding two chapters of this thesis have suggested that NPY neuron
pioneer projections develop prenatally (Chapter 3), and that this process may be, at least in
part, under the control of the axon growth cue Netrin-1 (Chapter 4). Therefore disruption
of NPY neuron Netrin-1 signalling pathways by IL-6 represents a possible mechanism by
which prenatal exposure to maternal obesity could predispose offspring to later life obesity.
5.1.1 Hypothesis and aims
I hypothesised that:
Increased exposure to the pro-inflammatory cytokine interleukin-6 (IL-6) during maternal
obesity directly impairs Netrin-1 signalling and disrupts the growth and development of
NPY neurons.
To address this hypothesis I aimed to:
1 Identify Netrin-1 receptor expression changes in the fetal arcuate nucleus in response
to maternal obesity in vivo
2 Determine if these expression changes can be replicated by IL-6 exposure in vitro




The data presented in this section (5.2, Fig. 5.1) were submitted as preliminary findings for
the degree of Master of Science, awarded December 2012. They are included here as they
form the preliminary work of this chapter and work during my PhD included increasing the
sample sizes and statistical power of these experiments for publication [259]).
To investigate whether maternal obesity was able to affect Netrin-1 signalling I used a
mHFD mouse model and qRT-PCR to determine whether the expression levels of Netrin-1 or
its receptor Dcc in the arcuate nucleus were different between GD17 fetuses developing in
mHFD compared with control fed mothers. I found that the arcuate nucleus of GD17 fetuses
developing in mHFD mothers showed a significant increase in Dcc expression (mean fold
change 1.45 ± 0.18, P = 0.03, Student’s two-tailed t-test, 70% statistical power, n = 6 pooled
litters, see Fig. 5.1). However, I did not identify any significant change in arcuate nucleus
expression of Netrin-1 between the 2 groups (mean fold change 1.25 ± 0.16, P = 0.19, n = 6
pooled litters, see Fig. 5.1).
In order to understand if the cytokine interleukin-6 (IL-6) might be, at least in part,
responsible for the gene expression changes I observed in fetal arcuate nucleus from obese
mothers, I used an in vitro slice culture assay. GD17 fetal arcuate nucleus tissue was
exposed to 100 ng/mL IL-6 and then changes in gene expression analysed. Exposure to IL-6
significantly increased the expression of Dcc approximately 2 fold (mean fold change 2.1 ±
0.37, P = 0.04, Student’s two-tailed t-test, 80% statistical power, n = 5 pooled litters, See Fig.
5.1) over vehicle treated arcuate nucleus tissue, a similar change to that which I observed
in mHFD fetal arcuate nucleus. Again there was no significant change to the expression
of Netrin-1 in IL-6 treated arcuate nucleus (mean fold change 1.3 ± 0.17, P = 0.11, n = 5






























Fig. 5.1 Maternal HFD (mHFD) and IL-6 increase Dcc gene expression in the GD17
arcuate nucleus. Bar graphs showing the relative fold change in gene expression for Netrin-
1 and Dcc when exposed to mHFD in vivo, and IL-6 in vitro, compared with controls. n
= 6 and 5 pooled litters both mHFD and IL-6 groups, respectively. * P<0.05, Student’s





Figure 5.2 has been published in Endocrinology (Sanders et al. (2014) [259]).
5.3.1 Netrin-1 receptor expression in response to mHFD in vivo and
IL-6 in vitro
To investigate whether maternal obesity affected the expression of Netrin-1 receptors other
than Dcc I analysed GD17 arcuate nucleus expression of the Unc5 family of receptors
(Unc5a-d). I found that the arcuate nucleus of GD17 fetuses developing in mHFD mothers
displayed a significant decrease (mean fold change 0.63 ± 0.08, P = 0.002, Student’s two-
tailed t-test, 80% statistical power) in Unc5d receptor expression (see Fig. 5.2A). I identified
no significant change in the expression of the other Unc5 receptors Unc5a (mean fold change
0.83 ± 0.12), Unc5b (mean fold change 0.86 ± 0.08) or Unc5c (mean fold change 0.72 ±
0.12), although there was a trend of decreased expression (see Fig. 5.2A). There was no
significant change in arcuate nucleus Neogenin gene expression in response to mHFD (mean
fold change 1.04 ± 0.1, see Fig. 5.2A).
Since I had previously found that in vitro IL-6 treatment was able to induce similar
changes in Dcc gene expression to maternal obesity, I again undertook an in vitro slice
culture assay to assess whether Unc5d expression might respond similarly. However, I
detected no significant change in GD17 arcuate nucleus Unc5d expression (mean fold change


























































Fig. 5.2 Maternal HFD (mHFD), but not IL-6, decreases Unc5d gene expression in the
GD17 arcuate nucleus. (A) Bar graph showing the relative fold change in GD17 arcuate
nucleus gene expression for Netrin-1 receptors Neogenin and Unc5a-d when exposed to
mHFD in vivo. (B) Comparison of relative fold changes in Unc5d expression in responce
to mHFD in vivo and IL-6 treatment in vitro. n=5 and 6 pooled litters for mHFD and IL-6




5.3.2 Response of fetal NPY neurons to IL-6 in vitro
In order to understand the effect of IL-6 on NPY neuron development I treated fetal NPY
neurons in primary cell culture with 100 ng/mL IL-6 on its own (IL-6 group), or in combina-
tion with 200 ng/mL Netrin-1 (IL-6/Netrin-1 group) 4 hours after plating. I then measured
different growth parameters of these NPY neurons after 2 days in vitro (2DIV).
Effects on neuron stage
Having already established the normal proportions of NPY neuron stages in 2 DIV cultures
(Chapter 4) I moved to looking at how this changed in response to IL-6 treatment. I found
that IL-6 treatment alone had no significant effect on the proportions of NPY neurons in each
developmental stage (stage 1, 44.1% ± 6.6; stage 1.5, 25.9% ± 5.6; stage 2, 17.1% ± 2.2;
12.9% ± 4.0) compared with PBS vehicle treatment (stage 1, 43.4% ± 2.1; stage 1.5, 31.9/%
± 2.1; stage 2, 11.8% ± 0.5; 13.0% ± 2.7; see Fig 5.3). n=343 PBS and 458 IL-6 treated
NPY neurons across 5 experiments for all staging analyses.
Effects on the growth cone
I was also interested in how IL-6 might affect the normal NPY growth cone response to
Netrin-1. Firstly I found that in the IL-6/Netrin-1 treated NPY neurons the normal growth
cone response to Netrin-1 appeared to be inhibited, with the average growth cone area
(average area 82.66 µm2 ± 12.67) not deviating significantly from PBS vehicle treated NPY
neurons (average area 84.67 µm2 ± 18.04, P = 0.99, see Fig. 5.4). n = 25 PBS, and 31


























Fig. 5.3 IL-6 has no effect on NPY neuron stage. Bar graph displaying the proportions of
each of the 4 stages of NPY neuron development in PBS (vehicle) and IL-6 treated groups. n


















































Fig. 5.4 IL-6 inhibits the Netrin-1 dependent growth cone response in vitro. Bar graphs
showing (A) significant increased in NPY neuron growth cone area in response to Netrin-
1 treatment (data from Fig. 4.5), and (B) inhibition of this response when neurons are
treated with IL-6 in combination with Netrin-1. n = 75 PBS and 67 Netrin-1 treated neurons
across 10 experiments (graph A), n = 25 PBS and 31 IL-6/Netrin-1 treated neurons across 5
experiments (graph B). * P < 0.05, Student’s two-tailed t-test
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Effects on neurite growth
Lastly I investigated the effects of IL-6 on the growth and development of the primary neurite,
both in the context of a direct effect and modulation of a possible Netrin-1 response. There
was no significant effect of IL-6 on neurite branching with average branch point numbers
being similar in the IL-6 treated (0.6 ± 0.11) group when compared to the PBS vehicle
control (0.80 ± 0.22) treated group (see Fig. 5.5A). Similarly, no effect was seen in the
average total number of neurites extending from stage 3 NPY neurons in the IL-6 (1.18 ±
0.06) groups when compared to the PBS vehicle control (1.2 ± 0.09) treated group (see Fig.
5.5B). There was also no significant effect of combined IL-6 and Netrin-1 treatment on either
of these metrics (average branch point number, 0.86 ± 0.3; average neurite number, 1.19 ±
0.06) compared with the PBS treated group (see Fig 5.5A, B).
The effects of IL-6 on neurite length were also analysed. I measured the average length
of stage 3 neuron primary neurites but found no difference in the IL-6 (average length 61.39
µm ± 4.2) treated group when compared to the PBS treated group (average length 61.89
µm ± 4.0, see Fig. 5.5C). No difference was found in total neurite length between the IL-6
treated group (average length 65.2 µm ± 4.0) and the PBS treated group (average length
71.01 µm ± 5.73, see Fig. 5.5D). Again, combined IL-6 and Netrin-1 treatment also had
no significant effect on average length of the primary neurite (66.6 µm ± 10.0) or average
total neurite length (77.37 µm ± 9.7) over the PBS treated group (see Fig. 5.5C, D). n = 36




























































































































































































































































































































Maternal obesity during pregnancy is associated with increases in proinflammatory cytokines,
including IL-6, which may play a role in the maternal programming of offspring obesity.
Since it has already been identified that offspring of obese mothers have decreased NPY
innervation to the PVN, and I have shown that Netrin-1 may be involved in the development
of NPY projections (Chapter 4) I investigated changes in fetal arcuate nucleus Netrin-1
signalling as a result of maternal obesity in vivo or IL-6 treated in vitro. After identifying
changes in Netrin-1 receptor expression which implicated IL-6 in the fetal programming
effects of maternal obesity, I moved to looking at the effect of IL-6 treatment on Netrin-1
signalling in NPY neurons in culture. Here I identified changes to NPY neuron Netrin-1
growth cone responsiveness.
5.4.1 Netrin-1 receptor expression is altered by maternal obesity in the
fetal arcuate nucleus
Both the Netrin-1 receptors Dcc and Unc5d were found to have altered gene expression in the
arcuate nucleus of fetuses developing in high fat fed mothers, in comparison to control fed
mothers. Expression of Dcc was up-regulated where as Unc5d was down-regulated which is
interesting because these two receptors mediate opposing responses by developing axons to
Netrin-1. Therefore this represents an imbalance in two important receptors which dictate
the way in which a developing axons respond to a growth cue in their environment, and thus




Effects on axon guidance
One way in which this Netrin-1 receptor imbalance might perturb the development of NPY
projections to their target regions is if Netrin-1 is acting as a directional guidance cue, a
role consistent with the data presented in chapter 4. In systems where Netrin-1 signalling
is better described the ratio of DCC receptor to UNC5 receptor by a growth cone has been
shown to be instrumental in the correct (either attractive or repulsive) response to Netrin-1
[207, 214]. Although when present alone, DCC mediates attractive growth cone responses to
Netrin-1, it is also involved in growth cone repulsion when dimerised with UNC5 receptors
[124, 147, 214]. This is hypothesised to allow a growth cone to be sensitive to low concen-
trations of Netrin-1 in cases of long range repulsion, whereas in short range, high Netrin-1
concentration situations, UNC5 receptors are sufficient to mediate repulsion alone [183]. In
C. elegans, mutations in unc-5 result in a high level of pathfinding errors in VD motor neuron
axons, which are normally repulsed dorsally by a ventral source of Netrin-1 [117, 214]. This
is most likely due to both a loss of UNC5 mediated repulsion of axons dorsally, but also an
excess of DCC receptor, now not dimerised with UNC5, mediating attraction back towards
the ventral source of Netrin-1 [183, 214]. As described in the previous chapter (Chapter
4), Netrin-1 is expressed specifically in the arcuate nucleus at GD17 where it could play a
role in repulsing NPY neuron axons out towards their more dorsally located targets. It is
therefore possible to imagine a situation in which decreased expression of Unc5d causes
pathfinding errors in arcuate nucleus axons, such as from NPY neurons, similar to what is
observed in the VD axons of unc5 mutant C. elegans. Additionally, the increased expression
of Dcc would only exacerbate this phenotype by further increasing attraction of axons back
to the ventral source of Netrin-1 expression.
Supporting this model are studies where ratios of DCC and UNC5 receptors present
in developing axons have been observed to change in vertebrate systems in response to
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pathological conditions. For example, it has been reported that, in a mouse slice culture
model of epilepsy, aberrant neuronal activity upregulates expression of Unc5a, switching
Netrin-1 mediated attraction of hippocampal mossy fibres to repulsion [207]. This results in
miswiring of hippocampal neural circuitry [207].
Effects on axon pausing
The effects of Dcc/Unc5d imbalance on a role for Netrin-1 signalling in NPY neuron growth
cone pausing, as proposed in the previous chapter, are less clear. It is known that growth
cone expansion responses to Netrin-1 in dissociated culture models are mediated through
DCC [270]. The role of the UNC5 receptors in growth cone pausing is currently unknown.
Since DCC mediates growth cone expansion, and UNC5 receptors usually act in the opposite
way to DCC, then it could be speculated that they may be involved in growth cone collapse.
Therefore one possible result of Dcc up regulation and Unc5d down regulation in this sce-
nario is that growth cones may stay paused in in the arcuate nucleus for longer than usual,
or pause in intermediate locations where they normally would not. This would mean that
growth cone advance would be slower and the developing axons may be delayed making it
to their target regions.
In order to better understand the effect of the receptor gene expression changes seen in the
mHFD exposed fetal arcuate nucleus genetic manipulation experiments could be undertaken.
For example, in culture NPY neurons could be manipulated to over-express Dcc transcript
and under express Unc5d transcript, via use of constitutive expression vectors and siRNAs,
respectively. The phenotype of these NPY neurons, and their responsiveness to Netrin-1,
could then be assessed. Additionally genetic mouse models of Dcc over expression, or
Unc5 under expression could be used to assay the development of NPY projections in vivo,
although assessing the combined effects together in one mouse model would be technically
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difficult. Lastly an in vitro timelapse assay of NPY projection development in situ in slice
culture would be incredibly beneficial to assay for directional and pausing defects, however,
again, replicating the combination of Netrin-1 receptor changes in this experiment would be
difficult.
5.4.2 Netrin-1 receptor expression is altered by IL-6 in the fetal
arcuate nucleus
Once it was established that maternal obesity was affecting the expression of Netrin-1 re-
ceptor in the arcuate nucleus an in vitro slice culture assay was used to determine if IL-6
might be responsible for these changes. It was found that after a 1 hour acute treatment
with IL-6, Dcc gene expression was upregulated in the GD17 arcuate nucleus in a manner
which mirrored the effects of maternal obesity. This finding indicates that increased levels of
circulating IL-6 may be, at least in part, responsible for the gene expression changes observed
in fetal arcuate nucleus from obese pregnancies, and in turn the aberrant development of
NPY projections. This is consistent with previous studies that found injection of IL-6 during
pregnancy is able to both predispose offspring to obesity and perturb their neural development
[59, 274]. It is also consistent with previous work from our lab which indicated that in vitro
IL-6 had the ability to perturb the development of axons out of the fetal arcuate nucleus [259].
Exactly how IL-6 is acting to affect expression of Dcc is currently unclear. IL-6 is able
to directly affect the expression of target genes by the activation of the transcription factors
signal transducer and activator of transcription 3 (STAT3) or ERK1/2 [119, 329]. Previous
work I had carried out involved using in silico analysis to predict possible transcription
factor binding sites in the promoter region of the Dcc gene [259]. It was found that Dcc
contains predicted binding sites for downstream molecules in the IL-6 signalling pathway,
such as nuclear factor-κB (NFκB) and IL-6 regulatory element binding protein [259]. This
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is consistant with findings in other systems that NFκB is a modulator of IL-6 transcriptional
changes in the Netrin-1 signalling pathway [200]. Further analysis of the Dcc promoter could
shed light on exactly how IL-6 might be regulating it. For example, promoter dissection
studies would help identify key regions of the Dcc promoter which are key in IL-6 mediated
regulation of expression.
There is also the possibility that IL-6 is acting to intrinsically change the way developing
arcuate nucleus neurons express Dcc via an epigenetic mechanism (discussed further in
chapter 6). However since this change in receptor expression appears over such a short
period of IL-6 treatment it seems more likely that IL-6 is acting as an extrinsic modulator
of acute changes in gene expression. This does not exclude the possibility that chronic
exposure to IL-6, such as would probably be seen by the fetus during maternal obesity, could
cement intrinsic changes in Dcc gene regulation. Therefore further analysis of IL-6 mediated
epigenetic modifications of Dcc would be an interesting future direction.
Intriguingly, when Unc5d expression was analysed in IL-6 treated arcuate nulceus no
change was identified. This is at odds with the observation that Unc5d expression is down-
regulated in fetal arcuate nulceus from obese pregnancies, and indicates that IL-6 does not
appear to be involved in the regulation of this gene. This is perhaps not entirely surprising
because maternal obesity is associated with increases in a range of different factors which
the developing fetus may be exposed to, and it is unlikely that just one is responsible for all
the changes we see. For example, when levels of cytokines in fetuses exposed to maternal
obesity in the mHFD mouse model were measured it was identified that along with IL-6,
there were significant increases in the cytokines IL17A and IFNG [153]. Similar to IL-6, both
these cytokines signal via activation of transcription factors such as the STATs or NFκB and
therefore are good candidates for directly regulating Unc5d expression [90, 280]. In addition
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there are likely numerous other factors increased during maternal obesity such as fatty acids
or other signalling molecues which could be responsible for gene expression changes in
fetuses exposed to maternal obesity. Future experimental work focusing on treating arcuate
nucleus slice cultures with some of these other factors and analysing gene expression changes
may help to clarify the cause of down regulated Unc5d expression. Additionally, in silico
analysis of the Unc5d promoter region may help to identify binding regions for specific
factors or signalling pathways to narrow down the list of candidates.
The major limitation of both the in vivo and in vitro gene expression analyses performed
here is that they were assessed across all of the cell types present in the arcuate nucleus.
When interpreting these results we assumed that the overall gene expression changes in the
arcuate nucleus would be representative of gene expression changes occurring in developing
NPY neurons. However this may not be the case. To avoid this problem in the future, cell
type purification techniques such as fluorescence-activated cell sorting (FACS) or immuno-
magnetic cell separation could be used to isolate only the NPY neurons in the fetal arcuate
nucleus samples [222, 247]. Additionally, further gene expression analyses of this type
could take advantage of laser capture and single cell qRTPCR technologies to assess gene
expression changes specifically in NPY neurons [145].
5.4.3 IL-6 disrupts NPY axon response to Netrin-1 in vitro
To further investigate how IL-6 might affect Netrin-1 signalling and general axon devel-
opment in NPY neurons I utilised dissociated cultures of GD15 arcuate nucleus neurons
which I had developed for study in chapter 4. The cultures were treated with a combination
of 100 ng/mL IL-6 and 200 ng/mL Netrin-1 or PBS vehicle control. When I assessed the
average growth cone area of NPY neurons which were vehicle PBS treated, or treated with a
combination of IL-6 and Netrin-1 I found no difference in size between the two groups. The
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data from this experiment had a lower number of biological replicates than the experiments in
chapter 4 where I found that under normal circumstances NPY neurons respond positively to
Netrin-1. However, the lack of even a trend of growth cone responsiveness strongly suggests
that IL-6 is able to block Netrin-1’s effects on NPY axon development. This finding is
interesting because at first it appears to be discordant with the response which would be
predicted from the gene expression analyses. As described above (sections 5.4.1 and 5.4.2)
if Dcc expression is increased and Unc5d decreased it would be expected that growth cone
responsiveness would be increased, not diminished. However this result may indicate that
IL-6 affects Netrin-1 signalling in more than one way, both at the gene expression level, and
further down the signalling pathway.
Where else IL-6 might interfere with Netrin-1 signalling in NPY neurons is not entirely
clear. One possibility is that IL-6 is causing acute changes in calcium signalling. Positive
growth cone responses to Netrin-1 via the DCC receptor are mediated by calcium signalling
[125, 179, 213]. In other, both in vitro and in vivo, models of neuro-inflammation it has been
found that chronic exposure to IL-6 alters calcium signalling [208, 302]. In particular it is
interesting to note that IL-6 appears to reduce the levels of L-type Ca2+ channels [302]. When
blocked these channels have been shown to switch positive growth responses of Netrin-1
responsive growth cones to negative ones [125]. Therefore IL-6 mediated disruption of
calcium signalling represents an intriguing model of how normal Netrin-1 responses might
be disrupted in fetuses from obese pregnancies exposed to IL-6 during gestation. Further
analysis of this mechanism could include specific pharmacological blocking of L-type Ca2+
channels in NPY neuron cultures to investigate whether this replicates the phenotype observed
in IL-6 treated cultures. Additionally, western blot analysis of calcium channel expression
levels in IL-6 NPY neuron cultures would be valuable.
112
5.4 Discussion
Another possibility is that the absence of Netrin-1 growth cone response observed in
combined Netrin-1/IL-6 treated cultures is not a direct effect of IL-6 itself. How long IL-6
persists in vitro is unclear, although in vivo studies estimate its half life to be anywhere from
20 to 55 minutes in rat plasma to 4.2 to 15 hours in humans [34, 202, 308, 318]. Additionally,
IL-6 signalling activates the expression of suppressor of cytokine signalling 3 (SOCS3)
through a feedback mechanism, and SOCS3 is in turn known to be inhibitory of neurite
growth [56, 198]. Therefore a situation could arise in which by the time the neurons are
assayed, at 48 hours, there may be little or no functionally active IL-6 left in the culture
system, however the effects of SOCS3 may still be evident leading to the inhibited growth
cone response which appears to be directly related to IL-6. In order to more accurately assay
the effect of IL-6 on NPY growth cone Netrin-1 response it would be helpful to treat the
neuron cultures more acutely with Netrin-1, only a few hours before assaying growth cone
size. This would better represent the effect of IL-6 on the Netrin-1 response while it is still
biologically active.
Lastly, gene expression analysis in the slice culture experiments is representative of the
overall changes across the whole arcuate nucleus, not NPY neurons in particular. Expression
analysis of Netrin-1 receptors specifically in the IL-6 treated cultured NPY neurons would
help to clear up some of these inconsistencies. In addition, mRNA expression levels of
receptors, as assessed in this study, are not always directly correlative with functional
receptor protein levels as growth cone dynamics are mediated by local changes in protein
synthesis [33, 293]. It is possible that IL-6 may somehow act to decrease DCC receptor
levels at the growth cone, which in turn could cause the neuron to up regulate the Dcc mRNA
production. A mechanism such as this could explain an IL-6 effect that suppressed growth
cone responsiveness to Netrin-1, via decreased receptor levels, while also causing an increase
in mRNA expression. Further analysis of DCC protein levels and distribution in response to
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IL-6 and Netrin-1 using both immunocytochemistry and western blotting is necessary here to
fully understand IL-6 mediated changes in DCC receptor levels.
5.4.4 Validity of the in vitro IL-6 exposure model
In the data presented in this chapter I attempted to model in vitro some of the effects of NPY
neuron development in vivo during maternal obesity by treating both fetal arcuate nucleus
slice and dissociated cultures with the cytokine IL-6. While this model has highlighted some
interesting potential effects of IL-6 exposure on NPY neuron development there are some
overall limitations of this approach. Firstly, while it has been shown that IL-6 is increased in
the fetal circulation during maternal obesity it is not known for sure that the fetal brain is
exposed to it [153]. It is likely that IL-6 in the fetal circulation can gain access to the arcuate
nucleus, similar to what is observed in the adult, either via the blood brain barrier (BBB),
or free diffusion if the BBB is not yet fully formed [12, 232]. However, experiments where
tagged IL-6 is traced across the BBB into the fetal, or even early postnatal, brain would be
valuable.
Another limitation of this study is the high concentration of IL-6 which the slice and
dissociated cultures were exposed to. The concentration used here (100 ng/mL) is several
orders of magnitude higher than the concentration of IL-6 detected in the circulation of
fetuses from mHFD pregnancies (~3 pg/mL) [153]. Often neurons in culture require higher
than physiological concentrations in order for a response to be identified. This can be due to
changes in receptor regulation and how the factor is presented to them in their environment.
Additionally, although we know the concentration of IL-6 in fetal blood we have no idea
what concentration it might be in the brain, where the NPY neurons would be exposed to
it. Despite this, it would be important for additional experiments to include a IL-6 dosage
response in case it elicits different responses at lower concentrations. Further experimental
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work might also include an in vivo approach utilising genetically modified mice where IL-6
is over expressed, or knocked out to see if the maternal obesity programming effect could be
either replicated, or abated.
5.4.5 Conclusions
Overall, the data presented in this chapter support my hypothesis that increases in the pro-
inflammatory cytokine interleukin-6 (IL-6) during maternal obesity directly impairs Netrin-1
signalling and disrupts the growth and development of NPY neurons. Exposure to maternal
obesity deregulates the expression of key Netrin-1 receptors, and this phenotype appears
to be at least partially replicated by IL-6 treatment in vitro where similar gene expression
changes occur and NPY neuron growth cone development is dysregulated.
These data support a model by which increases in IL-6, and other cytokines, in the fetal
circulation during maternal obesity result in exposure of developing NPY neurons to these
factors which they would not normally encounter during the fetal period. This exposure then
results in a combination of different signalling changes which results in dysregulation of the
normal schedule and mechanisms of NPY axon growth leading to aberrant development of
NPY projections into their target regions.
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Chapter 6
Maternal obesity causes intrinsic
changes in NPY neuron development
6.1 Introduction
During the formation of the nervous system the particular fate that a developing neuron will
assume is determined by a combination of different signals that it is exposed to. These signals
can be intrinsic, cell autonomous cues, or extrinsic factors in the local environment. It is by a
combination of these mechanisms that a relatively small group of extrinsic developmental
factors can define the large number of different neuronal cell types present in the adult
nervous system.
A striking example of the combination of extrinsic and intrinsic signals governing cell
fate is in the differentiation of neural progenitor cells into either neurons or glia. Neocortical
stem cells cultured from rat fetuses early in their development will differentiate at much
higher frequency into neurons than glia [137, 238]. However if they are cultured later this
ratio is reversed, indicating that there is an intrinsic ‘clock’ within these stem cells which
dictates their fate [137, 238]. Extrinsic factors also appear to be important in this process as
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certain growth factors can either enhance this differentiation process, or override it - changing
the ratios of neurons and glia produced at the different timepoints [137, 238]. In vivo the
combination of intrinsic and extrinsic influences on the neural stem cell populations will
determine the exact spatial and temporal distribution of the cell types they give rise to in the
mature brain.
The interaction of both extrinsic and intrinsic mechanisms are also critically important
later in neuron development. A developing axon from a specific neuron would be exposed to
a deluge of different factors in its local environment. All of these cues have the potential to
influence the growth of the axon, however intrinsic mechanisms within that neuron, including
the expression of specific receptors and the signal transduction pathways they are coupled to,
will mean the axon only responds to a select group of extracellular, extrinsic cues in order
to develop correctly. For example retinal ganglion cell (RGC) axons change their response
to a Netrin-1 cue several times during their journey from the retina to the tectum. They are
attracted towards Netrin-1 as they leave the retina, then become unresponsive, and finally are
repulsed by Netrin-1 as they approach the tectum [65, 272].
The way in which aberrant environmental factors negatively affect the normal develop-
ment of cell types such as neurons can also be thought of as acting either extrinsically or
intrinsically. Often this is thought of as an entirely extrinsic scenario, where the presence of
a factor acts to derail development of a particular cell type as it is occurring, only when the
factor is present. However it is also possible for environmental factors to disrupt a certain
developmental event before it occurs by altering a cell’s intrinsic properties. Therefore an
environmental insult that occurs early in development could still have dramatic effects on
events that occur much later in development.
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As discussed in chapter 5 I have identified that the proinflammatory cytokine IL-6 can
elicit changes in the expression of Netrin-1 receptors and thereby alter and NPY neuron
responsiveness to Netrin-1. I identified these changes in an acute culture model which defined
the potential of IL-6 to act extrinsically to derail NPY axon growth. However this does not
rule out the potential of IL-6, or other factors the fetus is exposed to in an environment of
maternal obesity, to also alter the intrinsic ability of NPY neurons to develop normally.
6.1.1 Hypothesis and aims
I hypothesised that:
Maternal obesity intrinsically changes the way NPY neurons develop and respond to cues
in their environment.
To address this hypothesis I aimed to:
1 Identify intrinsic changes in the baseline development of NPY neurons derived from
fetuses developing in obese dams
2 Identify intrinsic changes in the Netrin-1 responsiveness of NPY neurons derived from




6.2.1 Intrinsic changes in NPY devlopment in response to mHFD
In order to understand the intrinsic effect of maternal obesity on NPY neuron development I
cultured GD15 NPY neurons from both control and maternal high fat diet (mHFD) pregnan-
cies and assessed their growth properties after 2 days in vitro. This allowed me to remove all
extrinsic influences in the mHFD environment, and concentrate solely on intrinsic differences
between the two groups when cultured in identical conditions. In addition to this I also
treated the cultures with PBS vehicle control or Netrin-1 4 hours after plating to investigate
intrinsic differences in Netrin-1 responsiveness.
Effects on neuron stage
I first compared the proportion of NPY neurons in each stage between the control (c) and
mHFD (hf) pregnancies I found significant differences in the proportion of stage 1 and stage
1.5 NPY neurons. There was a significant increase in the proportion of stage 1 neurons
present in the mHFD cultures treated with PBS (hfPBS, 45.4% ± 2.1) over the control
cultures treated with PBS (cPBS, 32.9% ± 5.5, P = 0.0096, 2 way ANOVA with Tukey’s
post hoc multiple comparisons test. See Fig. 6.1B).
Additionally there was a significant decrease in the proportion of stage 1.5 neurons
present in the hfPBS (21.3% ± 2.1) cultures over the cPBS cultures (33.6% ± 2.1, textitP =
0.001, P = 0.04. 2 way ANOVA with Tukey’s post hoc multiple comparisons test. See Fig.
6.1C). Proportions of stage 2 and 3 NPY neurons did not differ significantly between the
control and mHFD culture groups (see Fig. 6.1A).
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I then assessed the effect of Netrin-1 on the NPY neurons from control and mHFD
pregnancies and found no effect on the proportion of neurons in each developmental stage
in either the PBS or Netrin-1 treated groups (see Fig. 6.1A). This is consistent with what
I had already established in chapter 4. When I compared the proportions of neurons in
stages 1 and 1.5 between the cNetrin-1 (stage 1, 37.1% ± 3.3; stage 1.5, 30.22% ± 2.7) and
hfNetrin-1 (stage 1, 50.7% ± 2.2; stage 1.5, 19.9% ± 1.0) groups I found the same increase
in stage 1 and decrease in stage 1.5 neurons in the hf group (stage 1, P = 0.0036; stage 1.5,
P = 0.04; 2 way ANOVA with Tukey’s post hoc multiple comparisons test. See Fig. 6.1B,
C). This is consistent with a mechanism unrelated to Netrin-1 signalling perturbing NPY
neuron stage in mHFD exposed NPY neurons. n = 736 cPBS, 717 cNetrin-1, 783 hfPBS,
675 hfNetrin-1 NPY neurons across 5 experiments for all staging analyses. All significant

























































































































































































































































































































































































































Effects on the growth cone
I then moved to assessing how mHFD might affect the development of NPY neuron growth
cones in culture, and their normal response to Netrin-1. Firstly I found that stage 3 NPY neu-
rons from control pregnancies responded positively to Netrin-1, as I had already established
in chapter 4. Average NPY neuron growth cone area in Netrin-1 treated control cultures
(cNetrin-1, average area 104.48 µm2 ± 13.47) was significantly elevated over PBS treated
control cultures (cPBS, average area 60.06 µm2 ± 9.05, P = 0.02, 1 way ANOVA with
Bonferroni’s post hoc multiple comparisons test. See Fig 6.2).
However, this response appeared to be attenuated in the mHFD cultures. While Netrin-1
treated NPY neuron growth cones still had an increased area (hfNetrin-1, average area 94.13
µm2 ± 13.47) over PBS treated (hfPBS, average area 62.26 µm2 ± 8.35) this effect was no
longer significant (P = 0.2, 1 way ANOVA with Bonferroni’s post hoc multiple comparisons
test. See Fig 6.2). Comparisons between the control and mHFD cultures were not significant
(both cPBS vs. hfPBS, and cNetrin-1 vs. hfNetrin-1 P > 0.9). n = 75 cPBS and 61 cNetrin-1
stage 3 NPY neurons across 8 experiments, and 52 hfPBS and 45 hfNetrin-1 stage 3 NPY

























Fig. 6.2 mHFD may attenuate Netrin-1 growth cone response in NPY neurons Bar graph
showing the average growth cone area of NPY neurons cultured from fetuses exposed to
control (c) or mHFD (hf) pregnancies and treated with PBS or Netrin-1. n = 75 cPBS and
61 cNetrin-1 stage 3 NPY neurons across 8 experiments, and 52 hfPBS and 45 hfNetrin-1
stage 3 NPY neurons across 6 experiments. * P<0.05; ns, not significant; 1 way ANOVA
with Bonferroni’s post hoc multiple comparisons test, 80% statistical power.
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Effects on neurite growth
Lastly I investigated the effects of mHFD on the growth and development of the primary
neurite. There was no significant effect of mHFD on neurite branching with average branch
point numbers not differing significantly between any of the control cultures treated with
PBS (cPBS, 0.55 ± 0.23) or Netrin-1 (cNetrin-1, 0.43 ± 0.21), or the mHFD cultures
treated with PBS (hfPBS, 0.52 ± 0.14) or Netrin-1 (cNetrin-1, 0.42 ± 0.13, P = 0.1, one
way ANOVA, see Fig. 6.3A). Similarly, no effect was seen in the average total number
of neurites extending from stage 3 NPY neurons in the cPBS (1.4 ± 0.2), cNetrin-1 (1.8
± 0.6), hfPBS (1.5 ± 0.3) or hfNetrin-1 (1.3 ± 0.1, P = 0.8, one way ANOVA, see Fig. 6.3B).
The effects of mHFD on neurite length were also analysed. Average length of the primary
neurite of stage 3 NPY neurons in each of the culture groups were measured (average length
78.0 µm ± 15.84, 68.21 µm ± 6.40, 63.96 µm ± 5.76, 62.03 µm ± 5.01 for cPBS, cNetrin-1,
hfPBS, and hfNetrin-1 cultures, respectively) but did not differ significantly (P = 0.6, one
way ANOVA, see Fig. 6.3C). Lastly, average total neurite length of stage 3 NPY neurons
was also measured (average length 78.19 µm ± 13.25, 83.74 µm ± 18.13, 73.46 µm ± 7.46,
70.56 µm ± 5.28 for cPBS, cNetrin-1, hfPBS, and hfNetrin-1 cultures, respectively), but
again, this did not change significantly between the groups. (P = 0.9, one way ANOVA, see
Fig. 6.3D). n = 75 cPBS and 61 cNetrin-1 stage 3 NPY neurons across 8 experiments, and
52 hfPBS and 45 hfNetrin-1 stage 3 NPY neurons across 6 experiments for all branch point,














































































































































































































































































































































The factors that derail NPY neuron development during maternal obesity could act in an
extrinsic or intrinsic manner. In the previous chapter (chapter 5) I investigated the ability of
IL-6 to extrinsically affect Netrin-1 responsiveness in NPY neurons. Therefore in this chapter
I moved to investigating possible intrinsic growth differences between cultured GD15 NPY
neurons from both control and mHFD pregnancies. I identified changes in the proportion of
NPY neurons in each of the 4 stages of in vitro development, and changes in NPY neuron
responsiveness to Netrin-1.
6.3.1 mHFD intrisically affects NPY neuron maturity
Broadly speaking, cultured fetal neurons go through several stages of morphological de-
velopment which were defined in rat hippocampal neurons in the late 1980s by Dotti et al.
(1988) [71]. In the 2 days in vitro GD15 arcuate nucleus cultures, NPY neurons representing
the first threes stages of development were identified. That is, no neurite outgrowth (stage
1), multiple short neurites (stage 2), and specification of an axon via the rapid growth on
one neurite (stage 3) [71]. However, in the NPY neurons I identified an additional stage of
development not originally identified in hippocampal neurons. Therefore, stage 1 neurons
were further classified into stage 1, where neurons were symmetrical and had no neurite
outgrowth, and stage 1.5, where the symmetry of the cell body had been broken by bulging
of microtubules in regions around the cell body but no neurites were observed. Stage 1 and
stage 1.5 are analogous to stage 0 and stage 1, respectively, of the re-evaluation of the classic
stages of cultured hippocampal neuron development carried out by de Anda et al. (2008) [60].
In mHFD cultures there were a significantly higher proportion of stage 1 NPY neurons
over controls, and a significantly lower proportion of stage 1.5 NPY neurons (see Fig. 6.1).
From this data it appears the NPY neurons from mHFD exposed fetuses are in a more
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immature state than those from control fetusus. This was observed to the same degree in both
control PBS treated and Netrin-1 treated NPY neurons indicating that this effect of mHFD
on NPY neuron maturity was independent of Netrin-1 signalling. This is unlikely to be due
to a general delay in neural development in mHFD fetuses as effects on brain development
tend to be region specific. For example, a study of the fetal development of the hippocampus
in mHFD mice found that development appeared to be delayed in the dentate gyrus, with
decreased neurogenesis and differentiation when compared with controls [211]. However, by
contrast, differentiation in the cortical and hippocampal neuroepithelium was increased [211].
Therefore changes seen in NPY neuron development are likely to also be region specific,
if not specific to NPY neurons themselves. Further analysis of non-NPY arcuate nucleus
neuron maturity, and neurons from other regions of the brain in the mHFD model would
confirm this.
Exactly how the mHF environment might be affecting the ability of NPY neurons to ma-
ture in culture is uncertain although it appears to be via disruption of an intrinsic mechanism
regulating NPY neuron development. This is evident by the fact that although both mHFD
exposed and control NPY neurons were cultured in identical conditions they still develop
differently. This means that observed differences are not due to extrinsically acting factors
present in vivo but instead due to intrinsic changes in neuron development between the two
groups.
A mechanism for mHFD NPY neuron immaturity
One scenario which could explain the phenotypes observed in mHFD exposed NPY neurons
is that the intrinsic timing mechanism of the neuron is disrupted or slowed down. Although
the mechanisms which drive the differentiation and development of arcuate nucleus NPY
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neurons is at present unknown it is likely that they rely on a combination of intrinsic and
extrinsic signals to initiate each stage of development at a specific timepoint. Therefore it is
possible that, due to an earlier environmental insult the intrinsic mechanisms which regulate
NPY development are delayed, impinging on the ability of the neurons to mature correctly.
One place this could conceivably be occurring is during neurogenesis. If NPY neurons
were being generated later then they might be in a more immature state in culture. However,
this was concluded to be unlikely as it has been described previously that there appears to
be no changes to fetal arcuate nucleus cell density or levels of neurogenesis as a result of
exposure to maternal obesity [39].
Another place where NPY neuron development may be affected is during polarisation.
Neurons are one of the most polarised cell types within the body, and every neuron must
undertake this process, defining developing processes as axon or dendrite, in order to develop
correctly [15]. The transition between stage 1 and 1.5 in NPY neuron is the first morpho-
logical change which observably breaks the symmetry of the neuron cell body. It is at this
stage that microtubules will begin to bulge in regions where neurites are beginning to sprout
[60, 61, 93]. The increased proportion of stage 1, and decreased proportion of stage 1.5, NPY
neurons from mHFD exposed cultures suggests that these neurons are delayed, or inhibited,
from going through this process. However exactly how this might be occurring is unclear.
There is some debate in the literature about the relative contribution of intrinsic and
extrinsic signals during the process of neuron polarisation. Work highlighting the importance
of intrinsic signals comes largely from hippocampal neuronal cultures where polarisation
still occurs in vitro despite the absence of possible polarising extrinsic environmental cues
[71]. This observation led to studies showing that these hippocampal neurons are already
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polarised very soon after leaving the cell cycle, possibly as a result of requiring the formation
of a leading and trailing edge in order to migrate to their correct anatomical location before
forming projections [60, 61]. In fact even more recent evidence suggests that the intrinsic
mechanisms which determine neuron polarity may be inherited by a daughter neuron from
the progenitor cell it divided from [233]. This fits well with a mechanism by which an envi-
ronmental insult early in development, such as might occur during maternal obesity, could
directly affect neural progenitor cell in a way that would affect their ability to intrinsically
define correct polarity in their daughter cells, such as NPY neurons. This would give rise to
a population that when cultured would fail to, or be delayed in, developing morphological
polarisation in the absence of that original environmental insult.
In contrast to this, there is also a large body of literature which explores the extrinsic
factors in the local environment of the developing neuron which may affect its polarisation.
Interestingly, Netrin-1, when present in culture as a bound gradient is able to polarise hip-
pocampal neurons, with more axons emerging from the side of the neuron facing the highest
concentration of Netrin-1 [184]. This study also found that the neurotrophic factor BDNF
was able to both positively and negatively polarise neurons in a concentration dependent
manner [184]. In addition, dissociated cortical neurons have been shown to polarise in a
similar manner when exposed to Sema3A [234]. These observations also hold in vivo where
Netrin-1 signalling has been shown to be instrumental in C. elegans motor neuron axon
specification [1].
The possible polarisation defects evident in mHFD exposed NPY neurons appear not to be
the direct result of changes in extrinsic factors because the environment they were cultured in
was devoid of these cues. While they were exposed to Netrin-1, as discussed in chapter 4 this
factor did not have any effect on normal NPY neuron maturation when bath applied as it was
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here. However, it is possible that extrinsic factors are responsible for polarising NPY neuron
development very soon after differentiation. If this was the case then an environmental insult
could affect an extrinsic factor which would in turn cause the NPY neuron to not properly
undergo polarisation, and once cultured appear intrinsically different to control NPY neurons.
In reality, it is probably a combination of both intrinsic and extrinsic factors which
determine the polarisation of NPY neurons in vivo. The data presented here fit with an
overall mechanism by which an early insult by factors within the mHFD environment
disrupts the normal mechanisms for NPY polarisation, be they intrinsic, extrinsic, or both.
This then leads to changes in the ability of the exposed NPY neurons to develop polarised
structures later in development, even though they are no longer exposed to the original mHFD
environmental factor. Further experimental work would be wise to firstly establish whether
intrinsic differences in mHFD exposed NPY neurons delay polarisation, or entirely inhibit
this process. This could be carried out, either by using timelapse microscopy to continuously
document NPY development in vitro or by assessing stage proportions in control and mHFD
exposed NPY neurons after longer growing in vitro. In addition further work could utilise
techniques to visualise intercellular components to detect exactly when NPY neurons become
polarised, as has been done in hippocampal cultures [60, 61]. Developmental factors such
as Netrin-1 could also be introduced in vitro in gradients to understand further the extrinsic
factors regulating polarisation.
Effects of mHFD NPY neuron immaturity
This disruption of the correct temporal development of NPY neurons could have long lasting
effects on hypothalamic bodyweight circuitry. As was discussed in chapter 4, the pool
of NPY neurons cultured from the GD15 hypothalamus displayed a range of different
developmental stages. One explanation for this that NPY neurons in different stages of
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development represent the different waves of projections which leave the arcuate nucleus,
from initial pioneer axons, to later follower axons. Another explanation is that the different
stages of NPY neuron development represent different populations of NPY neurons which
respond to developmental cues in a specific way, and go on to innervate specific target
regions. In both these interpretations, if a group of NPY neurons are delayed in their
development, as is evident in the mHFD exposed NPY neurons, then they will no longer be
in the correct developmental stage to respond to cues which define the correct development
of their projections. Even if they eventually caught up to the rate of normal development later
on in the postnatal period they would have already missed critical windows in which their
correct developmental trajectory would be defined. This could result in aberrant development
of NPY projections and contribute to the decreased innervation of the PVN, and other target
regions, that is observed in offspring of mHFD mothers [155, 259].
6.3.2 mHFD intrisically affects Netrin-1 responsiveness
In chapter 4 it was identified that NPY neuron growth cones respond positively to bath
applied Netrin-1 in vitro by increasing in size. Here, this effect was replicated with cultured
NPY neurons from control pregnancies, however with NPY neurons from mHFD pregnancies
the effect of Netrin-1 on the growth cone was no longer significant. This indicates that there
may be an intrinsic difference between the control and mHFD exposed NPY neurons in terms
of their response to Netrin-1.
While not as dramatic in nature the decrease in growth cone response to Netrin-1 in the
mHFD group is similar to the inhibition of a Netrin-1 growth cone response by in vitro IL-6
treatment described in chapter 5. Here it was found that IL-6, an extrinsic factor increased
in the mHFD environment, could directly affect the expression of key Netrin-1 receptor
genes and dysregulate growth cone elaboration. So it appears that similar growth cone
131
6.3 Discussion
dysregulation is evident in the mHFD exposed NPY neurons, even when IL-6 is not present.
One possible interpretation of this observation is that changes in gene expression induced by
exposure to IL-6 are cemented by permanent changes to the regulation of these genes, and
thus are apparent even when exposure to IL-6 has ceased or is removed. A mechanism by
which this could be occurring is epigenentic changes, that is, changes at the chromatin level
of a gene which regulate its expression on a semi-permanent or permanent basis. In this case,
epigenetic changes to Netrin-1 receptor genes by IL-6 is a particularly attractive concept
because IL-6 mediated, and mHFD mediated changes to the Netrin-1 response are similar,
and because IL-6 has been described in other systems to have the ability to regulate epigenetic
changes [84, 122, 167]. Analysis of epigenentic changes such as DNA methylation or histone
modification in NPY neurons exposed to mHFD would aid understanding in this area.
Although the phenotypes of IL-6 treated and mHFD exposed NPY neuron growth cone
responses are similar, this does not mean that the same mechanisms are affected. In order for
a growth cone to respond to Netrin-1 in its environment a complex combination of different
processes needs to occur, any one of which could be a target for epigenetic regulation by an
environmental insult. For example the analysis of growth cone area reported here focused
on the overall area of microtubule staining as a metric of growth cone size. Microtubules
are organised into bundles down the axon shaft and therefore need to be destabilised at the
growth cone so they are able to spread out appropriately [103, 287]. Missexpression of the
proteins which regulate this process, or even disrupted transport of these proteins to the
distal end of the axon shaft, would result in aberrant stability of microtubules at the growth
cone which therefore would be less spread out and growth cone size would be decreased
[103]. A more detailed analysis of microtubule dynamics is required here, along with further




Other intrinsic mechanisms of growth cone development could also be disrupted. Retinal
ganglion cell (RGC) axons have been described to respond positively to Netrin-1 early in their
journey from the retina to the tectum, and negatively later on [272]. When studied in vitro in
the absence of any developmental cues, these axons still displayed these changes in a time
dependent manner, and the ‘switch’ was discovered to be related to the intrinsic cAMP levels
in the growth cone [272]. If neurons utilise this ‘switch’ between attraction and repulsion in
their normal development it is possible that an insult by the mHFD environment is activating
it abnormally through decreases in the intrinsic levels of cAMP in the NPY growth cone.
Changes in the mechanisms which control normal levels of cAMP could conceivably happen
early in NPY development, but then only become apparent later on when levels fall below a
set point and the switch to negative response to Netrin-1 is activated. Mature RGC axons
with low cAMP levels can be partially switched back to reponding positively to Netrin-1 by
increasing their cAMP levels again in vitro [272]. It would therefore be interesting to know if
increasing cAMP levels in mHFD exposed NPY neurons would restore their normal Netrin-1
mediated growth cone response.
6.3.3 Conclusions
The data presented in this chapter support my hypothesis that maternal obesity is able to
intrinsically change the way NPY neurons develop and respond to cues in their environment.
Exposure to a mHFD environment in vivo appears to intrinsically change the ability of NPY
neurons to develop when cultured in vitro, perhaps by affecting their ability to polarise.
Additionally cultured NPY neurons seem less able to respond appropriately to Netrin-1 in
their environment than controls, indicating intrinsic components to this ability have been
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disrupted while the neurons were still developing in vivo.
Overall, this data supports a model by which factors within an environment of maternal
obesity act upon NPY neurons early in their development to intrinsically change the way they
will develop and respond to environmental cues when they later begin to grow axons and
establish projections to target regions. Future work is needed to understand when the critical
period in early development in which this environmental insult takes place is, which aberrant





This thesis focused on investigating the effects of maternal obesity on the developing hy-
pothalamic NPY neuron circuitry in the fetal mouse brain. Previous work in this field has
shown in rodent models that offspring of obese mothers display decreased innervation of the
PVN by NPY neuron projections at birth, and that this phenotype must begin to develop in
the prenatal period [155, 259]. However, there is little to no current knowledge about the
establishment of NPY neuron projections before birth, and how an environment of maternal
obesity might disrupt their development during this period. The work presented in this
thesis firstly set out to define the prenatal formation of NPY projections into the PVN, and
investigate the developmental mechanisms that regulate this process. Secondly, it aimed to
determine both intrinsic and extrinsic mechanisms by which factors in the maternal obese
environment could interfere with the correct developmental mechanisms of NPY neurons.
The general discussion which follows will outline the main findings of this thesis, and
present a model by which factors the fetus is abnormally exposed to during maternal obesity
can deregulate the correct formation of NPY neuron projections to their correct targets. I
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will then go on to discuss how these findings fit into broader hypotheses in the field of
developmental origins of disease, and their relevance in the context of human heath and
disease.
7.2 Summary of main findings
Initially I defined the normal development of NPY projections in the prenatal mouse brain.
The time course of NPY neuron projection development before birth was almost entirely
unknown, apart from the observation that low levels of projections were present in some
target regions at birth, although this was debated by other studies [24, 25, 212]. I have
confirmed that at GD15 NPY neuron axons were already leaving the arcuate nucleus, and by
GD17 were present in the PVN (chapter 3). This indicates that a small number of ‘pioneer’
NPY neuron axons lay down a scaffold of NPY projections into specific target regions in
utero. Such a scaffolding is likely to then be elaborated on postnatally during a period of
rapid projection growth (P8-16) as has been well described previously [24].
I then investigated the role of the axon growth regulator Netrin-1 in the normal develop-
ment of the prenatal hypothalamus. Netrin-1 mRNA was found to be expressed in a pattern
consistent with NPY neuron axon development, and when Netrin-1 was applied in vitro NPY
neurons were shown to respond positively via growth cone elaboration (chapter 4). Thus,
Netrin-1 may play a role in regulating NPY neuron pioneer axon development.
Perturbations in the fetal NPY neuron circuitry would no doubt affect the proper develop-
ment of post-natal circuitry, and thus affect the neural weight regulatory mechanisms of the
animal for the rest of its life. I therefore hypothesised that Netrin-1 signalling as a target for
dysregulation of correct arcuate nucleus to PVN projections during maternal obesity. Using
a primary cell culture model of arcuate nucleus development I established the cytokine IL-6,
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a factor to which the fetus has increased exposure in a prenatal environment of maternal
obesity, is able to act extrinsically on NPY neurons to modulate Netrin-1 receptor expression
and growth cone responsiveness to Netrin-1 (chapter 5). Additionally I found that, when
removed from their in vivo environment, NPY neurons from fetuses exposed to maternal
obesity in utero displayed changes in growth cone Netrin-1 responsiveness, and maturity
(chapter 6). This suggests that aberrant factors which the fetus is exposed to during maternal
obesity are also able to intrinsically affect NPY neuron development via the Netrin-1 growth
cone response, as well as Netrin-1 independent mechanisms.
7.3 Proposal of a model
The data presented in this thesis lead to the proposal of a model that defines (1) the normal
development of NPY neuron projections in the developing hypothalamus, and (2) how this
process is disrupted by factors present in an environment of maternal obesity.
7.3.1 Normal development of NPY neurons
In the rodent brain the growth of NPY neuron axons was thought to be a process which
occurred entirely in the postnatal period, largely under the control of leptin [24, 25]. However
the data in this thesis has found that a proportion of the NPY neuron population begin to
extend axons shortly after differentiation, about GD15, and traverse their way through the
developing hypothalamus to NPY projection target regions. NPY neuron axons first make it
to one of these target regions, the PVN, about GD17, and by birth further innervation has
occurred. This fits with a model where the NPY neuron circuitry forming in the prenatal
period is the work of pioneer axons which form a scaffold for later follower axons to elaborate
on (summarised in Fig. 7.3). The mass innervation of NPY target regions, under the control
of leptin, in the early postnatal period described by Bouret et al. (2004) would be an example
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of elaboration of this preexisting pioneer circuitry. Further support for this comes from
the fact that leptin appears to be a trophic factor but does not have a defined guidance role,
indicating it is encouraging growth of axons along pre-exiting pathways, not providing any
directional cues [25, 298].
By their very nature pioneer axons need numerous growth and guidance cues to take
the correct path to their target regions. As was discussed in chapter 4 the data in this
thesis suggest that the axon growth regulator Netrin-1 could fit into this model of NPY
axon pioneer development in two ways (summarised in Fig. 7.1). Firstly, Netrin-1 may be
acting to encourage growth cones to undergo pausing behaviour before leaving the arcuate
nucleus. Pausing behaviour in other systems is associated with growth cones receiving
further growth and directional cues at intermediate targets [187]. Therefore the function
of Netrin-1 here could be to prime newly formed growth cones to identify and respond to
further developmental cues to modulate their growth to their targets. Netrin-1 may also be
acting as a guidance factor. If this is the case then Netrin-1 expression in the arcuate nucleus
may be acting to repulse NPY axons out, towards their targets, where as expression in target
regions could be an attractive force, to encourage growth of NPY axons into these areas.
These scenarios are, of course, not mutually exclusive and in both cases Netrin-1 would have
to be working collectively with other guidance factors to properly regulate the growth of
NPY axons to their target regions.
7.3.2 Aberrant development during maternal obesity
Based on the data obtained in chapters 5 and 6 of this thesis I propose that in utero exposure
to maternal obesity disrupts the model of normal NPY neuron axon development described
above via two ‘hits’ - one intrinsic and the other extrinsic (summarised in Fig. 7.2). During
the first hit intrinsic changes in NPY neuron development occur before GD15, the age at
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NPY axon responds to Netrin-1 
• Growth cone pauses 
• Axon is repulsed dorsally 
Fig. 7.1 Model of the role of Netrin-1 signalling in NPY axon development. NPY neurons
polarise and begin to extend neurites. One of these neurites becomes the developing axon
and responds to Netrin-1 (blue crosses) in its environment via growth cone pausing or as
a repulsive push dorsally out of the arcuate nucleus towards its target regions. Both these
mechanisms allow the developing axons to then respond to further growth cues (black
crosses).
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Hit 1 – Intrinsic changes 
• Delayed development 
• Altered Netrin-1 responsiveness 
Hit 2 – Extrinsic changes – IL-6 
• Netrin-1 receptor expression changes 
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Fig. 7.2 Model of the two environmental hits which derail NPY axon development dur-
ing maternal obesity. NPY neurons are hit with intrinsic changes mediated by factors in
the maternal environment which slow their polarisation and extention of neurites, and alter
their later responsiveness to Netrin-1. A second extrinsic hit mediated by IL-6 occurs later in
development and further alters growth cone responsiveness to Netrin-1 (blue crosses). The
sum of these changes leads to the developing axon growing incorrectly and missing further
growth cues in its environment (black crosses).
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which I identified them in culture (chapter 6), possibly even occurring in progenitors, before
NPY neurons have fully differentiated. These intrinsic changes slow the progress of NPY
neurons to a level of maturity in which they are able to begin to develop axons. They also
alter their responsiveness to Netrin-1 once they do develop axons. Both these deficits become
apparent as the neurons develop further. Overall, this means that NPY neuron maturity is
mismatched with the extrinsic signals which normally regulate their development. Even if
the NPY neurons eventually catch up in their development they may have already missed the
critical window in which they can be guided successfully out of the arcuate nucleus, and/or
be less responsive to growth cues in their local environment. This would help to explain why
offspring exposed developing in obese mothers display decreased NPY innervation of the
PVN.
The second hit comes as levels of the cytokine IL-6 increase in later gestation when
NPY neuron pioneer axons are developing towards their target regions [153]. IL-6 acts
extrinsically on these neurons to alter their responsiveness to Netrin-1 (chapter 5), further
exacerbating the detrimental intrinsic changes they already possess. As detailed above the
exact role of Netrin-1 in normal NPY axon development is not entirely clear. Regardless
of whether it is playing a role in growth cone pausing, or axon guidance, or both, if NPY
neuron axons respond incorrectly then this would result in incorrect axon growth. In this
context, IL-6 exposure late in gestation would result in miswiring of prenatal NPY circuitry
in the hypothalamus. These errors would then be elaborated on by postnatal follower axons
impairing their development as well, albeit indirectly (summarised in Fig. 7.4).
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Fig. 7.3 Model for the relationship between pre- and postnatal NPY projections. Initial
pioneer NPY projections form in the prenatal period (GD15-P0). In the postnatal period (P8-










Fig. 7.4 Model for the relationship between pre- and postnatal NPY projections during
maternal obesity. Initial pioneer NPY projections formation in the prenatal period (GD15-
P0) is disrupted and fewer axons correctely innervate the PVN. These mistakes are further





Although specific further experimental work has been discussed within each chapter of this
thesis, some overarching future approaches using molecular, in vivo, and in vitro techniques
to test this model will also be highlighted here.
7.4.1 Normal growth and guidance of NPY neuron axons
A limitation of current in vivo techniques for assessing NPY neuron projections is that they
must be imaged in sections, making it difficult to trace the journey of a single NPY axon
to its target. To overcome this problem, transgenic technology in the form of Agrp-Ires-cre
mice crossed with a fluorescent reporter which would specifically label the arcuate nucleus
population of NPY neurons could be combined with new histological and microscopy tech-
niques such as CLARITY [48]. Using a fluorescent reporter mouse such as Tau-GFP, where
the GFP will label the entire extent of the neuron [81, 251], this would allow the visualisation
of NPY neuron projections in the whole hypothalamus without having to section, and would
be ideal for this system as the size of the developing hypothalamus is much smaller than
other brain regions previously imaged with this technique [48, 328]. This approach would
be valuable because if single NPY neuron projections could be specifically traced through
the hypothalamus it would be possible to more clearly define the prenatal development of
projections into target regions other than the PVN, such as the LHA and DMH. Current
attempts to undertake this in sections have been hindered by how diffuse the NPY projections
are through these large nuclei. Other applications of transgenic technology would also be
useful tools. For example by crossing the Agrp-Ires-cre mouse with a DCC or UNC5D floxed
mouse, different Netrin-1 receptor capabilities could be knocked out and the resulting effect
on NPY axon guidance tested. The exact phenotype of the NPY circuitry in these mice would




Despite the advances in in vivo technologies, in vitro culture systems still remain valuable
in the future directions of this project. It is currently impossible to image NPY neurons in
real time, as has been done in experiments studying development of postnatal projections
[236],as they develop prenatally. Therefore timelapse experiments both in slice culture, and
dissociated culture are critical in understanding the role of Netrin-1 in NPY development,
and its possible function in both growth cone pausing and axon guidance.
Finally, while it is clear that Netrin-1 is involved in NPY neuron development, almost
nothing is known about other growth or guidance molecules which it might be collaborating
with in order for correct NPY circuitry formation. Therefore an in situ hybridisation gene
expression study of the major families of axon growth molecules in the arcuate nucleus and
periventricular path NPY axons take to their targets, similar to the study carried out by Xu et
al. (2008) in the PVN, would be helpful in identifying candidates [323]. Additionally, single
cell qRTPCR could be utilised to screen NPY neurons at different stages of maturity for
expression of receptors for these developmental molecules. This would provide information
about the proportion of NPY neurons in a population expressing a certain receptor and the
level a particular receptor is expressed at within an individual neuron, giving clues to how
the response of axons to certain molecules might change over time.
7.4.2 Extrinsic and intrinsic changes during maternal obesity
Use of a technique such as CLARITY would be invaluable in assaying exact dysfunction of
NPY neuron axons during maternal obesity. For example, if single axons could be traced
through the brain it could be determined if they are (1) hindered from leaving the arcuate
nucleus, or (2) leave the arcuate nucleus but do not follow the correct path to the PVN.
144
7.4 Future directions
This would provide a great deal of information about not only how NPY neuron axons are
responding to maternal obesity, but also the role of Netrin-1 in this system.
The importance of IL-6 as an extrinsic factor affecting NPY development could be
assessed in vivo using mice with transgeneic alterations in IL-6 signalling. IL-6 and IL-6
receptor knockout mice would be a good model to test the importance of IL-6 signalling in
disruption of NPY circuitry in offspring of obese mothers. If IL-6 is heavily involved in the
aberrant development of NPY circuitry during maternal obesity, then it would be expected
that this phenotype could be prevented by eliminating IL-6 signalling. Likewise, mice with
constitutive IL-6 expression would be expected to replicate the disruption of IL-6 circuitry in
the absence of maternal obesity.
In vitro cultures represent a system which could be used to assay extrinsic factors which
may affect NPY neuron development, including, the cytokines IL-17A and IFNG. This
system would further narrow the list of candidates involved in abnormal NPY projection
growth, which could then be investigated in vivo using more time consuming methods as
described above. Culture systems are also perfectly placed to reveal intrinsic changes in
mHFD exposed NPY neurons as they are devoid of the extrinsic influences present in vivo.
The intrinsic deficits in NPY neuron maturity could be further investigated by studies of NPY
neuron polarisation, as have be undertaken in other systems [60, 61], and how this process is
changed in mHFD exposed NPY neurons.
Lastly, molecular approaches could also be used to further understand intrinsic changes
which might be occurring in NPY neurons as a result of maternal obesity. Epigenetic modifi-
cations are a way in which the environment can effect intrinsic changes to the genome of a
cell. Analysis of epigenetic modifications such as DNA methylation or histone modifications
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in NPY neurons from fetuses exposed to maternal obesity could be carried out using bisulfite
conversion, or chromatin immunoprecipitation (ChIP), respectively, combined with next
generation sequencing methods to give a broad picture of changes occurring across the
genome of NPY neurons. This could also provide information about the processes behind
the intrinsic changes identified in this thesis, and about other changes which are yet to be
identified.
7.5 An adaptive brain or dysregulated growth?
Within the field of developmental programming a hypothesis called ‘the thrifty phenotype’
has been put forward. It states that because the nutritional status of the mother is linked to
the fetus, the fetus is able to developmentally prepare itself for the environment it is being
born into [111]. For example, if the mother was undernourished the developing fetus would
prepare for an environment with little food, with physiological changes promoting food
intake and energy storage. What is interesting about the opposite situation, where the fetus is
exposed to an overnourishing environment is that offspring display a phenotype of decreased
NPY innervation of the PVN. NPY is orexigenic, a stimulator of food intake, and therefore it
is tempting to interpret a decrease in NPY signal to the PVN as a pre-emptive fetal adaptation
to decrease food intake in the overnourishing environment it will be born in to. If this is
the case then the changes in NPY neuron development identified in this thesis would be
examples of an evolutionary mechanism by which the fetus could predict and prepare for the
outside world.
However, while superficially this hypothesis is appealing, there are several reasons why
it does not fully explain the phenotype of offspring exposed to maternal obesity in utero.
Firstly, while a decrease in NPY innervation strictly speaking should result in decreased food
intake, offspring of obese mothers display an increased risk for obesity over offspring from
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normal pregnancies, who would presumably not have undergone any in utero adaptation.
This implies that other changes are occurring in the fetal development of the mechanisms
which control body weight homeostasis that are maladaptive. Although it is entirely possi-
ble that maladaptive changes are occurring it undermines the original thesis of ‘the thrifty
phenotype’ hypothesis, that the fetus is able to prepare itself for the environment, in this
case nutritional environment, that it is born in to. Offspring born to obese mothers end up
being less prepared for an overnourishing postnatal environment then their peers, not more
prepared as the hypothesis would state.
An additional point is that it is hard to understand how evolutionary forces might be
driving a mechanism by which a fetus can prepare for an overnourishing postnatal envi-
ronment. In the case of undernutrition the picture is more clear. In our evolutionary past
the human species would have gone through many periods of decreased food intake or
famine. In these cases offspring that could adapt to undernutrion by altering physiolog-
ical mechanisms of food intake and energy storage would have been healthier and more
likely to survive to reproduce, and thus the processes underlying this ability would be
positively selected for. Therefore, even in the modern era, offspring of undernourished
mothers are at risk of excessive weight gain [170, 243]. However, the obesity epidemic,
and with it cases of maternal overnutrition, is an incredibly recent event in human history.
It is much too recent for evolutionary processes to select for mechanisms which enable a
developing fetus to adapt to this environment by decreasing food intake. Further to this,
the morbidities associated with overnutrition onset later in life, and largely do not affect an
individual’s ability to reproduce. Therefore it is difficult to see how a mechanism by which
a fetus could adapt to an overnourishing postnatal environment would evolve in the first place.
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There are many examples of adverse maternal environments which affect the neural
development of offspring in utero. During maternal stress the developing fetus is exposed
to increased levels of cortisone and adrenocorticotropic hormone leading to changes in
the development of the HPA axis, and a resulting increased risk of offspring anxiety and
depression [309]. Likewise, it is has long been acknowledged that exposure to an activated
maternal immune system during gestation can predispose offspring to a range of mental
health disorders, including schizophrenia, via changes in neural development [28, 29, 274].
Therefore a more parsimonious explanation of the neurodevelopmental changes seen in
offspring of obese mothers is that they are result of dysregulated neuron development in
response to environmental factors which the fetus would not normally be exposed to. It is
likely that these environmental insults on the fetus, such as cytokine exposure, result in a
constellation of changes in the formation of the fetal brain. The decrease in NPY innervation
of the PVN might not, in itself, be of detrimental consequence. Rather it is one of many
changes in the hypothalamic circuitry as a consequence of an adverse maternal environment,
which could also include changes in gene expression of weight regulating neuropeptides, or
their receptors, and changes in the circuitry of other weight regulating neurons such as the
anorexigenic POMC neurons resident with the NPY neurons in the arcuate nucleus. It would
be the sum of these changes which would result in dysregulated control of body weight.
Therefore further work identifying other neurological changes in offspring of obese mothers,
and whether these are regulated by similar mechanisms to those identified in this thesis, is
critical.
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7.6 Implications of this work for human health
7.6.1 Relevance to human obesity
In light of the increasing rates of obesity in the Western world, prenatal programming of
obesity risk is of particular concern. Public health interventions which aim to promote healthy
eating practises before pregnancy occurs are attractive, but in reality difficult to implement
due to high rates of unplanned pregnancies, estimated at about 40% of all pregnancies in New
Zealand [204]. Therefore it is of high importance to further investigate when and how the
maternal environment is impacting on the developing fetus in order to better target strategies
for reducing obesity risk in offspring. The data presented in this thesis suggest that there
are two critical windows during which factors in the maternal environment impinge on the
formation of hypothalamic feeding circuitry. Additionally, they also support a mechanism
by which it is the state of obesity itself, not the content of the maternal diet, which leads
to the programming effect. While these findings are preliminary, they suggest that even
if a woman is obese at conception, concerted efforts to lower her weight or dampen her
immune response would avoid the second critical window in which IL-6 interferes with
feeding circuitry development. This could result in decreased obesity risk in the resulting
offspring. Obviously, there are large differences in development between humans and mice
and much more research needs to be carried out in this area.
7.6.2 Relevance to the origins of other neurological disorders
The finding in this thesis that increased levels of the proinflammatory cytokine IL-6 can
modulate the response of neurons to growth cues in their environment, and thus derail their
development, is of high relevance to the fetal origins of other neurological disease. The risk
of many neuropsychiatric disorders have a known or suspected contribution by exposure to an
activated maternal immune system during gestation. This was first identified in schizophrenia,
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with both epidemiological studies of woman who suffered infections during pregnancy, and
maternal immune activation (MIA) rodent models [28, 138, 197, 274]. IL-6 seems to play a
significant role during MIA. Smith et al. (2007) found that use of an IL-6 receptor knock
out mouse, or administration of an IL-6 antibody, is able to fully prevent the ability of MIA
to induce a schizophrenic-like phenotype [274]. The researchers additionally found that
sole injection of IL-6 during pregnancy was enough to cause some of the schizophrenic
neurological deficits in offspring [274]. Therefore it seems likely that IL-6 is directly af-
fecting fetal brain development in the MIA model. Netrin-1 signalling is involved in the
development of regions of the brain associated with schizophrenia, such as the hippocampus
[14, 100, 283, 301]. Therefore the finding in this thesis that IL-6 can modulate growth cone
responsiveness to Netrin-1 is particularly interesting and further work analysing whether IL-6
mediated interference of Netrin-1 signalling could contribute to schizophrenia pathology
would be a compelling future direction.
The idea that IL-6 might be responsible for in utero programming of neurological disease
risk brings forth the question of whether prenatal programming of risk for obesity and psy-
chiatric disorders is associated. For example, as was outlined in the introduction to this thesis
(see section 1.3.2), there is evidence that in a wide variety of situations where the maternal
immune system is activated during pregnancy, the resulting offspring are predisposed to obe-
sity. Additionally there is also evidence in the literature that in these same situations offspring
are predisposed to neurological disorders. Some examples include, that high pre-pregnancy
BMI (>30) is associated with increased risk of schizophrenia in adult offspring [260], that
maternal autoimmune diseases are associated with increased risk of offspring neurodevelop-
mental disorders such as learning disabilities and autism spectrum disorder [189, 209, 255],
and finally that exposure to air pollution activates the maternal immune system and leads
to offspring neurodevelopmenal changes in mice, and is associated with increased risk of
150
7.6 Implications of this work for human health













Fig. 7.5 Model for how different maternal inflammatory situations could programme
similar disease risk in offspring. Maternal infection, obesity and exposure to pollutants all
result in exposure of the developing fetus to cytokines in utero. This in turn programmes risk
of the same suite of disorders via cytokine interference with neurocircuitry formation.
offspring social, developmental and language delays in humans [127, 139, 289].
Overall this data fits with a model whereby any maternal situation which increases
prenatal levels of cytokines, particularly IL-6, will cause changes in neurocircuitry formation
via modulation of normal neuron responses to growth cues. This in turn lays down increased
risk in offspring for a plethora of different neurological disorders, including neuropsychiatric
disorders, developmental delay, or dysregulation of neural feeding circuitry leading to obesity
(summarised in Fig. 7.5). Which of these disorders, if any, the offspring will actually develop
would be dependent on the exact nature of the exposure, that is to say, acute exposure as would
be present in maternal illness, or chronic low grade exposure as would be present in maternal
obesity. Additionally it would be dependent on postnatal environmental triggers such as an
obesogenic diet in the case of offspring obesity, or drug use in the case of schizophrenia
[113, 225]. Overall the commonalities in the prenatal origins of these neurodevelopmental




That offspring born to obese mothers are predisposed themselves to obesity has gained
general acceptance by the scientific community. The work presented in this thesis provides
novel insight in to a mechanism by which this could be occurring and supports my hypothesis
that activation of maternal immune system during pregnancy affects the development of
arcuate nucleus circuitry via changes in the expression of important developmental molecules.
Firstly, I have described the prenatal development of projections from the arcuate nu-
cleus population of NPY neurons, part of the hypothalamic circuitry which regulates body
weight. I have also identified a role for the axon growth regulator Netrin-1 in the growth and
development of these projections. This represents the first time a growth factor critical in the
prenatal development of hypothalamic circuitry regulating body weight has been identified
and studied. In the second part of this thesis I identified both intrinsic and extrinsic changes
to NPY neuron development during maternal obesity which derail the correct formation
of prenatal NPY projections. In particular I found that the cytokine IL-6 appears to act
extrinsically on NPY neurons and deregulates their responsiveness to Netrin-1.
With the current rise in the incidence of obesity worldwide it is critical to understand the
mechanism by which maternal obesity can increase subsequent offspring risk for obesity.
Through better understanding of the molecular mechanisms which underpin this process we
can understand how prenatal programming of obesity risk occurs and how best to prevent it.
In the future this will contribute to improved human health by creating a research-informed
basis for human pregnancy health guidelines to reduce the risk of childhood obesity.
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Fig. A.1 Dosage response of GD14 cortical neurons to Netrin-1. (A, B) Graphs displaying
neurite length and number of GD14 cortical neurons treated with different concentrations
of Netrin-1 in vitro. Only 200 ng/mL elicits a significant response. (C) GD14 cortical
neuron braching reponse when treated with 200 ng/mL Netrin-1. * P<0.05, ** P<0.01, ****
P<0.0001, 1 way ANOVA with Tukey’s post hoc multiple comparisons test.
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Maternal Obesity and IL-6 Lead to Aberrant
Developmental Gene Expression and Deregulated
Neurite Growth in the Fetal Arcuate Nucleus
Tessa R. Sanders,* Dong Won Kim,* Kelly A. Glendining, and Christine L. Jasoni
Centre for Neuroendocrinology, Gravida: National Research Centre for Growth and Development,
Department of Anatomy, University of Otago School of Medical Sciences, Dunedin 9054, New Zealand
Maternal obesity during pregnancy increases the risk of obesity in the offspring. Several obser-
vations have pointed to a causative role for the proinflammatory cytokine IL-6, but whether it is
present in the fetal circulation and how it acts on the developing fetus are unclear. We first
observed that postnatal day 0 offspring from obese mothers had significantly reduced neuropep-
tide Y (NPY) innervation of the paraventricular nucleus (PVN) compared with that for offspring of
normal-weight controls. Thus, the growth of NPY neurites from the arcuate nucleus (ARC) was
impaired in the fetal brain by maternal obesity. The neurite growth regulator, Netrin-1, was
expressed in the ARC and PVN and along the pathway between the two at gestational day (GD) 17.5
in normal animals, making it likely to be involved in the development of NPY ARC-PVN projections.
In addition, the expression of Dcc and Unc5d, receptors for Netrin-1, were altered in the GD17.5
ARC in obese but not normal weight pregnancies. Thus, this important developmental pathway is
perturbed by maternal obesity and may explain the defect in NPY innervation of the PVN that
occurs in fetuses developing in obese mothers. To investigate whether IL-6 may play a role in these
developmental changes, we found first that IL-6 was significantly elevated in the fetal and ma-
ternal circulation in pregnancies of obese mice compared with those of normal-weight mice. In
addition, treatment of GD17.5 ARC tissue with IL-6 in vitro significantly reduced ARC neurite
outgrowth and altered developmental gene expression similar to maternal obesity in vivo. These
findings demonstrate that maternal obesity may alter the way in which fetal ARC NPY neurons
respond to key developmental signals that regulate normal prenatal neural connectivity and sug-
gest a causative role for elevated IL-6 in these changes. (Endocrinology 155: 2566–2577, 2014)
Childhood obesity is a significant health concern. It af-fects not only the Western world, but also developing
nations (1–3) and is associated with a number of metrics
of poor health, including type II diabetes and heart disease.
Recent longitudinal studies have shown a clear link be-
tween maternal body weight and offspring risk for ele-
vated body weight and obesity (1, 4–6). There are many
factors that could affect childhood body weight. These
include learned attitudes about food and exercise, social
circumstances that facilitate consumption of an obeso-
genic diet, and maternal care and nursing in the antenatal
period. In addition, one oft overlooked predisposing fac-
tor for childhood obesity is maternal overweight or obe-
sity during pregnancy. In humans, it is difficult to separate
prenatal and postnatal contributions to offspring body
weight, but animal models have allowed us to tease apart
the critical periods and contributing factors (7–10)
Several animal models have successfully recapitulated
the observations made in humans and have gone one step
further to allow the definition of critical periods when
maternal body weight can influence offspring body
weight. A number of studies have examined a maternal
high-fat diet or obesity during lactation and have been
instrumental in defining the postnatal factors that are im-
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portant to later-life obesity (7, 11). However, cross-fos-
tering studies have been crucial in defining the contribu-
tion of maternal obesity during gestation to elevating an
individual’s risk for obesity later in life (12). How the
prenatal environment might influence or program the fe-
tus to later life obesity is unclear; however, a role for pro-
inflammatory cytokines appears to be growing.
Proinflammatory cytokine levels are elevated in obese
individuals as a consequence of adipose-resident immune
cells (13–15). Obesity during pregnancy additionally ele-
vates cytokine production by the placenta (16–19). More-
over, at least some of these elevated cytokines appear to be
able to gain access to the developing fetus (20). One such
cytokine that shows elevated maternal and fetal expres-
sion and that has been shown to gain access to the fetus is
IL-6. In support of IL-6 as a causative factor for predis-
position to obesity, IL-6 injection into pregnant dams of
normal weight is able to elevate the risk of offspring obe-
sity (21). Moreover, artificial maternal immune activa-
tion, which elevates several cytokines including IL-6 (22),
has been shown recently to increase offspring body weight
(23). However, whether IL-6 actually makes it into the
fetal circulation and how and where IL-6 acts on the fetus
to increase obesity risk remain open questions.
The arcuate nucleus of the hypothalamus (ARC) is the
primary site within the brain for acquisition and integra-
tion of information about the body’s state of energy bal-
ance. Neurons in the ARC possess receptors for blood-
borne signals such as leptin, insulin, and ghrelin (24–26).
Upon receiving such peripheral signals, ARC neurons are
able to set in motion appropriate feeding behaviors (either
eat or do not eat) through their communication with
higher centers in the brain. A number of elegant studies
have defined the postnatal development of ARC projec-
tions to higher brain centers and have characterized their
dependence on circulating neonatal factors, such as leptin,
for their proper development (27–29). However, because
body weight control neurons in the ARC are born in mid/
late gestation (30, 31) and because there is a clear contri-
bution of prenatal factors, we reasoned that this early pre-
natal phase of ARC development might represent an
additional window in which maternal or fetal factors
could have a perturbing influence on later life body weight
control.
Here, we have examined the possibility that IL-6 has a
negative influence on the formation of the neural circuits
that control body weight and that this occurs at least in
part through its ability to alter the expression of genes
involved in the growth and navigation of ARC axons to
their targets in higher brain centers.
Materials and Methods
Maternal high-fat diet (HFD)
All animal procedures performed in this study were approved
by the University of Otago Animal Ethics Committee. Female
C57BL/6 mice were obtained at 6 weeks of age and housed 3 per
cage under standard conditions (25°C, 12-hour light-dark cycle,
and food and water ad libitum). Mice were weighed on arrival
and randomly assigned to receive either a standard control diet
(10% kcal as fat; D12450B, Research Diets) or a HFD (45% kcal
as fat; D12451, Research Diets). Details on the diets can be
obtained at http://www.researchdiets.com/opensource-diets/
stock-diets/dio-series-diets. Mice were weighed weekly until the
HFD group became significantly heavier than the control diet
group (Student t test) (Supplemental Figure 1), and then both
control and HFD-fed animals were paired with a chow-fed male
of normal weight until the presence of a vaginal plug was
detected.
Single- and dual-label immunohistochemistry
Timed pregnant female C57BL6/J mice of normal body
weight were killed by cervical dislocation on gestational day
(GD) 17.5, where the day of the vaginal plug was counted as
embryonic day 0.5. Embryos were dissected from the uterus and
decapitated, and the fetal brains were fixed by immersion in 2%
paraformaldehyde in PBS (0.1 M sodium phosphate and 0.9%
NaCl) for 30 minutes at room temperature, cryopreserved by
incubation in a 50:50 mixture of 30% sucrose-OCT (Optimal
Cutting Temperature solution; Leica) overnight at 4°C, frozen in
the sucrose-OCT mixture, cryosectioned at 20 m in the coronal
plane, and collected onto gelatin-coated slides. Tissue sections or
coverslips containing primary ARC neurons (described below)
were subjected to dual-label immunocytochemical analysis with
either mouse anti-DCC (AF5; Abcam) diluted 1:1000 in incu-
bation solution (0.5% Triton X-100 and 1% BSA; Sigma-Al-
drich) or mouse anti-UNC5D (AB58141; Abcam) diluted 1:100
in incubation solution and rabbit anti-neuropeptide Y (NPY)
(T-4070; Bachem) diluted 1:2000 in incubation solution, plus an
additional 2% normal goat serum (Vector Laboratories) and 2%
normal donkey serum (Sigma-Aldrich). Primary antibodies were
incubated with sections for 24 hours at 4°C and then were
washed 3 times in PBS for 15 minutes each at room temperature.
Secondary antibodies, donkey anti-mouse-Alexa Fluor 594 (In-
vitrogen) and goat anti-rabbit Alexa Fluor 488 (Invitrogen),
were diluted 1:1000 (for tissue sections) or 1:500 (for cultured
neurons) in incubation solution and incubated for 90 minutes at
room temperature, protected from light. Sections were washed 3
times in PBS for 15 minutes each at room temperature and im-
aged on an LSM-510 inverted confocal microscope (Zeiss). Be-
cause DCC and UNC5D immunofluorescence was considerably
dimmer than that of NPY, fluorescence levels were matched
across the 2 channels for the entire image (ie, no specific features
were singled out for enhancement) in Adobe Photoshop version
12.0.1 (x64) (Adobe Systems Inc), to create images for publica-
tion that depicted dual labeling clearly. Decorations were added
with Adobe Illustrator version 15.0.1 (Adobe Systems Inc).
Single-label immunohistochemical analysis for NPY fibers in
neonatal brains was performed as described above. Quantifica-
tion of NPY nerve fibers in the paraventricular nucleus (PVN) in
vivo was performed, based on previously published protocols
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(28, 32) using ImageJ software (National Institutes of Health).
Confocal stacks were compressed into a single plane in the z axis,
binarized, and then skeletonized to adjust each fiber into 1-pixel
thickness. A region of interest was chosen as a rectangle of 150
m (height)  200 m (width), positioned along the third ven-
tricle, and fiber density was measured as the number of skele-
tonized fibers (pixels) occupying the region of interest. Fiber
density was compared using a nonparametric, pairwise Mann-
Whitney U test (two-tailed).
In situ hybridization
GD17.5 fetal brains were collected as described above and
immediately snap-frozen on dry ice. Brains were then cryosec-
tioned at 14 m and collected onto Superfrost slides (Thermo
Fisher). Netrin-1 sense and antisense digoxigenin-labeled ribo-
probes were synthesized using human Netrin-1 cDNA (a gift
from Professor Linda Richards, Queensland Brain Institute,
Queensland, Australia). A standard in situ hybridization proto-
col was used with an overnight hybridization temperature of
55°C. Bound riboprobe was visualized by incubation in alkaline
phosphatase–conjugated anti-digoxigenin antibody (1:1500;
Roche) and then developed in nitro blue tetrazolium chloride/
5-bromo-4-chloro-indolylphosphate solution (Roche).
ARC primary cell culture
Whole fetal brains were collected as described above, and the
ARC was dissected out into L-15 medium (Leibovitz medium;
Life Technologies) with 4.5% glucose. Tissue was transferred to
DMEM (Life Technologies), cells were dissociated by the addi-
tion of 0.025% trypsin (Life Technologies) and incubation at
37°C for 10 minutes, followed by gentle mechanical dissociation
and a further 5 minutes at room temperature. Fetal bovine serum
(to 10%; Sigma-Aldrich) was added, and the medium was re-
placed with Neurobasal medium (2% B27, 0.5 mM Glu-
taMAX, and 0.1% penicillin/streptomycin; Life Technologies).
Cells were plated onto 12-mm poly-D-lysine (0.5 g/mL; Sigma-
Aldrich)–coated coverslips (Milton Adams), maintained in cul-
ture for 3 days, and then fixed with 4% paraformaldehyde for 10
minutes.
ARC explant cultures
Whole fetal heads were collected as described above,
mounted in 4% agarose (low-gelling temperature; Sigma-Al-
drich), submerged in ice-cold artificial cerebrospinal fluid solu-
tion (118 mM NaCl, 3 mM KCl, 0.5 mM CaCl2, 6 mM MgCl2,
5 mM HEPES, 25 mM NaHCO3, and 11 mM D-glucose, pH 7.3
[33] when gassed with 95% O2 and 5% CO2) and sectioned at
300 m using a Vibratome (VT2000S; Leica). Sections contain-
ing the ARC (see Figure 1) were transferred into ice-cold L-15
medium containing 4.5 g/L D-glucose, and the ARC was micro-
dissected and then rendered into 200  200  300-m blocks
with a tissue chopper (McIlwain; Ted Pella). Collagen gels were
prepared as described previously (34–37) and contained either 1,
10, or 100 ng/mL recombinant IL-6 (PeproTech) or vehicle (ster-
ile H2O). ARC explants were placed in the center of the collagen
gel base, overlain with 25 L of the appropriate collagen solu-
tion, and then cultured in a humidified 37°C/5% CO2 incubator
for 36 to 40 hours. After culture, explants were fixed in situ with
4% paraformaldehyde-PBS for 15 minutes at room temperature
and then were rinsed 3 times in PBS for 30 minutes each.
Explant immunocytochemistry, imaging, neurite
quantification
Fixed explants were subjected to immunocytochemical anal-
ysis with antibodies to -III tubulin (TuJ1, monoclonal; R & D
Systems) diluted 1:1000 in incubation solution (0.5% Triton
X-100), 1% BSA, and 2% normal donkey serum). Primary an-
tibodies were incubated with explants for 24 to 48 hours at 4°C
and then were washed 3 times in PBS for 1 hour each at room
temperature. Donkey anti-mouse-Alexa Fluor 594 secondary
antibodies were diluted 1:1000 in incubation solution and in-
cubated for 90 minutes at room temperature, protected from
light. Explants were then washed 3 times in PBS for 1 hour each
and imaged on an LSM-510 inverted confocal microscope within
48 hours of completing the immunocytochemical analysis.
Each explant was imaged in quadrants at 10 magnification,
with a fixed Z plane thickness of 100 m. Image capture was
automated so that all explants were exposed to confocal laser
light for the same amount of time, thus eliminating the possibility
that differential photobleaching may influence the results. The
four quadrants that comprised each explant were then merged
using ImageJ64 (version 1.46a) to form a montage of the explant.
All montage images were then coded so that the experimenter
was blind to the identity of the samples until after the measure-
ments had been performed. For publication, the levels of the
individual subregions within each montage were adjusted indi-
vidually using Adobe Photoshop version 12.0.1 (x64) to give a
resulting image devoid (or nearly so) of obvious subdivisions.
Montaged images thus prepared were then imported into Adobe
Illustrator version 15.0.1 for the addition of decorations.
TuJ1 outgrowth was quantified using a previously de-
scribed and widely used method (35, 36). In brief, ImageJ was
used to outline the border of each explant, and the image outside
of the explant was thresholded and converted to a binary image.
The total number of nonzero pixels outside the explant was then
divided by the number of pixels in the explant to arrive at an
outgrowth ratio. Outgrowth was then averaged for all explants
in a given condition to arrive at a mean  SEM for each condi-
tion, and these were then compared statistically among condi-
tions using one-way ANOVA with a Student-Newman-Keuls
multiple comparison post hoc test (Prism; GraphPad Software,
Inc).
In vitro IL-6 treatment
For in vitro IL-6 treatment, timed pregnant C57BL/6 female
mice of normal body weight were killed at GD17.5, fetal brains
were collected and Vibratome sectioned as described above. The
resulting 300-m-thick sections containing the ARC were trans-
ferred into artificial cerebrospinal fluid prewarmed to 37°C,
which contained either 100 ng/mL IL-6 or vehicle (H2O), and
were incubated at 37°C for 1 hour.
Tissue collection and RNA extraction
Fetal brain sections (in vitro IL-6 or in vivo HFD-fed mothers)
were then microdissected as described above using fine forceps
that had been treated with RNase AWAY, and ARC tissue pieces
thus dissected were placed in RNase-free microcentrifuge tubes
on ice.
RNA was extracted (RNeasy Mini Kit; QIAGEN), DNase
treated (DNA-free Kit; Ambion), and converted to cDNA (Su-
perScript III First Strand Synthesis System; Invitrogen) following
2568 Sanders et al Maternal Obesity Alters Fetal ARC Development Endocrinology, July 2014, 155(7):2566–2577
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 26 August 2015. at 20:29 For personal use only. No other uses without permission. . All rights reserved.
standard protocols. A no RT (RT) reaction was also run along-
side the experimental samples to eliminate DNA or RNA false
positives. cDNA sample concentrations were then standardized
via dilution in fresh MilliQ so that equal amounts of experimen-
tal and control cDNA (ie, HFD-fed vs control fed or IL-6-treated
vs not treated) were used.
Quantitative RT-PCR (qRT-PCR)
All qRT-PCR was performed with the LightCycler 480 Real-
Time PCR System (Roche), using SYBR Green chemistry and
white 96-well plates (Roche). Primers were designed using Na-
tional Center for Biotechnology Information (NCBI) Primer-
BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast) or
were reported previously in the literature and are found in Sup-
plemental Table 1. PCRs were run in triplicate with 2 L of
cDNA in a 20-L reaction. A standard PCR thermocycler pro-
tocol was used. All qRT-PCR runs also included 2 types of neg-
ative controls: (1) no RT; or (2) no cDNA. ARC tissue from all
fetuses in pregnancy were pooled to give a single RNA prepara-
tion, and at least 3 individual pregnancies were assayed inde-
pendently to reduce interpregnancy variations in developmental
timing or fetal health. qRT-PCR data were analyzed using the
2CT relative quantification method (38) to calculate fold
changes in gene expression in the control and experimental
groups. Student t tests were performed to determine the signif-
icance in gene expression changes between the control and ex-
perimental groups. Importantly, a power analysis was per-
formed on these statistics and indicated that for the given sample
sizes and typical SDs within our qRT-PCR experiments, all re-
ported P values are significant at 80% power.
Multiplex cytokine assay
Cytokine protein levels were measured from maternal and
fetal blood plasma samples at GD17.5 in both dietary groups
using a multiplex assay (Bio-Plex Pro Mouse Cytokine Th17
Panel A; Bio-Rad Laboratories). Maternal and fetal blood sam-
ples were collected after decapitation using EDTA-coated (K2
EDTA, 1–2 mg/mL) microcapillary tubes (Innovative Med
Tech). Pregnancies with between 6 to 8 fetuses were used to
collect both maternal and fetal blood samples, and, for fetuses,
blood from the entire litter was pooled to obtain sufficient sam-
ples. Microcapillary tubes were then centrifuged to collect blood
plasma, and these samples were transferred to endotoxin-free
tubes (Axygen Scientific) and stored at 80°C until the assay.
Plasma samples with hemolysis were excluded. A cytokine assay
was prepared following the manufacturer’s protocol with each
sample run in duplicate using the Bio-Plex 200 system (Bio-Rad
Laboratories). The assay data were analyzed with Bio-Plex Man-
ager Software (version 6.0; Bio-Rad Laboratories), and the ana-
lyte concentrations were calculated in picograms per milliliter
based on standard curve dilutions.
Results
Maternal obesity results in decreased NPY
innervation of the PVN
It has been previously reported that diet-induced ma-
ternal obesity results in impaired innervation of the PVN
by NPY neurites in offspring (28). Because ARC NPY
neurons are generated and begin growing their neurites to
the PVN before birth (30) and because there is a clear effect
of maternal obesity on offspring during the fetal period,
we evaluated whether NPY innervation of the PVN was
altered in fetuses developing in obese mothers. Female
mice were fed a HFD beginning an average of 4 weeks
before mating and typically became significantly heavier
with feeding of the HFD by 2 to 3 weeks (Supplemental
Figure 1A), so that by the time of mating they were on
average 1.6-fold ( 0.2) significantly (P  .05) heavier
than age-matched females eating a control diet (Supple-
mental Figure 1B). Offspring body weights were signifi-
cantly higher on average for animals that underwent ges-
tation in a HFD-fed obese mother than those of age and
postnatal diet-matched controls, and this was especially
evident in offspring themselves eating a HFD (Supplemen-
tal Figure 2). These observations are consistent with a
number of independent studies that have used maternal
HFD-fed rodent models for inducing developmental pro-
gramming of obesity risk in the offspring (7, 11, 12, 39).
Densitometry analysis of NPY fibers in defined areas of
the PVN on the day of birth revealed a visible (Figure 1,
A–C) and significant approximately 50% reduction in
NPY fiber innervation of the PVN (289  123 greyscale
units vs 613  91 greyscale units, P 	 .025) (Figure 1C).
In addition, qRT-PCR analysis of ARC NPY expression at
GD17.5 showed no change between the 2 groups, indi-
cating that overall NPY gene expression in the fetal ARC
is not affected by maternal obesity (Figure 1D). These ob-
servations in controls are consistent with the typical rel-
ative timing of events in neuronal development with NPY
neuron differentiation in late gestation, followed by axon
outgrowth and target innervation (30, 40). They are also
supportive of observations that diet-induced maternal
obesity reduced ARC NPY innervation of the PVN at post-
natal ages (28) and suggest the possibility of a link between
the 2 stages of development.
Netrin-1 signaling is involved in NPY-PVN
projection development
To understand how ARC-PVN projections might be
disrupted in offspring from obese mothers, we first sought
to determine which neurite growth regulators are involved
in establishing the correct circuitry of these areas during
prenatal development. We initially concentrated on the
axon guidance molecule Netrin-1, because preliminary
data (not shown) indicated that receptors involved in Ne-
trin-1 signaling were expressed in ARC cells during fetal
development, making Netrin-1 a likely candidate for me-
diating normal neurite growth and navigation from the
ARC to the PVN. In situ hybridization for Netrin-1 at
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GD17.5 (Figure 2) demonstrated that Netrin-1 was ex-
pressed within the ARC (Figure 2A), as well as the ven-
tromedial nucleus of the hypothalamus (Figure 2B) and
the PVN (Figure 2C). Thus, Netrin-1 is expressed in re-
gions of the hypothalamus that are consistent with it play-
ing a role in the growth and/or navigation of ARC NPY
neurites to their target brain areas, including the PVN.
If Netrin-1 signaling is involved in ARC NPY neurite
growth, then NPY neurons would be expected to express
one or more receptors for Netrin-1. Dual-label fluores-
cence immunocytochemical analysis for NPY and Dcc, a
Netrin-1 receptor, at GD17.5 revealed that numerous
















































Figure 1. Maternal obesity leads to reduced innervation of the PVN
by NPY nerve fibers. A, Fluorescent image showing normal amount of
NPY nerve fibers in the PVN in postnatal day 0 (day of birth). B,
Fluorescent image from the same level of the PVN as shown in A, but
from offspring that developed in an obese mother. Scale bar
corresponds to 50 m. C, Bar graph showing quantification of the
fiber densities depicted in A (normal development, ) and B
(development in obese mother, f). D, Bar graph showing no change in
Npy gene expression at GD17.5 in fetal ARC from normal () and
maternal obese (f) pregnancies. *, P  .05. Numerals at the base of
bars indicate number of animals (from at least 3 independent
pregnancies) from which 3 representative sections of the PVN were
quantified or number of litters (average fetuses per litter 	 8) used for
collection of tissue for qRT-PCR analysis. 3v, third ventricle.
Figure 2. Netrin-1 is expressed in the ARC and in target areas for NPY
projections. Representative images of Netrin-1 in situ hybridization
staining in the ARC (A), ventromedial nucleus of the hypothalamus (B),
and PVN (C). Dotted lines surround areas of staining. The arrow in
panel C indicates a broad area of Netrin-1 expression in the thalamus.
D, Sense probe negative control sections show no specific staining.
Scale bar corresponds to 200 m. 3v, third ventricle.
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could be detected in the cell bodies of 34.5% (7.3%) of
ARC NPY neurons (Figure 3, B and C and data not
shown), and expression appeared to be highest in the neu-
rites extending from these cells (Figure 3, B and C). Oc-
casional cell bodies or neurites expressing Dcc, but lacking
detectable NPY expression, could also be found near the
ARC (not shown). Dual-label fluorescence immunocyto-
chemical analysis for NPY and the Netrin-1 receptor
Unc5d was performed on GD17.5 NPY neurons in pri-
mary cell culture. As with Dcc, Unc5d expression in NPY
cells was present in both the cell bodies and neurites, but
the neurites appeared to show slightly higher Unc5d ex-
pression than the cell bodies (Figure 3D).
These data are consistent with a role for Netrin-1 and
its receptors Dcc and Unc5d in the growth and guidance of
NPY neurites and thus is the first description of a potential
role for this conserved neurodevelopmental signaling
pathway in the formation of ARC NPY neural circuits.
Modulation of Netrin-1, Dcc, and/or Unc5d expression
by environmental factors present in maternal obesity
may be one reason that the innervation of the PVN by
NPY neurites is reduced in fetuses developing in obese
mothers.
Maternal obesity alters the expression of the
neurite growth regulators
To support the proposition that maternal obesity im-
pairs normal ARC NPY nerve fiber development by alter-
ing the expression of genes involved in neurite growth, we
used qRT-PCR to determine whether the expression levels
of Netrin-1 and/or its receptors in the ARC were different
between GD17.5 fetuses developing in obese compared
with control (normal body weight) mothers.
The ARC of GD17.5 fetuses developing in obese moth-
ers showeda significant increase (mean fold change1.45 
0.18, P 	 .03) in Dcc expression (Figure 4A). To gain a
more complete picture of Netrin-1 signaling changes in the
brains of fetuses developing in obese mothers, we also
examined the Unc5 family of Netrin-1 receptors, which
typically function to oppose Dcc in Netrin-1 signaling
(41), and Neogenin, which mediates chemoattraction by
Netrin-1 (42). Unc5d showed a significant decrease in ex-
pression (mean fold change 0.63  0.08, P 	 .002) (Figure
4B), whereas none of the other family members (Unc5a,
Unc5b, and Unc5c) or Neogenin were changed (Figure
4C). There was also no change in the expression of Ne-
trin-1 (Figure 4D).
These observations indicate that Netrin-1/Dcc/Unc5d
signaling is a molecular focal point for disruption by ma-
ternal obesity. Furthermore, they suggest that maternal
obesity programming of offspring obesity may be under-
pinned by altered expression of key developmental genes
whose role is to regulate the normal formation of neural
circuits that control body weight.
IL-6 is elevated in the fetal and maternal plasma in
maternal HFD pregnancies
We next sought to establish which factors were present
in the maternal and fetal circulation that may play a caus-
ative role in the observed developmental changes. Prior
work has shown that cytokines are elevated in maternal
obesity (18, 43), and, in particular, IL-6 has been impli-










Figure 3. Dual-label immunocytochemical analysis reveals that ARC
NPY neurons express Dcc and Unc5d. A, Distribution of NPY
immunoreactive neurons and their processes at GD17.5, indicating
several neurites that are shown dual labeled and at higher
magnification in subsequent panels. B, Example of cell bodies
(arrowheads) and a neurite (arrow) immunoreactive for NPY (left), Dcc
(middle). or both (merge, right). C, Example of a single neurite
showing immunoreactivity for NPY (left), Dcc (middle), and both
together (merge, right). D, Example of a neuron in culture
immunoreactive for both NPY and Unc5d. Arrowheads depict the
course of the neurite. Scale bar corresponds to 100 m for A, 50 m
for B and C, and 20 m for D.
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ming. Analysis of fetal blood plasma revealed a significant
increase in the mean concentration (SEM) of IL-6 at
GD17.5 in HFD-fed (3.2  0.6 pg/mL) compared with
control (1.2  0.04 pg/mL, P  .05) mice, where n 	 6
pooled fetal samples from 6 individual pregnancies each
containing 6 to 8 fetuses (Figure 5A). In addition, ma-
ternal IL-6 was significantly elevated in HFD-fed obese
pregnant mice at GD17.5 (17.4  2.4 pg/mL, n 	 3)
compared with that in normal-weight animals fed a con-
trol diet (7.6  0.7 pg/mL, P  .05, n 	 3) (Figure 5B).
These observations are consistent with previous find-
ings in maternal obesity (18) and suggest that elevated
fetal IL-6 may impinge on the developing fetus to alter
brain development.
IL-6 dose dependently inhibits ARC neurite growth
Because NPY fiber innervation of the PVN was reduced
during the fetal period, we sought to examine whether this
may be causally related to the presence of elevated IL-6.
Body weight–regulating neurons in the ARC become post-
mitotic in mid/late gestation (30, 31). If they develop in a
sequence similar to that of neurons elsewhere in the brain,
they would then be expected to begin to migrate into their
adult position and establish their circuitry shortly after
their terminal division. Thus, GD17.5 represents a time
when most body weight–regulating neurons are expected
to be actively growing their neurites to establish connec-
tivity with higher brain centers.
The ability of IL-6 to modulate neurite growth from
GD17.5 ARC neurons was examined using a 3-dimen-
sional collagen gel assay, a standard assay for determining
the effects of diffusible factors on neurite growth (35, 36,
44). The growth of ARC neurites was dose dependently
impaired by IL-6 (Figure 6). At 1 ng/mL (outgrowth ratio
0.11  0.015, n 	 34 explants), 10 ng/mL (outgrowth
ratio 0.05  0.023, n 	 28 explants), or 100 ng/mL (out-
growth ratio 0.04  0.028, n 	 19 explants), IL-6 signif-
icantly reduced ARC neurite growth compared with that
in controls without IL-6 (outgrowth ratio 0.15  0.015,
n 	 30 explants, P  .05 compared with 1 ng/mL, P  .01
compared with 10 or 100 ng/mL) (Figure 6, B and C). The
morphology of the neurites that extended from the ex-
plants in the presence of IL-6 appeared indistinguishable
from that of controls (Figure 6B), indicating that the ex-
plants were healthy and were not likely to be structurally
impaired as a result of IL-6 exposure. Thus, ARC neurites
at GD17.5, when connections to higher brain centers are
forming, appear to be susceptible to growth inhibition by























































Figure 4. Maternal HFD (mHFD) affects ARC developmental gene
expression in vivo. A–D, Bar graphs showing the relative fold change in
gene expression for Netrin-1 and 3 of its receptors in the ARC from
control (ctrl) vs HFD fetuses. Numbers at bases of bars indicate
numbers of litters (average fetuses per litter 	 8) used for collection of












































Figure 5. IL-6 is elevated in the fetal and maternal circulation in
pregnancies complicated by obesity. A, Bar graph showing the
concentration (in picograms per milliliter) of IL-6 in the fetal circulation
of normal weight (ctrl, white bars) and mHFD (black bars) pregnancies
at GD17.5. B, Bar graphs showing the concentration of IL-6 in the
maternal circulation (dam) at GD17.5 from normal weight (ctrl, white
bars) and mHFD pregnancies. *, P  .05, two-tailed unpaired t test.
Numbers at bases of bars indicate numbers of pools of fetal plasma
(representing 36 total fetuses) each from 1 of 6 independent
pregnancies (A) or numbers of pregnant adult female mice (B).
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appropriately exposed to IL-6 during their development,
malformation of circuitry may result, which in turn could
disrupt normal body weight regulation later in life.
IL-6 stimulates changes in developmental gene
expression that are similar to changes induced by
maternal obesity
To support the proposition that IL-6 is, at least in part,
responsible for the gene expression changes seen in the
GD17.5 fetal ARC in maternal obesity, we examined
whether the expression of Netrin-1 or its receptors could
be modulated by IL-6 treatment in vitro in a manner sim-
ilar to the in vivo manner. GD17.5 fetal ARC tissue was
treated in vitro with IL-6 (100 ng/mL), and changes in gene
expression were assayed by qRT-PCR. Dcc showed an
approximately 2-fold increase (mean fold change 2.1 
0.5, P  .05) (Figure 7B) over that in untreated ARC tis-
sue, which was strikingly similar to what was observed in
maternal obese fetal ARC. Again, similar to maternal
obese ARC, Netrin-1 (mean fold change 1.3  0.27)
showed no evidence of altered expression in the presence
of IL-6 (Figure 7A). Despite displaying decreased expres-
sion in vivo in maternal obesity, Unc5d expression did not
change in response to IL-6 treatment (Figure 7C). This
finding suggests that Unc5d expression may be modulated
by a factor(s) other than IL-6 present in the fetal environ-
ment in maternal obesity.
Taken together, these observations suggest that aber-
rant exposure of the fetal brain to maternal obesity-in-
duced factors, such as IL-6, impair the ability of the de-
veloping ARC NPY neurons to make neural connections,
and that this is underpinned by changes in developmental
gene expression. Because IL-6 receptor engagement can
directly alter gene expression via activation of signal trans-
ducer and activator of transcription 3 (STAT3) (45) and
ERK1/2 (46), we used in silico analysis with PROMO
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Figure 6. IL-6 reduces ARC neurite growth in vitro. A, Image of a
section of GD 17/18 mouse brain taken at the level of the ARC
(modified from Ref. 62). The dotted line indicates the border of the
ARC along which tissue was microdissected for explant culture and
PCR analyses. DMH, dorsomedial nucleus of the hypothalamus; ME,
median eminence; VMH, ventromedial nucleus of the hypothalamus.
B, Representative images of normal control levels of TuJ-1
immunofluorescent neurites (upper) or a similar image from an explant
treated with 10 ng/mL IL-6 (lower). The explant borders are indicated
by a dotted line. The arrows indicate normal-appearing neurites, and
arrowheads indicate blunted neurites in the presence of IL-6. Scale bar
corresponds to 50 m. C, Bar graph showing the effects of different
10-fold dilutions of IL-6 on ARC neurite outgrowth. *, P  .05; **, P 
.01, one-way ANOVA, with a Student-Newman-Keuls post hoc test.








































Figure 7. IL-6 affects ARC developmental gene expression in vitro.
A–C, Bar graphs showing the relative fold change in gene expression
for Netrin-1 (A) and its receptors Dcc (B) and Unc5d (C) in the ARC in
the presence or absence of IL-6 in vitro. Numbers at bases of bars
indicate numbers of litters (average fetuses per litter 	 8) for collection
of tissue. *, P  .05, Student t test.
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whether Dcc has the potential to be regulated by IL-6
signaling. This analysis revealed several binding sites for
IL-6 downstream signaling molecules, including nuclear
factor-B and IL-6 regulatory element binding protein, in
the Dcc promoter (Supplemental Figure 3), supporting the
notion that Dcc may be directly regulated by IL-6
signaling.
Discussion
Maternal obesity–associated proinflammatory cytokines,
including IL-6, have been implicated causally in the ma-
ternal programming of offspring obesity (18, 20, 21, 47,
48). This study examined, first, whether ARC neuronal
circuitry was disrupted during the fetal period by maternal
obesity and, second, whether IL-6 was present in the fetal
circulation and if so, whether it might be responsible for
altering the fetal development of ARC neuronal circuitry.
Fewer NPY fibers were present in the PVN of neonates
that had developed in obese mothers, indicating that pre-
natal development of NPY nerve fibers is disrupted by
maternal obesity. This finding is consistent with results of
cross-fostering studies (12), which indicated offspring
obesity risk factors associated with the gestational period,
and is strikingly similar to previous observations of re-
duced NPY innervation of the PVN in the postnatal period
in the offspring of diet-induced obese mothers (28). In the
postnatal period, ARC to PVN nerve fiber growth, elab-
oration, and organization is modulated powerfully by lep-
tin under normal circumstances, and in its absence/resis-
tance normal innervation is curtailed (27, 28). In other
areas of the brain, neural circuits that are involved with
perception of the outside world develop in two stages: an
early prenatal period in which fundamental or scaffold
circuits are formed, followed by a later, postnatal period
in which this scaffolding is further built upon under the
influence of the outside environment (49). The formation
of body weight–regulating circuits thus appears to follow
a similar course, with scaffolding circuitry forming pre-
natally, and massively elaborated circuitry forming later
under the control of the environmental factor leptin (27,
28). One curious link between prenatal and postnatal
ARC neurite development is that IL-6 and leptin share the
pSTAT3 signaling pathway. Thus, when a fetus develops
in an obese maternal environment, it may be that elevated
maternal leptin is also able to access the forming ARC and
further exacerbate the IL-6–mediated neurite growth de-
fects. However, despite sharing similar signaling via
pSTAT3, leptin and IL-6 have different overall effects on
neurite growth, with leptin stimulating growth postna-
tally and IL-6 retarding it prenatally, which may relate to
developmental changes in cellular responsiveness or dif-
ferences in signaling. Neurites are often modulated by lo-
cal cytoskeletal changes, which typically would not be
mediated by a transcription factor such as pSTAT3. Thus,
distinguishing between the signaling pathways used by
leptin and IL-6 to modulate neurite growth would add
clarity to this important question.
One additional similar point is whether IL-6 or leptin in
the peripheral circulation actually reaches the fetal ARC to
affect developmental gene expression. In the adult, these
factors, when present in the peripheral circulation, can
impinge on ARC neurons (50, 51). There is some contro-
versy regarding the exact time of maturation of the blood-
brain barrier (BBB) during embryonic development (52).
Thus, if the BBB is already intact and functioning in an
adult-like capacity before GD17.5, it is likely that periph-
eral IL-6 is able to gain access to the ARC neurons in a
manner similar to how it would in adults. If the BBB is not
yet fully functional, then IL-6 may be able to gain access
via free diffusion or some other process that is not present
in the mature BBB. Tagging of peripheral IL-6, as has been
done with leptin (53, 54), may be one approach to resolv-
ing this important question.
To address the underlying causes of ARC NPY neurite
growth defects, we examined multiple axon growth reg-
ulators. We observed that Netrin-1 was expressed both in
the ARC (origin) and PVN (target) of the ARC NPY neu-
rites as well as along their pathway between the two. Thus,
Netrin-1 appears to be in the right anatomical locations to
act as an extracellular factor that modulates the growth
and navigation of NPY neurites from the ARC to the PVN.
Further supporting a role for Netrin-1 signaling break-
down in maternal obesity, we observed changes in the 2
main Netrin-1 receptors, Dcc and Unc5d. The finding in
vivo that Dcc was up-regulated and that Unc5d was
down-regulated by maternal obesity may at first glance
seem counterintuitive because they are both receptors for
Netrin-1. In areas of the brain where neurite growth and
navigation are better characterized, Dcc typically regu-
lates attractive responses of neurites to Netrin-1, whereas
Unc5d typically regulates repellant responses to Netrin-1
(41, 55). In these systems, the balance of attraction and
repulsion changes over time, such that neurites may be
attracted into a novel territory or repelled (or pushed
away) from their existing location into new territory or a
combination of the two (56). The changes we observe are
consistent with a model in which ARC NPY neurites are
normally repelled away from the ARC, where we have
detected Netrin-1 expression, to head toward their target
areas, such as the PVN. In fetuses developing in obese
mothers, however, this repulsive force may not occur be-
cause of overexpression of Dcc, which mediates attraction
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(55), and underexpression of Unc5d, which mediates re-
pulsion (41). Consequently, NPY neurites may have a re-
duced ability to leave the ARC, which retards their ability
to reach the PVN. Once out of the ARC, NPY neurites
would be attracted normally along the path to the PVN
and into the PVN itself even in situations of maternal obe-
sity. However, there is the possibility that additional
changes to Netrin-1 signaling also occur to further derail
NPY innervation of the PVN. Further work is required in
this area to dissect out the role of Netrin-1 signaling in
NPY neurons along their entire course of growth and nav-
igation to their eventual target brain areas.
Having established that fetal ARC circuitry and gene
expression were disrupted as a result of maternal obesity,
we sought to link these changes with increases in circu-
lating IL-6 associated with obesity during pregnancy (19).
We found first that both maternal and fetal plasma had
elevated levels of IL-6 in obesity compared with those of
normal-weight control pregnancies at GD17.5. To our
knowledge, this is the first report of elevated IL-6 in the
fetal circulation at this age, and it supports the supposition
that fetal cytokine levels are related to maternal levels (18).
Moreover, these observations are consistent with previous
findings of IL-6 elevation in the maternal circulation in
pregnancies complicated by obesity (18, 48, 57), raising
two outstanding questions for future exploration: first,
whether the IL-6 that is present in the fetal circulation
originates from the mother, placenta, or fetus; and second,
whether IL-6 has a role in the normal development of ARC
NPY projections. Similar to other maternal programming
models, such as maternal immune activation models of
autism and schizophrenia, IL-6 has been identified as a key
player in the disruption of neural development. However,
in none of these studies has a normal role for IL-6 been
identified (see for example, Ref. 22). Genetic manipula-
tion of IL-6 production in both normal and obese preg-
nancies would be one further way to test for answers to
both of these outstanding questions and may give addi-
tional insight into methods to reduce fetal exposure to
inflammation in obese pregnancies.
The exposure of fetal ARC to IL-6 in vitro led to sub-
stantially reduced neurite growth and changes to the ex-
pression of Dcc, both observations mirroring the changes
seen in vivo in fetuses from obese mothers and supporting
the notion that fetal exposure to increased levels of IL-6 in
obese pregnancies is responsible for the ARC-PVN cir-
cuitry changes we see in neonates from obese mothers.
These results are consistent with previous studies, which
have shown that injected IL-6 during pregnancy has the
ability to increase offspring obesity risk and to derail neu-
ral development (20, 22). Although our data support the
idea that IL-6 exposure in vivo can alter neurite growth,
the observation that IL-6 in vitro is not able to modulate
Unc5d expression suggests that IL-6 is not the only factor
operating in vivo to negatively affect ARC NPY neurite
growth. Thus, although Unc5d expression is modulated in
vivo by maternal obesity, this appears to be the conse-
quence of factors other than IL-6, which is in many ways
not surprising because it is likely that increases in a number
of cytokines, fatty acids, and other signaling molecules are
responsible for the full body weight phenotype seen in the
offspring of obese mothers. Which of these is responsible
for altering Und5d expression and how this is accom-
plished remain questions for further investigation. Injec-
tion of IL-6 into pregnant dams followed by investigation
of NPY neurite growth and innervation of the PVN may
be one strategy to address these questions. However, be-
cause ARC NPY neurite growth proceeds over a pro-
tractedperiod, itmaybe technicallydifficult to supply IL-6
at the right time/place to have such a specific effect in vivo.
One caveat to our in vitro studies is that the concentrations
of IL-6 were larger than those identified in the maternal or
fetal circulation. Although we saw an effect of 1 ng/mL
IL-6, the growth of ARC neurites and circulation levels of
IL-6 are 1 to 1.5 orders of magnitude lower. It is not un-
usual for factors to be present in vitro at concentrations
larger than those in vivo for many reasons, including the
fact that cells in culture may down-regulate receptor ex-
pression or signal transduction or that cofactors may not
be present. For explants of brain tissue placed in 3-dimen-
sional collagen gel, the environment within the explant is
more like the in vivo environment than the environment
outside the explant. Thus, the cells/neurites may be influ-
enced more strongly by near neighbors and factors present
in the explant than they would be in vivo, which may help
explain why cells in culture require elevated concentra-
tions compared with those in vivo.
We performed a bioinformatic analysis on the pro-
moter of Dcc to gain better insight into whether it could be
regulated directly by IL-6. Although our findings support
this role, there are many ways that Dcc expression could
be regulated, and so functional promoter dissection stud-
ies are essential to substantiate this interesting finding.
Given that ARC NPY neurons express functional IL-6 re-
ceptors, at least in adult animals (58), it is likely that IL-6
signaling actually does take place in NPY neurons them-
selves. However, further studies should define the bio-
chemical pathways that IL-6 signals through in ARC NPY
neurons to clarify whether shared biochemical cascades
control gene expression and neurite growth.
In summary, we have observed that maternal obesity
reduces NPY ARC-PVN projections during that fetal pe-
riod and alters the expression of two key receptors for
Netrin-1, a signaling pathway that is probably involved in
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the development of these projections. Altered expression
of the receptor Dcc seen in vivo is mirrored in vitro by
treating the fetal ARC with the proinflammatory cytokine
IL-6. These observations support a model whereby the
exposure of the developing fetal brain to novel maternal
factors, such as elevated cytokines, associated with obesity
is likely to derail normal development of NPY neuronal
circuits that control body weight and energy homeostasis.
The impaired ability of ARC neurons to establish connec-
tivity in the fetal period represents an adaptive response of
the developing brain to the adverse environment of ma-
ternal obesity. Such an adaptation may increase offspring
obesity risk through the formation of circuitry that does
not function optimally later in life. However, because
NPY neurons are orexigenic, it may be difficult see how
reducing their innervation of the PVN would result di-
rectly in elevated body weight. The developing brain is
able to adjust aspects of the developmental process in ac-
cordance with factors present in its environment. This has
been hypothesized to allow the developing fetus to be re-
sponsive to signals of its outside world imparted to it via
its mother’s physiology (59–61). When these changes are
maladaptive, disease risk results. However, not all devel-
opmental changes must necessarily be maladaptive. Thus,
one interpretation of our findings is that the fetal brain is
receiving signals of an environment that is rich in caloric
supply and adapting to this by reducing orexigenic drive
via fewer NPY projections to the PVN. It may be that other
cell types involved in body weight homeostasis attempt
also to adapt to the mother’s obesity, but there are a vast
number of ways in which this could happen. This might
include changes in the expression of genes (eg, via pro-
moter methylation) encoding a variety of body weight reg-
ulating neuropeptides, their processing enzymes or recep-
tors, altered innervation of the PVN by
proopiomelanocortin nerve fibers, changes to the forma-
tion and/or maintenance of synapses in the body weight
control neuronal network. How the sum of these changes,
which appear to occur in an attempt to adapt, turns out to
be maladaptive is a tantalizing question that remains for
further exploration.
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